Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
36032269	s-testovl	pmol/l (pmol/l)	8246	14277	0.08%
36032269	s-testosteroni,vapaa,laskettu	pmol/l (pmol/l)	2395	3203	0.00%
36032269	s-testovl	— (—)	1311	2057	100.00%	Distribution not available
36032269	s-testo-vl	pmol/l (pmol/l)	911	1584	0.00%
36032269	testosteroni,vapaalaskettu	pmol/l (pmol/l)	304	532	0.00%
36032269	s-testo-vl	— (—)	223	381	100.00%	Distribution not available
36032269	s-testovl	pmol/l____ (pmol/l)	124	183	0.00%
36032269	s-testosteroni,vapaa,laskettu	— (—)	92	109	100.00%	Distribution not available
36032269	s-testosteronivapaalaskettu	pmol/l (pmol/l)	77	102	0.00%
36032269	testosteroni,vapaalaskettu	— (—)	69	102	100.00%	Distribution not available
36032269	s-testosteroni,vapaa,laskettu,seerumista	pmol/l____ (pmol/l)	23	29	0.00%	Distribution not available
36032269	s-testosteroni,vapaalaskettu	pmol/l (pmol/l)	23	26	0.00%
36032269	testosteroni,vapaa,laskettu	pmol/l (pmol/l)	21	26	0.00%
36032269	s-testosteroni,vapaa,laskettu	pmol/l____ (pmol/l)	19	23	0.00%
36032269	s-testo,vapaa,laskettu	pmol/l (pmol/l)	13	16	0.00%	Distribution not available
36032269	testosteroni,vapaalaskettu	pmol/l____ (pmol/l)	12	17	0.00%
36032269	s-testosteroni,vapaalaskettu(ko)	pmol/l (pmol/l)	11	13	0.00%
36032269	s-testostoni,vapaa,laskettu	pmol/l (pmol/l)	11	16	0.00%	Distribution not available
36032269	testosteroni,vapaa,laskettu,seerumista	pmol/l (pmol/l)	7	10	0.00%	Distribution not available
36032269	testosteroni,vapaa,laskettu,seerumista	— (—)	5	6	100.00%	Distribution not available	Distribution not available
36032269	testosteroni,vapaa,laskettu	— (—)	5	5	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Exclusions for E4_PCOS_CONSORTIUM

1533

3171

3.09

308.25

3.1

1.7

168.42

184.42

pmol/l

4.76

1474

3017

Sleep apnoea, including avohilmo

2769

7240

2.37

307.65

2.2

1.8

196.83

208.35

pmol/l

5.82

2636

6904

Hypogonadotropic hypogonadism

802

880

23.17

307.65

3.8

1.9

181.78

224.00

pmol/l

14.42

785

843

Sleep apnoea

2760

7338

2.44

307.65

2.2

1.8

193.95

210.79

pmol/l

12.96

2626

7009

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1365

2804

5.20

307.65

3.2

1.8

180.74

198.38

pmol/l

6.08

1306

2673

Testicular hypofunction

884

959

21.13

307.65

3.6

1.6

213.89

225.74

pmol/l

1.52

872

913

Disorders of other endocrine glands

2390

3968

6.45

307.65

3.1

1.6

180.83

200.61

pmol/l

10.30

2315

3779

Exclusions for E4_PCOS_BROAD

1296

1937

7.73

307.65

3.3

1.8

176.07

207.68

pmol/l

14.58

1255

1837

Hypopituitarism

1045

1170

12.79

307.65

3.6

1.6

183.78

221.35

pmol/l

14.39

1009

1112

Testicular dysfunction

986

1075

20.49

307.65

3.5

1.6

214.48

225.19

pmol/l

1.41

973

1023

Sleep disorders (combined)

2747

6530

2.24

280.72

2.1

1.7

195.82

203.59

pmol/l

2.72

2609

6230

Other antidepressants

2838

6875

2.15

260.91

2.1

1.8

199.01

203.94

pmol/l

1.48

2682

6586

Depression or dysthymia

1885

4182

2.53

251.46

2.2

1.7

202.12

203.06

pmol/l

0.12

1771

4015

Polycystic ovarian syndrome

189

112

18.07

230.58

1.4

1.2

22.63

18.34

pmol/l

1.07

177

Ovarian dysfunction

199

148

14.16

214.48

1.4

1.2

23.58

17.55

pmol/l

2.27

185

132

Selective serotonin reuptake inhibitors

2643

6881

2.04

212.28

2.1

1.8

197.70

203.99

pmol/l

1.95

2495

6590

Polycystic ovarian syndrome, broad definition

232

230

10.49

207.39

1.3

1.2

20.68

16.72

pmol/l

2.27

217

206

Polycystic ovarian syndrome, consortium definition

445

448

5.74

189.19

1.3

19.64

17.60

pmol/l

0.90

415

406

Recurrent or chronic depression

1198

3221

2.66

188.82

2.2

1.7

200.49

205.00

pmol/l

0.61

1119

3118

Benign neoplasm: Pituitary gland, craniopharyngeal duct

310

517

6.83

182.28

3.3

1.9

169.20

207.54

pmol/l

6.32

295

489

Endocrine, nutritional and metabolic diseases

2237

5623

2.05

181.34

2.3

1.5

188.18

217.04

pmol/l

22.77

2137

5411

Behavioural syndromes associated with physiological disturbances and physical factors

2458

8808

1.93

179.64

2.2

1.8

202.18

201.71

pmol/l

0.07

2347

8420

Episodal and paroxysmal disorders

2492

6862

1.87

157.17

2.1

1.7

190.65

206.26

pmol/l

9.29

2377

6548

Sleep disorders

2300

8616

1.87

155.45

2.1

1.8

202.70

201.82

pmol/l

0.13

2192

8246

Insomnia

2212

8590

1.82

137.89

2.1

1.9

203.04

201.02

pmol/l

0.35

2109

8233

Female infertility, associated with anovulation

134

111

12.45

134.91

1.2

1.4

20.18

22.33

pmol/l

0.30

125

Depression medications

1046

2193

2.47

129.94

2.2

1.6

200.85

216.73

pmol/l

3.64

993

2142

Medical observation and evaluation for suspected diseases and conditions

1765

4690

1.96

127.63

2.2

1.8

200.54

207.52

pmol/l

1.70

1695

4497

Codeine

2216

6747

1.80

126.49

2.1

1.8

195.83

201.17

pmol/l

1.28

2097

6478

Used for control exclusion in common control thyroid runs

2655

7994

1.70

121.71

2.3

1.7

193.10

205.86

pmol/l

7.09

2534

7632

Tramadol

1854

6096

1.86

119.61

2.2

1.8

198.49

204.33

pmol/l

1.27

1728

5852

Mood disorders, excluding more controls

2258

7695

1.75

119.26

2.2

1.8

193.49

204.64

pmol/l

4.32

2120

7377

Benign neoplasm of other and unspecified endocrine glands

405

1191

3.58

115.04

3.0

1.8

172.58

204.19

pmol/l

7.28

384

1125

Mood [affective] disorders

2410

9278

1.69

113.71

2.2

1.8

193.02

203.81

pmol/l

4.34

2264

8889

Codeine or tramadol medication

2544

8349

1.68

113.40

2.1

1.8

196.23

200.73

pmol/l

1.13

2414

7986

Mood disorders

2411

9280

1.69

113.05

2.2

1.8

192.98

203.81

pmol/l

4.38

2265

8891

Irregular menses

281

440

4.83

113.04

1.2

1.3

17.78

17.52

pmol/l

0.07

265

398

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1377

6934

1.96

113.00

2.1

1.9

208.82

202.89

pmol/l

1.31

1302

6634

Opioids

2270

6865

1.73

112.20

2.1

1.8

199.35

201.38

pmol/l

0.32

2155

6589

Diseases of male genital organs

2360

7086

1.73

112.00

2.1

1.9

216.47

216.49

pmol/l

0.00

2274

6801

Impotence

366

1051

3.93

111.26

2.5

1.9

215.88

211.15

pmol/l

0.30

351

997

Amenorrhoea

106

12.84

108.85

1.2

19.14

21.77

pmol/l

0.37

101

Hypothyroidism (congenital or acquired)

843

1975

2.46

107.48

2.5

1.6

192.49

212.53

pmol/l

4.87

806

1927

Hypothyroidism and >3 levothyroxin purchases

836

1963

2.46

106.36

2.5

1.6

192.57

212.58

pmol/l

4.79

799

1915

Hypothyroidism, levothyroxine purchases

836

1963

2.46

106.36

2.5

1.6

192.57

212.58

pmol/l

4.79

799

1915

Neurological diseases

1911

5491

1.77

101.69

2.1

1.7

195.72

207.58

pmol/l

4.07

1826

5259

Depression

2239

9128

1.66

100.94

2.2

1.8

192.82

204.24

pmol/l

4.45

2107

8756

Coxibs

645

1265

2.74

100.00

2.2

1.6

208.96

202.78

pmol/l

0.60

613

1202

Female infertility

194

181

6.49

94.15

1.2

1.3

18.26

21.55

pmol/l

0.93

184

159

Hyperprolactinaemia

131

177

8.03

92.79

3.3

1.5

153.53

196.83

pmol/l

2.46

126

163

Any death

283

6307

0.31

91.87

1.8

1.9

178.16

203.72

pmol/l

4.71

263

5972

Use of hypnotics and sedatives

2390

8634

1.60

90.23

2.1

1.9

201.02

201.77

pmol/l

0.12

2256

8245

Hyperfunction of pituitary gland

170

313

5.82

89.02

3.2

1.6

158.41

204.73

pmol/l

4.44

164

294

Exposure to other specified factors

1891

9958

1.65

87.22

2.1

1.9

205.79

199.54

pmol/l

1.55

1796

9508

Other dorsopathies, not elsewhere classified

2277

7426

1.61

86.50

2.1

1.8

198.64

201.22

pmol/l

0.49

2161

7106

General examination and investigation of persons without complaint and reported diagnosis

1564

4690

1.76

81.72

2.1

1.8

197.52

207.52

pmol/l

2.62

1478

4497

Oxicams

473

977

2.81

79.25

2.2

1.7

195.76

198.59

pmol/l

0.19

446

927

Anxiety disorders, excluding more controls

1874

7414

1.64

78.96

2.2

1.8

198.53

205.25

pmol/l

1.63

1779

7126

Genitourinary diseases

1949

6056

1.65

78.61

2.1

1.9

206.26

215.93

pmol/l

3.88

1862

5824

Dorsalgia

2184

7398

1.58

77.33

2.0

1.8

196.50

200.87

pmol/l

1.00

2067

7078

Anxiety (asthma-related co-morbidities)

1497

6787

1.70

75.67

2.2

1.8

194.42

205.93

pmol/l

3.10

1421

6546

Neurological diseases, wide definition

772

1799

2.20

75.25

2.2

1.6

199.55

217.60

pmol/l

3.44

743

1743

Abnormalities of breathing

1976

7147

1.60

74.59

2.2

1.8

195.81

201.63

pmol/l

1.57

1873

6846

Dislocation, sprain and strain of joints and ligaments of knee

1549

8556

1.66

73.58

2.0

1.9

205.06

202.27

pmol/l

0.50

1488

8189

Neurotic, stress-related and somatoform disorders

2014

8966

1.57

71.90

2.2

1.9

196.19

203.76

pmol/l

2.10

1914

8591

Anxiety disorders

2024

9000

1.56

71.26

2.2

1.9

196.34

203.72

pmol/l

2.02

1924

8622

Other diseases of upper respiratory tract

2209

7527

1.54

70.43

2.0

1.8

199.79

198.71

pmol/l

0.18

2084

7189

Pain in throat and chest

1883

7102

1.59

69.41

2.1

1.8

199.23

203.06

pmol/l

0.75

1797

6806

Other intervertebral disc disorders

1784

6714

1.60

68.56

2.1

1.8

198.94

202.75

pmol/l

0.78

1682

6422

Soft tissue disorders

2234

7543

1.53

68.54

2.1

1.8

197.90

202.12

pmol/l

0.89

2108

7238

Deviated nasal septum

1005

5596

1.84

68.49

2.0

1.9

210.59

207.64

pmol/l

0.41

948

5352

Obesity related asthma

791

4094

1.97

67.49

2.3

1.9

180.95

201.59

pmol/l

6.76

746

3901

Dorsopathies

2222

7445

1.53

66.88

2.1

1.8

201.41

201.35

pmol/l

0.01

2113

7125

Female infertility, cervical, vaginal, other or unspecified origin

147

164

5.78

66.64

1.2

1.3

15.91

21.01

pmol/l

1.64

137

144

All anxiety disorders

1514

7306

1.63

65.33

2.2

1.9

192.79

204.53

pmol/l

3.23

1438

7031

Acute upper respiratory infections of multiple and unspecified sites

1580

7224

1.61

64.96

2.0

1.8

200.97

199.09

pmol/l

0.26

1502

6896

Nonorganic sleeping disorders, excluding more controls

515

2307

2.29

64.72

2.5

1.7

196.81

200.75

pmol/l

0.33

489

2227

Psychiatric diseases

2042

6703

1.54

64.12

2.1

1.8

195.87

204.56

pmol/l

2.92

1918

6433

Acetic acid derivatives and related substances

546

1212

2.37

63.99

2.1

1.6

212.03

200.93

pmol/l

1.17

521

1150

Shoulder lesions

1613

6062

1.61

63.83

2.1

1.9

203.35

204.26

pmol/l

0.12

1520

5807

Lumbar disc prolapse

1416

6461

1.65

62.87

2.1

1.8

199.11

203.93

pmol/l

0.92

1335

6180

Exposure to unspecified factor

2140

9814

1.50

62.44

1.9

203.38

199.28

pmol/l

0.92

2025

9368

Panhypopituitarism

115

210

6.39

62.32

3.7

1.9

189.50

222.06

pmol/l

1.43

103

198

Mouth breathing

1078

6304

1.75

61.77

2.2

1.9

203.30

205.57

pmol/l

0.32

1023

6016

Parasetamol

1832

6013

1.56

60.36

2.1

1.8

203.06

207.97

pmol/l

0.93

1739

5777

Obesity and other hyperalimentation

1274

7367

1.65

59.13

2.2

1.9

153.50

199.18

pmol/l

39.88

1189

7037

Obesity

1268

7339

1.65

59.00

2.2

1.9

153.71

199.11

pmol/l

39.35

1183

7010

Other nutritional deficiencies

1332

7666

1.61

55.74

2.2

1.9

155.03

199.58

pmol/l

39.17

1245

7317

Other joint disorders

1975

6947

1.50

54.80

2.1

1.8

198.00

200.58

pmol/l

0.48

1858

6673

Symptoms and signs involving the circulatory and respiratory systems

2108

7209

1.48

54.62

2.1

1.8

199.49

201.94

pmol/l

0.41

2013

6907

Obesity due to excess calories

942

5490

1.74

54.45

2.3

1.8

154.89

197.24

pmol/l

25.75

882

5248

Benign neoplasms

2294

8705

1.45

54.22

2.1

1.8

196.78

202.18

pmol/l

1.54

2173

8342

Injuries to the shoulder and upper arm

1865

9783

1.49

53.55

2.0

1.9

207.54

204.02

pmol/l

0.73

1777

9340

Other special examinations and investigations of persons without complaint or reported diagnosis

1458

4691

1.59

52.88

2.2

1.8

202.04

207.52

pmol/l

1.01

1389

4497

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2056

9106

1.46

52.64

2.0

1.9

202.95

199.79

pmol/l

0.65

1947

8684

Injuries to the wrist and hand

2063

9486

1.46

51.99

2.0

1.9

202.97

198.83

pmol/l

0.88

1956

9046

Hyperkinetic disorders, excluding more controls

390

1586

2.37

51.95

2.3

1.7

195.31

203.85

pmol/l

0.58

378

1537

Sexual dysfunction

137

341

4.67

51.72

2.5

1.9

196.89

217.65

pmol/l

1.31

132

326

Pain (limb, back, neck, head abdominally)

1614

5288

1.55

51.46

2.0

1.8

203.63

207.96

pmol/l

0.77

1526

5078

Transport accidents

1041

5256

1.67

50.29

2.0

1.8

202.86

199.10

pmol/l

0.50

987

5034

Hypertrophy of breast in women and men

240

853

2.86

48.97

2.3

1.8

167.43

177.81

pmol/l

0.70

222

803

Other anxiety disorders

1079

5685

1.64

48.33

2.1

1.8

186.31

203.34

pmol/l

4.10

1027

5481

Nonorganic sleeping disorders

515

2586

2.04

48.28

2.5

1.9

196.81

196.87

pmol/l

0.00

489

2475

Rotator cuff syndrome

1234

5387

1.60

48.17

2.0

1.9

202.08

205.52

pmol/l

0.57

1169

5149

Other soft tissue disorders, not elsewhere classified

1891

7409

1.47

48.06

2.1

1.8

188.80

200.96

pmol/l

4.76

1772

7107

Pain in joint

1322

5211

1.58

48.00

2.2

1.8

198.42

207.17

pmol/l

2.26

1251

5007

Diseases of the musculoskeletal system and connective tissue

1217

3804

1.62

47.69

2.0

1.7

204.63

203.16

pmol/l

0.15

1160

3675

Chronic rhinitis, nasopharyngitis and pharyngitis

624

3352

1.89

47.54

2.2

1.8

206.22

197.46

pmol/l

1.10

579

3214

Other headache syndromes

622

3326

1.89

47.29

2.2

1.8

185.76

195.77

pmol/l

1.42

600

3166

Other specific joint derangements/joint disorders

1615

6781

1.50

46.87

2.2

1.8

199.12

199.46

pmol/l

0.04

1526

6517

Oter anti-inflammatory and antirheumatic agents, non-steroids

336

739

2.54

46.60

2.0

1.7

201.58

201.38

pmol/l

0.01

315

694

Propionic acid derivatives

531

1297

2.09

46.34

1.9

1.6

210.71

203.59

pmol/l

0.57

503

1234

L02BG Aromatase inhibitors

117

266

4.37

46.22

3.1

1.6

203.34

130.26

pmol/l

3.82

112

243

Inflammatory diseases of prostate (prostatitis)

475

2381

2.08

45.68

2.1

1.8

210.47

206.62

pmol/l

0.45

457

2258

Benzodiazepine use

2004

9584

1.42

45.12

2.2

1.8

194.36

199.98

pmol/l

1.39

1875

9161

Antihypertensive medication - note that there are other indications

1385

4727

1.55

44.93

2.0

1.8

188.54

207.56

pmol/l

6.32

1324

4571

Other diseases of intestines

2223

8897

1.40

44.66

2.0

1.9

197.04

201.39

pmol/l

1.07

2105

8521

Chronic sinusitis

788

4629

1.72

44.11

2.1

1.9

203.19

199.28

pmol/l

0.48

751

4425

Obesity, other/unspecified

609

3340

1.85

43.48

2.0

1.8

144.33

194.66

pmol/l

24.43

561

3196

Arthropathies

1953

6952

1.43

43.12

2.1

1.8

200.73

200.64

pmol/l

0.01

1852

6678

Intracranial trauma

1143

4930

1.58

43.10

2.0

1.7

202.43

208.50

pmol/l

0.89

1085

4735

Low back pain

1544

7101

1.48

42.99

2.1

1.8

192.84

199.15

pmol/l

1.42

1453

6793

Noninflammatory disorders of female genital tract

162

211

3.87

42.96

1.2

1.3

17.97

21.49

pmol/l

1.11

151

187

Spondylopathies

1507

6013

1.50

42.96

2.1

1.8

202.14

204.33

pmol/l

0.32

1408

5741

Hyperplasia of prostate

1164

4200

1.60

42.67

2.0

1.9

208.49

204.42

pmol/l

0.77

1109

3990

General symptoms and signs

2235

8108

1.39

41.99

2.1

1.8

195.93

204.07

pmol/l

2.52

2132

7753

Lower back pain or/and sciatica

2121

9556

1.39

41.26

2.0

1.9

193.79

199.70

pmol/l

1.67

1997

9127

Anti-inflammatory and antirheumatic products, non-steroids

514

1297

2.02

41.22

2.0

1.6

209.85

203.59

pmol/l

0.56

490

1234

Medicines for HER+ breast cancer

145

393

3.46

40.63

3.1

1.7

210.14

133.49

pmol/l

5.28

137

358

Persons encountering health services for examination and investigation

1397

4691

1.51

40.08

2.0

1.8

206.64

207.52

pmol/l

0.09

1322

4497

Special screening examination for infectious and parasitic diseases

773

3358

1.71

39.69

1.9

1.8

221.87

210.03

pmol/l

2.01

739

3247

Acute sinusitis

1071

6319

1.56

39.64

2.1

1.9

197.38

198.55

pmol/l

0.13

1020

6058

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

947

2925

1.65

39.25

2.1

1.7

204.75

213.00

pmol/l

1.32

905

2830

Mycoses, including avohilmo

1845

10097

1.40

39.11

2.0

1.9

197.74

200.56

pmol/l

0.54

1758

9626

Abdominal and pelvic pain

2207

8109

1.38

39.06

2.0

1.9

201.87

204.59

pmol/l

0.57

2101

7742

Artrosis, including avohilmo

1761

6828

1.43

38.50

2.1

1.9

203.41

205.18

pmol/l

0.27

1674

6530

Non-selective monoamine reuptake inhibitors

503

2613

1.87

37.10

2.2

1.7

188.21

202.26

pmol/l

2.34

466

2497

Any mental disorder

2105

7719

1.38

37.02

2.1

1.8

194.96

204.46

pmol/l

3.36

1981

7398

Disturbance of activity and attention

376

1818

2.08

36.77

2.3

1.8

196.01

198.18

pmol/l

0.11

365

1747

Paracetamol or NSAID medication

354

811

2.24

36.64

2.0

1.6

216.85

212.40

pmol/l

0.25

339

773

Disease of hard tissues of teeth, NOS

1069

3615

1.57

36.59

2.0

1.8

202.85

209.07

pmol/l

0.92

1001

3487

Intestinal infectious diseases, including avohilmo, including avohilmo

2180

8984

1.36

36.57

2.0

1.9

200.94

199.83

pmol/l

0.18

2058

8562

Continuous positive airway pressure

479

2132

1.91

36.46

2.1

1.7

201.41

220.11

pmol/l

3.78

444

2065

Examination and observation for other reasons

1235

4667

1.51

36.36

2.0

1.8

190.54

207.25

pmol/l

6.04

1181

4474

Male infertility

313

1490

2.29

36.12

2.7

1.9

219.90

223.25

pmol/l

0.21

301

1439

Irritable bowel syndrome

433

2267

1.94

35.81

2.2

1.8

196.12

190.71

pmol/l

0.43

412

2164

Concussion

973

4880

1.56

35.65

2.1

1.7

201.60

208.76

pmol/l

0.98

922

4686

Acute upper respiratory infections

1780

7688

1.40

35.63

2.0

1.8

196.38

197.88

pmol/l

0.22

1686

7312

Arthrosis

1455

5538

1.45

35.43

2.2

1.8

205.77

204.69

pmol/l

0.14

1371

5312

Persons encountering health services in other circumstances, wide

2323

8948

1.34

35.40

2.1

1.9

195.02

204.30

pmol/l

3.80

2187

8568

Hernia

1836

8888

1.38

35.21

2.0

1.9

210.71

204.91

pmol/l

1.52

1757

8483

Sciatica+with lumbago

973

5617

1.55

35.19

2.0

1.8

193.12

200.58

pmol/l

1.18

913

5369

Generalized anxiety disorder

361

1791

2.06

34.97

2.2

1.7

184.87

187.43

pmol/l

0.17

345

1719

Monoamine oxidase A inhibitors

221

904

2.51

34.47

2.1

1.8

205.99

208.65

pmol/l

0.13

207

868

Myalgia

395

2036

1.97

34.29

2.1

1.8

180.56

191.11

pmol/l

1.22

370

1948

Restless leg syndrome

250

1090

2.34

33.76

2.2

1.9

198.75

199.92

pmol/l

0.05

238

1026

Abnormalities of heart beat

560

3130

1.75

33.65

2.1

1.8

194.39

195.26

pmol/l

0.07

524

2985

Hyperkinetic disorders

390

1970

1.98

33.63

2.3

1.8

195.31

197.66

pmol/l

0.12

378

1895

Spondylosis

949

4841

1.55

33.49

2.2

1.8

198.80

203.88

pmol/l

0.78

879

4606

Injuries to the knee and lower leg

2232

9102

1.33

32.81

1.9

197.65

199.93

pmol/l

0.44

2121

8675

Chronic diseases of tonsils and adenoids

1553

7021

1.41

32.63

2.0

1.8

201.66

200.09

pmol/l

0.23

1475

6730

Symptoms and signs involving the digestive system and abdomen

2154

8109

1.34

32.25

2.1

1.9

202.94

204.59

pmol/l

0.28

2058

7742

Polyuria

436

2389

1.86

31.58

2.1

1.9

196.64

202.22

pmol/l

0.55

401

2241

Neoplasms

1883

7328

1.36

31.08

2.1

1.8

199.75

204.49

pmol/l

1.06

1807

7044

Disorders of skin appendages

949

6319

1.51

30.97

1.9

168.63

201.17

pmol/l

14.40

900

6043

Injury of muscle and tendon at shoulder and upper arm level

841

5514

1.55

30.67

2.1

1.9

206.78

204.20

pmol/l

0.27

801

5241

Migraine

694

3356

1.62

30.20

2.0

1.7

167.90

192.84

pmol/l

6.64

663

3201

Other enthesopathies

502

2912

1.75

29.78

2.1

1.9

193.60

202.62

pmol/l

1.35

480

2798

Hyperhidrosis

219

4.06

29.64

1.9

1.7

188.39

203.29

pmol/l

0.40

207

Persistent mood disorders

351

1831

1.95

29.61

2.2

1.9

178.88

204.53

pmol/l

4.39

330

1760

Internal derangement of knee

771

4941

1.56

29.53

2.2

1.8

201.59

202.82

pmol/l

0.12

724

4744

Statin medication

1394

5603

1.41

29.47

2.1

1.9

193.51

211.66

pmol/l

7.57

1336

5394

First line medication for Crohn's disease

2214

9118

1.31

29.42

2.1

1.9

198.26

201.29

pmol/l

0.65

2106

8701

Diseases of the skin and subcutaneous tissue

1969

7426

1.34

29.39

2.0

1.9

196.23

205.67

pmol/l

3.07

1872

7089

Visual disturbances

779

5059

1.56

29.34

2.1

1.9

191.74

196.34

pmol/l

0.62

745

4809

Other sleep disorders

243

1113

2.24

29.33

2.4

1.8

193.84

212.52

pmol/l

1.98

229

1049

ILD medications

2241

9268

1.31

29.28

2.0

1.9

199.89

200.74

pmol/l

0.14

2131

8842

Intestinal infectious diseases

1800

10036

1.34

29.22

2.0

1.9

200.13

199.99

pmol/l

0.02

1706

9571

Other disorders of penis

371

1995

1.93

29.21

2.0

1.8

209.91

212.17

pmol/l

0.18

357

1898

Gastro-oesophageal reflux disease

1250

7486

1.42

29.15

2.0

1.9

198.13

201.31

pmol/l

0.51

1191

7131

Other arthrosis

1012

4599

1.49

29.13

2.1

1.8

201.66

205.94

pmol/l

0.61

951

4399

Impingement syndrome of shoulder

438

2465

1.81

29.06

2.0

1.8

204.07

204.78

pmol/l

0.05

404

2350

Visual disturbances and blindness

819

5408

1.53

28.40

2.1

1.9

190.94

196.83

pmol/l

0.92

782

5137

Dermatophytosis, including avohilmo

1384

9879

1.39

28.38

2.0

1.9

202.56

203.25

pmol/l

0.09

1316

9428

Cardiovascular diseases

1388

5282

1.41

28.35

2.0

1.8

198.77

204.71

pmol/l

0.99

1330

5090

Other disorders of male genital organs

207

915

2.43

28.33

1.9

218.16

221.30

pmol/l

0.18

198

874

Bronchitis

1948

8874

1.32

27.94

2.0

1.9

200.45

197.90

pmol/l

0.46

1853

8444

Excessive, frequent and irregular menstruation

128

211

3.25

27.61

1.2

1.3

16.73

21.49

pmol/l

1.87

120

187

Diseases of the eye and adnexa

1806

6786

1.34

27.54

2.0

1.9

200.27

202.63

pmol/l

0.37

1729

6505

Nerve, nerve root and plexus disorders

1988

9118

1.32

27.47

2.1

1.9

193.41

201.47

pmol/l

2.59

1868

8708

Cervicalgia

337

1779

1.92

27.40

2.1

1.8

197.17

199.95

pmol/l

0.17

322

1695

Vasomotor and allergic rhinitis

697

4393

1.57

27.07

2.1

1.8

201.71

197.53

pmol/l

0.51

673

4223

Cervical disc disorders

630

3981

1.60

26.90

2.2

1.9

194.64

204.31

pmol/l

1.67

592

3785

Personality disorders, excluding more controls

563

3471

1.64

26.50

2.2

1.8

181.05

202.52

pmol/l

3.46

532

3360

Diarrhoea and gastroenteritis of presumed infectious origin

1406

9261

1.37

26.26

2.0

1.9

200.91

200.22

pmol/l

0.08

1333

8851

ILD medications: prednisolone, methylprednisolone, prednisone

2113

9087

1.30

26.19

2.0

1.9

198.74

200.29

pmol/l

0.27

2008

8668

Other extrapyramidal and movement disorders in other diseases

375

2078

1.83

26.18

2.3

1.9

189.07

199.35

pmol/l

1.04

357

1947

Asthma, excluding more controls

1452

5453

1.38

26.08

2.1

1.8

193.14

202.41

pmol/l

2.74

1379

5243

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

542

2901

1.66

25.74

2.3

1.8

192.99

197.18

pmol/l

0.29

523

2791

Factors influencing health status and contact with health services

809

2672

1.54

25.64

2.0

1.8

214.13

217.33

pmol/l

0.32

771

2573

Meniscus derangement

1088

5089

1.43

25.63

2.1

1.8

200.14

206.56

pmol/l

1.46

1027

4879

Other and unspecified tonsillitis

989

5748

1.45

25.56

2.0

1.9

207.19

202.22

pmol/l

0.69

942

5550

Asthma

1477

5607

1.37

25.55

2.1

1.8

193.56

202.08

pmol/l

2.36

1403

5387

Diseases of the ear and mastoid process

2227

8701

1.29

25.53

2.0

1.9

198.25

201.19

pmol/l

0.62

2123

8318

Spinal stenosis

747

3622

1.53

25.32

2.0

1.8

199.98

201.28

pmol/l

0.11

687

3423

Benign neoplasm of colon, rectum, anus and anal canal

972

5739

1.44

24.94

2.0

1.9

191.37

200.93

pmol/l

2.21

893

5426

Pain in thoracic spine

274

1396

2.00

24.87

2.0

1.9

192.68

202.05

pmol/l

0.84

259

1335

GASTRO-related operations

1574

5897

1.35

24.66

2.0

1.8

197.77

203.21

pmol/l

1.05

1501

5666

Any gastric operation

1574

5897

1.35

24.66

2.0

1.8

197.77

203.21

pmol/l

1.05

1501

5666

Gonarthrosis

1144

4603

1.42

24.63

2.2

1.8

199.62

204.51

pmol/l

0.84

1069

4395

Asthma (mode)

1451

5646

1.36

24.23

2.1

1.8

194.02

201.84

pmol/l

2.02

1380

5424

Viral hepatitis, IBD co-morbidity

173

751

2.39

24.07

2.5

1.7

182.65

228.04

pmol/l

5.69

165

729

Disorders of lacrimal system

530

3242

1.62

24.03

2.2

1.9

202.90

189.47

pmol/l

2.03

504

3067

Other pulmonary diagnosis

1520

5682

1.35

24.00

2.1

1.8

203.15

202.33

pmol/l

0.10

1448

5457

Pain, not elsewhere classified

488

2983

1.66

23.94

2.2

1.8

182.33

198.75

pmol/l

3.07

460

2837

Enthesopathies of lower limb, excluding foot

411

2405

1.73

23.86

2.1

1.8

206.31

201.77

pmol/l

0.39

391

2301

Other disorders of lacrimal gland

449

2687

1.69

23.82

2.2

1.9

202.14

191.10

pmol/l

1.25

424

2544

Haemorrhoids and perianal venous thrombosis

528

3272

1.62

23.72

2.0

1.8

199.89

199.86

pmol/l

0.00

495

3095

Bipolar affective disorders

395

2307

1.74

23.21

2.3

1.8

178.78

201.29

pmol/l

4.22

371

2228

Headache

1240

7050

1.37

23.13

2.1

1.8

186.04

202.50

pmol/l

5.07

1178

6737

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2137

8946

1.28

22.85

2.1

1.9

193.07

204.34

pmol/l

5.34

2018

8566

Injuries to the head

2066

9640

1.28

22.83

1.9

203.18

199.06

pmol/l

0.89

1955

9196

Migraine with aura

300

1617

1.87

22.83

1.9

1.7

168.67

173.55

pmol/l

0.30

290

1532

Metabolic disorders

1799

8348

1.30

22.76

2.1

1.9

192.33

206.52

pmol/l

6.71

1691

7995

Symptoms and signs involving the urinary system

1360

7671

1.35

22.76

2.0

1.9

191.62

203.36

pmol/l

4.23

1277

7309

Somatoform disorder

264

1389

1.93

21.86

2.1

1.8

180.65

199.82

pmol/l

2.02

250

1324

Excluding asthma or asthma-COPD overlap

1501

5682

1.33

21.83

2.1

1.8

202.67

202.33

pmol/l

0.04

1428

5457

Cardiovascular diseases (excluding rheumatic etc)

1390

5967

1.34

21.82

2.1

1.8

195.99

207.09

pmol/l

2.83

1323

5764

Temporomandibular joint disorders, including avohilmo

597

3781

1.54

21.78

2.0

1.8

184.29

179.37

pmol/l

0.42

563

3600

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

793

5258

1.45

21.77

2.1

1.9

197.84

195.65

pmol/l

0.23

762

5038

Certain infectious and parasitic diseases, including avohilmo

1285

4763

1.36

21.49

2.0

1.8

203.26

202.45

pmol/l

0.09

1216

4547

Allergic conjunctivitis

826

5565

1.44

21.33

2.1

1.9

197.51

195.93

pmol/l

0.16

795

5326

Use of pramipexole

297

1636

1.84

21.26

2.2

1.9

193.31

203.69

pmol/l

0.87

286

1537

ILD differential diagnosis

1487

5646

1.33

21.20

2.1

1.8

202.50

201.84

pmol/l

0.08

1418

5424

Hypertension, essential

1570

6802

1.31

21.18

2.1

1.9

189.96

212.02

pmol/l

12.80

1489

6544

Other/unspecified dorsalgia

577

3728

1.54

21.15

2.1

1.8

195.53

196.74

pmol/l

0.10

541

3564

Cardiac arrhythmias

1186

5624

1.36

20.89

2.2

1.8

203.94

209.78

pmol/l

1.12

1135

5427

COPD differential diagnosis

1485

5652

1.33

20.84

2.1

1.8

202.67

201.78

pmol/l

0.11

1416

5430

Medical treatment for female infertility

114

428

2.66

20.75

1.3

16.20

17.74

pmol/l

0.47

103

393

Voice disturbances

322

1834

1.77

20.56

1.8

1.9

176.97

193.17

pmol/l

2.02

298

1722

Hypertensive diseases (excluding secondary)

1165

5007

1.37

20.45

2.1

1.9

191.08

213.98

pmol/l

9.61

1111

4846

Panic disorder

300

1681

1.82

20.43

2.2

1.8

180.58

193.48

pmol/l

1.23

282

1616

Tinnitus

410

2503

1.66

20.40

2.0

1.9

203.51

203.44

pmol/l

0.00

388

2366

Diseases of oesophagus, stomach and duodenum

1952

9133

1.27

20.33

2.0

1.9

199.86

200.74

pmol/l

0.13

1855

8712

Other diseases of hard tissues of teeth

978

3629

1.41

20.14

2.1

1.8

206.69

208.80

pmol/l

0.20

919

3498

Infections with a predominantly sexual mode of transmission, including avohilmo

760

4859

1.44

19.90

2.0

1.9

207.48

194.20

pmol/l

1.96

718

4672

Pain and other conditions associated with female genital organs and menstrual cycle

208

3.23

19.86

1.1

1.3

16.49

21.41

pmol/l

1.74

185

Benign neoplasm: Colon

786

5189

1.43

19.83

2.0

1.9

187.97

200.41

pmol/l

2.96

720

4889

Mental and behavioural disorders due to opioids

167

784

2.26

19.75

2.8

2.0

179.54

225.37

pmol/l

3.30

160

753

Artificial joint operation, meniscal resection

1655

8268

1.29

19.74

2.0

1.9

201.77

206.07

pmol/l

1.09

1560

7887

Symptoms and signs involving the nervous and musculoskeletal systems

873

6277

1.40

19.56

2.2

1.9

189.58

196.21

pmol/l

0.98

820

5946

Malaise and fatigue

819

4568

1.42

19.35

2.2

1.8

193.50

199.05

pmol/l

0.78

769

4327

Pain in limb

1438

7024

1.31

19.35

2.0

1.8

186.21

199.22

pmol/l

4.55

1346

6733

Disorders of adult personality and behaviour

615

4177

1.49

19.12

2.2

1.9

184.58

196.82

pmol/l

1.47

582

4014

Subjective visual disturbances

373

2267

1.66

18.86

2.0

1.9

192.07

198.51

pmol/l

0.58

355

2146

Other reaction to severe stress, and adjustment disorders

662

4568

1.46

18.76

2.0

1.9

193.04

199.81

pmol/l

0.80

628

4408

Hypothyroidism, other/unspecified

1269

6339

1.32

18.65

2.3

1.8

177.44

190.61

pmol/l

3.63

1189

6011

Osteoporosis

213

1008

1.96

18.44

2.0

1.9

179.33

198.43

pmol/l

2.02

203

949

Finngen Rheumatological endpoints

1861

8431

1.26

18.22

2.1

1.9

200.31

200.29

pmol/l

0.00

1753

8079

Redundant prepuce, phimosis and paraphimosis

789

5591

1.42

18.22

2.1

1.9

212.58

219.61

pmol/l

1.25

760

5374

Deforming dorsopathies

404

2525

1.62

18.21

2.2

1.8

198.98

196.91

pmol/l

0.13

380

2413

Disturbances of skin sensation

456

2936

1.57

18.18

2.0

1.9

191.69

193.51

pmol/l

0.14

441

2798

Allergic asthma (mode)

415

2549

1.61

18.17

2.0

1.8

198.17

197.89

pmol/l

0.02

400

2457

Gastrointestinal diseases

1135

4250

1.35

17.97

2.0

1.8

202.29

199.97

pmol/l

0.25

1087

4075

Hypothyreosis and Thyroxine purchase for inclusion criteria

1275

6386

1.31

17.90

2.3

1.8

177.55

190.14

pmol/l

3.38

1195

6048

Allergic asthma (mode), excluding more controls

415

2566

1.60

17.67

2.0

1.8

198.17

197.51

pmol/l

0.04

400

2474

Spondylolisthesis/Spondylolysis

274

1561

1.78

17.65

2.3

1.8

200.33

205.09

pmol/l

0.24

257

1489

Dental pulpitis, including avohilmo

1855

9539

1.25

17.65

2.0

1.9

193.03

202.14

pmol/l

2.99

1748

9142

Substance abuse, excluding more controls

1188

7585

1.32

17.62

2.1

1.8

196.82

207.13

pmol/l

2.22

1095

7275

Psychotic depression

105

418

2.57

17.61

2.0

1.7

188.25

202.46

pmol/l

0.59

406

Migraine without aura

237

1294

1.85

17.49

2.0

1.7

160.00

172.21

pmol/l

0.75

224

1230

Symptoms and signs involving speech and voice

399

2512

1.60

17.47

1.8

1.9

182.48

194.63

pmol/l

1.06

369

2352

Inflammatory bowel disease treatment related agents

2130

9614

1.23

17.42

2.0

1.9

198.35

200.71

pmol/l

0.46

2027

9170

Phobic anxiety disorders

303

1782

1.73

17.40

2.2

1.8

191.49

200.33

pmol/l

0.73

288

1716

Hypertension

1569

6966

1.28

17.32

2.1

1.9

191.19

211.90

pmol/l

11.22

1493

6707

Hypertensive diseases

1569

6970

1.28

17.27

2.1

1.9

191.19

211.97

pmol/l

11.30

1493

6711

Postprocedural endocrine and metabolic disorders, not elsewhere classified

152

716

2.15

17.20

2.4

1.8

173.89

199.47

pmol/l

1.91

143

678

787

5655

1.39

17.04

2.2

1.9

195.48

200.58

pmol/l

0.67

745

5420

Dentofacial anomalies [including malocclusion]

1233

7439

1.30

16.86

2.0

1.9

194.37

200.76

pmol/l

1.17

1173

7127

Cervicobrachial syndrome

320

1927

1.68

16.84

2.3

1.8

185.29

198.91

pmol/l

1.38

304

1840

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

100

2242

0.43

16.70

2.0

1.9

151.29

199.08

pmol/l

4.89

2109

Extrapyramidal and movement disorders

505

3389

1.50

16.59

2.1

1.9

188.59

198.20

pmol/l

1.31

481

3175

Personality disorders

563

3869

1.47

16.57

2.2

1.9

181.05

196.91

pmol/l

2.10

532

3724

Other functional intestinal disorders

597

3749

1.46

16.57

2.1

1.8

188.22

194.22

pmol/l

0.55

566

3556

Asthma, including avohilmo

2167

9782

1.23

16.51

2.1

1.9

196.84

200.85

pmol/l

0.97

2059

9329

Diaphragmatic hernia

449

2952

1.53

16.28

2.0

1.8

196.17

198.66

pmol/l

0.19

420

2772

Diseases of appendix

1411

9977

1.27

16.10

2.0

1.9

202.62

201.13

pmol/l

0.23

1341

9519

Appendicitis, broad definition

1404

9965

1.27

16.01

2.0

1.9

202.61

201.14

pmol/l

0.23

1335

9507

Lateral epicondylitis

244

1393

1.78

15.75

2.2

1.9

194.68

205.50

pmol/l

1.10

234

1339

Specific personality disorders

469

3146

1.51

15.63

2.2

1.9

178.43

194.57

pmol/l

1.75

444

3017

Other metabolic disorders

165

832

2.01

15.60

2.3

1.8

177.75

198.64

pmol/l

1.50

155

791

Other and unspecified polyneuropathies, also in other diseases

331

2055

1.63

15.58

1.9

173.90

203.18

pmol/l

7.44

310

1930

Schizophrenia

157

2998

0.51

15.49

1.7

2.0

181.27

215.47

pmol/l

4.36

147

2880

Diseases of oral cavity, salivary glands and jaws

946

3631

1.35

15.43

2.0

1.8

203.60

208.77

pmol/l

0.61

883

3499

Orchitis and epididymitis

284

1709

1.71

15.41

2.0

1.9

211.50

212.73

pmol/l

0.07

273

1617

Gonarthrosis [arthrosis of knee](FG)

1298

5835

1.29

15.34

2.2

1.9

198.35

205.03

pmol/l

1.50

1215

5561

Disorders of lipoprotein metabolism and other lipidaemias

1546

7514

1.26

15.25

2.1

1.9

193.38

209.37

pmol/l

7.93

1460

7188

Social phobias

214

1191

1.84

15.16

2.3

1.8

199.37

204.43

pmol/l

0.28

201

1151

Cervicocranial syndrome

146

713

2.08

15.12

2.3

1.8

178.19

198.69

pmol/l

1.67

140

678

Disorders of the thyroid gland

1446

7456

1.26

15.06

2.3

1.8

180.90

193.50

pmol/l

3.93

1349

7082

Dental operations

1041

4061

1.33

15.04

2.0

1.8

200.65

208.75

pmol/l

1.53

973

3911

Symptoms and signs involving the skin and subcutaneous tissue

1105

8083

1.30

15.00

2.0

1.9

191.25

196.51

pmol/l

0.94

1046

7683

Other external causes of accidental injury

1353

5322

1.28

14.97

1.9

1.8

202.52

198.37

pmol/l

0.59

1286

5093

Other inflammation of eyelid, including avohilmo

717

5231

1.38

14.93

2.0

1.9

206.53

192.89

pmol/l

2.56

692

5002

Other shoulder lesions

176

926

1.94

14.83

1.9

1.8

190.75

208.07

pmol/l

1.26

160

888

Acute appendicitis

1334

9833

1.27

14.83

2.0

1.9

202.38

201.51

pmol/l

0.12

1267

9387

Diseases of the respiratory system

1002

3793

1.33

14.80

2.1

1.8

200.50

198.52

pmol/l

0.22

947

3626

Other heart diseases, wide

1758

8657

1.24

14.74

2.1

1.9

201.67

203.65

pmol/l

0.33

1673

8300

Infections with a predominantly sexual mode of transmission

522

3608

1.46

14.71

1.9

204.60

192.53

pmol/l

1.42

489

3465

Polyneuropathies and other disorders of the peripheral nervous system

372

2407

1.57

14.70

1.9

180.02

202.46

pmol/l

4.81

349

2264

Dysplasia of cervi uteri

153

3.04

14.32

1.2

1.3

18.22

20.83

pmol/l

0.47

136

Accidents

1345

5322

1.27

14.21

1.9

1.8

202.34

198.37

pmol/l

0.54

1279

5093

Anogenital herpesviral [herpes simplex] infection, including avohilmo

194

1068

1.85

14.19

2.0

1.9

188.96

181.23

pmol/l

0.34

181

1018

Diverticular disease of intestine

1118

5405

1.29

14.08

2.0

1.9

193.48

203.97

pmol/l

3.38

1037

5142

Fall on same level

2130

9450

1.21

13.94

2.0

1.9

198.75

200.70

pmol/l

0.35

2025

9022

Type 2 diabetes

1738

8221

1.23

13.92

2.0

1.9

170.03

207.99

pmol/l

37.91

1631

7885

Gingivitis and periodontal diseases

1744

7349

1.23

13.88

1.9

194.93

205.43

pmol/l

3.79

1644

7051

Emergency coronary revascularization (for ACS)

1484

7209

1.25

13.86

2.0

1.9

200.03

208.16

pmol/l

2.29

1413

6861

Cough

544

3577

1.43

13.78

2.1

1.8

188.64

197.18

pmol/l

1.11

522

3406

Umbilical hernia

620

4492

1.40

13.73

2.2

1.9

194.80

202.97

pmol/l

1.22

587

4265

1777

7374

1.23

13.62

2.0

1.8

196.59

197.63

pmol/l

0.14

1682

7013

Other and unspecified nerve root and plexus disorders, also in other diseases

405

2716

1.51

13.61

2.2

1.9

202.42

204.69

pmol/l

0.15

382

2600

Fissure and fistula of anal and rectal regions

439

2992

1.48

13.57

2.1

1.8

197.35

203.33

pmol/l

0.61

412

2852

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

627

4558

1.39

13.56

2.2

1.9

169.55

209.71

pmol/l

21.77

587

4358

Glucagon-like peptide-1 (GLP-1) analogues

627

4558

1.39

13.56

2.2

1.9

169.55

209.71

pmol/l

21.77

587

4358

Asthma (only as main-diagnosis), excluding more controls

1249

5453

1.27

13.52

2.1

1.8

197.44

202.41

pmol/l

0.89

1189

5243

Asthma-related infections

945

7105

1.30

13.43

2.2

1.9

193.83

200.65

pmol/l

1.18

890

6780

Asthma, hospital admission 2, infections

945

7105

1.30

13.43

2.2

1.9

193.83

200.65

pmol/l

1.18

890

6780

Autoimmune diseases

2153

9135

1.20

13.36

2.0

1.9

196.09

202.73

pmol/l

2.05

2047

8720

Pure hypercholesterolaemia

1354

6886

1.26

13.32

2.0

1.9

194.66

208.93

pmol/l

5.67

1276

6578

Certain infectious and parasitic diseases

1704

6979

1.23

13.25

1.9

1.8

195.16

201.45

pmol/l

1.45

1618

6660

Acromegaly and pituitary gigantism

5.15

13.19

3.4

1.6

176.45

248.39

pmol/l

2.27

Malignant neoplasm of bronchus and lung, including Hilmo

1485

0.43

12.89

1.6

1.8

183.61

198.56

pmol/l

0.77

1382

Coronary revascularization (ANGIO or CABG)

1417

6951

1.25

12.88

2.1

1.9

201.08

208.57

pmol/l

1.92

1352

6628

Percutaneous Coronary Intervention

1414

6945

1.25

12.85

2.1

1.9

199.56

208.54

pmol/l

2.84

1348

6622

Type 2 diabetes, strict (exclude DM1)

1643

7835

1.23

12.84

2.0

1.9

168.03

207.39

pmol/l

38.90

1546

7509

Achilles tendinitis

197

1125

1.78

12.84

2.2

1.8

200.26

207.47

pmol/l

0.48

191

1073

Dislocation, sprain and strain of joints and ligaments at neck level

303

1934

1.59

12.83

2.2

1.9

201.29

199.68

pmol/l

0.10

286

1846

Candidiasis, including avohilmo

360

2381

1.52

12.82

2.1

1.9

180.11

184.63

pmol/l

0.31

343

2259

Sleep disorders, other/unspecified

347

2.47

12.77

2.7

1.8

222.77

209.62

pmol/l

0.39

330

Heart failure, strict

485

4765

0.70

12.77

2.0

1.9

184.32

202.18

pmol/l

2.87

453

4471

Soft tissue disorders related to use, overuse and pressure

405

2749

1.49

12.76

2.1

1.8

193.81

204.06

pmol/l

1.26

382

2635

Disorders of refraction and accommodation

478

3336

1.44

12.75

1.9

199.11

195.25

pmol/l

0.32

461

3193

Atherosclerosis, excluding cerebral and coronary sclerosis

238

3044

0.61

12.73

1.8

171.63

196.93

pmol/l

4.19

212

2820

Type 2 diabetes, definitions combined

1637

7812

1.22

12.71

2.0

1.9

168.06

207.36

pmol/l

38.53

1539

7489

All-cause Heart Failure

470

4639

0.70

12.65

2.0

1.9

182.81

201.96

pmol/l

3.11

438

4351

Diseases of external ear

574

4162

1.39

12.57

2.0

1.9

194.28

199.70

pmol/l

0.59

533

3952

Sequelae of injuries, of poisoning and of other consequences of external causes

512

3649

1.42

12.55

2.0

204.86

206.81

pmol/l

0.14

485

3505

Polyp of the female genital tract

3.44

12.51

1.3

18.78

19.83

pmol/l

0.06

Other diseases of blood and blood-forming organs

138

712

1.99

12.49

2.5

2.0

202.44

207.64

pmol/l

0.22

131

676

Other and unspecified dermatitis

742

5597

1.33

12.48

2.1

1.9

193.79

195.66

pmol/l

0.17

704

5304

Stroke, including SAH

544

5388

0.72

12.43

1.9

198.92

202.65

pmol/l

0.29

498

5087

Triptan medication for migraine, min. 3 purchases

725

4054

1.34

12.36

2.0

1.9

172.66

183.60

pmol/l

1.85

696

3871

Malignant neoplasm of digestive organs

286

3392

0.64

12.35

1.7

1.9

197.89

202.68

pmol/l

0.36

271

3202

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

107

1778

0.49

12.35

1.7

1.9

193.72

198.73

pmol/l

0.20

102

1660

Type 2 diabetes, definitions combined, including avohilmo

1641

7807

1.22

12.34

2.0

1.9

167.88

207.84

pmol/l

40.02

1542

7487

Asthma (only as main-diagnosis)

1254

5607

1.26

12.26

2.1

1.8

197.08

202.08

pmol/l

0.91

1194

5387

Acne, including avohilmo

415

2297

1.48

12.25

2.1

1.8

174.55

194.55

pmol/l

2.08

396

2203

Allergic rhinitis

538

3829

1.40

12.20

2.2

1.9

199.50

197.90

pmol/l

0.13

525

3662

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

677

5071

1.35

12.16

2.1

1.9

206.75

208.69

pmol/l

0.20

646

4859

Diabetes mellitus

1810

8695

1.21

12.16

2.0

1.9

172.27

208.17

pmol/l

34.85

1703

8339

Infections of the skin and subcutaneous tissue

1222

9698

1.25

12.11

2.1

1.9

191.58

205.01

pmol/l

4.36

1174

9263

Nasal polyp

367

2477

1.50

12.03

1.8

1.9

198.30

202.88

pmol/l

0.44

350

2362

Diabetes, varying definitions

1801

8693

1.21

12.02

2.0

1.9

172.82

208.20

pmol/l

33.83

1696

8336

Other disorders of patella

295

1900

1.57

12.00

2.1

1.8

200.31

200.36

pmol/l

0.00

277

1830

Other symptoms and signs involving the nervous and musculoskeletal systems

599

4410

1.37

11.91

2.2

1.9

187.89

195.91

pmol/l

1.13

571

4192

Haemorrhage from respiratory passages

518

3289

1.40

11.88

2.0

1.8

196.36

204.20

pmol/l

0.85

487

3116

Mental and behavioural disorders due to sedatives or hypnotics

192

1120

1.76

11.84

2.4

2.0

187.93

218.09

pmol/l

2.89

179

1075

COPD, early/later onset

323

4057

0.66

11.83

2.1

1.8

189.56

198.09

pmol/l

0.70

289

3794

Disorders of thyroid, IBD co-morbidities

226

920

1.70

11.83

2.0

1.6

185.46

198.09

pmol/l

0.90

203

885

Symptoms and signs concerning food and fluid intake

156

851

1.85

11.74

2.5

1.9

200.76

200.55

pmol/l

0.01

147

804

Any reimbursement code in KELA

1231

4944

1.26

11.70

2.0

1.7

192.68

211.00

pmol/l

6.30

1181

4778

Influenza and pneumonia

1892

9797

1.20

11.68

2.0

1.9

196.20

201.16

pmol/l

1.14

1792

9367

Disorders of ocular muscles, binocular movement, accommodation and refraction

785

5976

1.31

11.66

1.8

1.9

195.37

196.67

pmol/l

0.12

751

5702

Heart failure,strict

468

4567

0.71

11.63

2.0

1.9

185.51

204.55

pmol/l

3.08

439

4305

Vocal cord dysfunction

205

1068

1.71

11.47

2.0

1.7

192.92

212.67

pmol/l

1.94

189

1026

COPD, hospital admissions

320

4013

0.67

11.44

2.1

1.8

189.57

198.08

pmol/l

0.69

286

3751

Other heart diseases

997

5115

1.28

11.33

2.1

1.9

204.94

213.45

pmol/l

1.71

944

4948

Anomalies of dental arch relationship, including avohilmo

334

2018

1.51

11.32

2.1

1.9

189.75

194.27

pmol/l

0.31

320

1924

Other (not insulin) diabetes medications

1659

8096

1.21

11.28

2.1

1.9

166.37

206.68

pmol/l

42.49

1551

7756

Hernia of abdominal wall, postoperative

330

2193

1.51

11.25

2.2

1.8

184.48

206.45

pmol/l

4.17

319

2090

Asthma and allergy

219

1318

1.66

11.18

2.0

1.8

204.73

195.96

pmol/l

0.59

210

1276

Post-traumatic stress disorder

130

682

1.93

11.15

2.2

1.7

160.25

173.29

pmol/l

0.58

125

653

Excessive attrition of teeth

1055

8368

1.25

11.10

2.0

1.9

192.39

198.40

pmol/l

1.09

995

7998

Asthma and allergy, excluding more controls

219

1322

1.65

11.07

2.0

1.8

204.73

195.53

pmol/l

0.63

210

1279

Stroke, excluding SAH

504

4983

0.73

11.05

1.9

195.61

202.44

pmol/l

0.90

456

4705

Persons encountering health services in other circumstances

665

4978

1.33

11.05

2.1

1.8

198.83

199.22

pmol/l

0.03

619

4760

Viral warts, including avohilmo

414

2908

1.44

11.04

2.1

1.9

206.37

200.50

pmol/l

0.42

399

2785

Dermatitis

929

7176

1.27

11.04

2.1

1.9

193.47

196.96

pmol/l

0.44

882

6802

Fenamates

152

559

1.87

11.03

1.8

1.6

187.87

180.53

pmol/l

0.29

143

528

Caries of enamel

1775

9756

1.20

10.99

2.0

1.9

198.61

202.70

pmol/l

0.84

1692

9317

Other enthesopathy of foot (+metatarsalgia)

125

651

1.94

10.94

1.9

1.8

194.60

201.88

pmol/l

0.36

119

622

Hallux rigidus

153

850

1.82

10.93

2.0

1.7

187.84

201.48

pmol/l

1.21

148

804

Diabetes medication

1814

8909

1.19

10.91

2.0

1.9

170.64

207.27

pmol/l

37.23

1697

8541

Dysphagia

323

2170

1.50

10.79

2.1

1.8

194.66

202.11

pmol/l

0.65

304

2046

Other and unspecified disorders of vitreous body

425

2943

1.42

10.67

1.9

1.8

194.94

195.76

pmol/l

0.06

392

2765

Benign neoplasm: Sigmoid colon

271

1761

1.56

10.65

1.8

1.9

191.31

200.91

pmol/l

0.73

248

1657

Peripheral artery disease

295

3477

0.67

10.65

1.8

173.92

199.13

pmol/l

4.73

264

3238

Benign neoplasm: Rectum

256

1643

1.58

10.64

1.9

189.97

201.83

pmol/l

1.18

233

1548

Metatarsalgia

113

575

1.99

10.59

1.9

1.8

193.44

201.11

pmol/l

0.37

107

549

Conjunctivitis (acute, non atopic), including avohilmo

1832

9342

1.19

10.57

2.0

1.9

200.60

201.77

pmol/l

0.18

1748

8908

Postprocedural disorders of nervous system

114

584

1.99

10.55

1.9

190.70

199.33

pmol/l

0.33

109

549

Other chronic obstructive pulmonary disease, including avohilmo

452

5121

0.72

10.53

2.1

1.9

193.96

199.21

pmol/l

0.49

411

4821

Emotionally unstable personality disorder

209

1283

1.65

10.49

2.2

1.9

157.58

187.03

pmol/l

1.87

197

1222

Malignant neoplasm of digestive organs, including Hilmo

347

3684

0.69

10.49

1.8

1.9

199.26

203.81

pmol/l

0.38

331

3483

Persons with potential health hazards related to communicable diseases

689

5244

1.31

10.35

2.0

1.9

200.61

196.80

pmol/l

0.37

659

5031

Diseases of salivary glands

456

3292

1.40

10.35

2.0

1.9

195.10

197.43

pmol/l

0.19

429

3139

Seborrhoeic keratosis

281

1851

1.53

10.33

2.0

1.9

212.42

197.23

pmol/l

1.11

265

1731

Small fibre neuropathy

300

2.42

10.33

2.0

1.9

172.28

206.87

pmol/l

1.89

282

Implicit viral Sepsis, including avohilmo

434

3101

1.41

10.33

2.1

1.9

184.98

200.34

pmol/l

2.33

408

2931

COPD, hospital admissions 1, only main diagnosis

202

2781

0.62

10.27

2.2

1.9

192.84

196.69

pmol/l

0.18

177

2585

Abnormal findings on examination of blood, without diagnosis

833

5930

1.28

10.25

1.9

192.73

200.26

pmol/l

1.21

790

5593

Other/unspecified enthesopathies of lower limb, excluding foot

119

625

1.94

10.25

1.7

1.8

223.31

207.45

pmol/l

0.73

113

595

Early lumbar disc prolapse, operated

275

1816

1.54

10.23

2.1

1.9

197.44

208.96

pmol/l

0.78

264

1757

Osteopathies and chondropathies

799

5715

1.28

10.20

2.1

1.9

188.64

200.24

pmol/l

2.80

763

5443

Biguanides

1599

8083

1.20

10.19

2.1

1.9

167.09

206.55

pmol/l

38.89

1496

7737

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1561

10187

1.20

10.18

2.0

1.9

200.36

199.58

pmol/l

0.10

1504

9691

Benign neoplasm: Rectum, anus and anal canal

276

1821

1.53

10.13

1.9

191.73

201.83

pmol/l

0.98

252

1707

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

809

6240

1.28

9.99

2.0

1.9

189.39

195.78

pmol/l

0.84

759

5896

COPD, hospital admissions 3, with asthma pneumonia sepsis

143

2121

0.57

9.97

2.1

1.8

191.18

198.51

pmol/l

0.31

122

1966

Disorders of sclera, cornea, iris and ciliary body

950

7630

1.25

9.94

2.1

1.9

196.94

203.53

pmol/l

1.35

919

7279

Other medical care

354

4225

0.70

9.93

2.0

1.9

184.10

199.66

pmol/l

2.29

339

3957

Contact with and exposure to communicable diseases

542

4033

1.35

9.90

2.0

1.9

197.15

192.91

pmol/l

0.35

522

3858

Other chronic obstructive pulmonary disease

321

3798

0.69

9.88

2.1

1.9

189.91

198.83

pmol/l

0.74

287

3553

Uterine polyps

3.33

9.78

1.2

1.3

21.72

16.59

pmol/l

0.31

COPD, hospital admission 2, with asthma infections

207

2801

0.63

9.72

2.0

1.9

190.12

197.68

pmol/l

0.43

180

2614

Migraine without aura and triptan purchases

175

1046

1.69

9.70

2.1

1.8

160.06

164.71

pmol/l

0.19

166

987

Benign neoplasm: Ascending colon

190

1163

1.65

9.67

2.0

1.9

186.90

200.82

pmol/l

1.23

174

1093

Abnormal involuntary movements

207

1295

1.62

9.66

2.2

1.9

195.92

205.22

pmol/l

0.40

189

1221

External causes of morbidity and mortality

1030

4146

1.25

9.65

2.0

1.8

203.04

197.69

pmol/l

0.68

974

3964

Blepharochalasis

239

1543

1.56

9.64

1.9

1.8

207.14

193.03

pmol/l

1.19

215

1444

Abnormal serum enzyme levels

596

4378

1.33

9.63

1.9

194.57

200.42

pmol/l

0.63

561

4098

Diseases of middle ear and mastoid

1083

7214

1.23

9.56

2.0

1.9

200.73

200.36

pmol/l

0.03

1033

6907

Pain associated with micturition

149

857

1.76

9.55

2.0

1.9

198.92

203.08

pmol/l

0.20

143

802

Any dementia

126

1548

0.56

9.50

1.6

1.8

166.83

191.51

pmol/l

2.82

113

1420

Complications of medical and surgical care

1021

7447

1.24

9.49

2.0

1.9

188.76

196.11

pmol/l

1.29

958

7057

COPD

346

3978

0.70

9.47

2.1

1.9

189.73

199.25

pmol/l

0.81

309

3725

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

357

2516

1.43

9.42

2.0

1.9

210.46

192.31

pmol/l

1.67

334

2420

Carpal tunnel syndrome

846

5835

1.26

9.36

2.2

1.9

188.98

199.18

pmol/l

2.22

790

5562

Cerebrovascular diseases

742

6526

0.78

9.30

1.9

197.41

202.11

pmol/l

0.53

693

6182

Herpesviral [herpes simplex] infections, including avohilmo

327

2272

1.45

9.28

2.1

1.9

202.00

187.66

pmol/l

1.33

317

2166

Other disorders of eyelid

416

2839

1.39

9.25

1.9

1.8

199.85

191.74

pmol/l

0.82

381

2655

Colonic or urogenital fistula

449

3302

1.37

9.21

2.1

1.9

196.26

202.42

pmol/l

0.65

421

3136

Ischemic heart diseases

1438

7171

1.20

9.20

2.1

1.9

201.69

208.54

pmol/l

1.72

1374

6840

Adhesive capsulitis of shoulder

213

1357

1.58

9.19

2.0

1.8

208.58

203.90

pmol/l

0.22

199

1297

Injuries to the neck

432

3161

1.38

9.17

2.1

1.9

199.55

199.51

pmol/l

0.00

403

3023

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

740

5812

1.28

9.16

2.0

1.9

188.07

195.42

pmol/l

1.13

694

5490

Conjunctivitis

1192

7932

1.21

9.15

2.1

1.9

197.74

199.88

pmol/l

0.28

1141

7594

Actinic keratosis

325

2051

1.45

9.12

1.9

1.8

187.02

191.66

pmol/l

0.42

298

1887

Melanocytic naevi

435

3189

1.37

9.06

1.8

1.9

193.39

192.23

pmol/l

0.08

414

3031

Other viral diseases, including avohilmo

724

5644

1.28

9.05

2.0

1.9

199.87

200.15

pmol/l

0.02

698

5424

Injuries to the ankle and foot

1350

9664

1.20

9.04

1.9

194.44

201.85

pmol/l

1.73

1300

9239

Lung cancer and mesothelioma

1327

0.49

8.97

1.6

1.8

183.77

195.46

pmol/l

0.56

1235

Skin changes due to chronic exposure to nonionizing radiation

335

2123

1.44

8.96

1.9

1.8

187.55

191.71

pmol/l

0.37

307

1952

Heart failure and bmi 25plus

308

2942

0.69

8.95

2.0

180.34

198.48

pmol/l

2.32

287

2762

Disorders of synovium and tendon

829

5615

1.26

8.94

2.1

1.8

196.67

199.13

pmol/l

0.25

784

5379

Anogenital herpesviral [herpes simplex] infection

110

591

1.89

8.92

1.9

209.07

189.30

pmol/l

0.90

102

558

Organic, including symptomatic, mental disorders

333

3310

0.70

8.92

1.9

181.32

198.72

pmol/l

3.08

294

3086

Disorders of vitreous body and globe

580

4196

1.31

8.92

2.0

1.9

193.40

198.10

pmol/l

0.52

537

3947

Substance use, excluding alcohol

480

3591

1.35

8.91

2.3

1.9

189.71

212.71

pmol/l

3.82

443

3460

Disorders of vitreous body

561

4065

1.32

8.91

1.9

193.11

198.34

pmol/l

0.59

519

3820

Hernia of abdominal wall

806

6445

1.26

8.87

2.2

1.9

193.75

202.59

pmol/l

1.74

765

6117

Infections, IBD-co-morbidities

229

1039

1.56

8.83

2.0

1.7

193.18

219.26

pmol/l

3.65

220

1004

Major coronary heart disease event

1431

7197

1.19

8.81

2.1

1.9

201.29

208.45

pmol/l

1.80

1365

6857

Falls/tendency to fall

1910

8224

1.17

8.71

2.0

1.9

197.20

200.86

pmol/l

0.72

1820

7866

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1353

6621

1.20

8.67

2.0

1.8

193.23

198.91

pmol/l

1.02

1289

6307

1353

6621

1.20

8.67

2.0

1.8

193.23

198.91

pmol/l

1.02

1289

6307

Gonarthrosis,primary

1301

6552

1.20

8.62

2.1

1.9

195.21

202.66

pmol/l

1.87

1220

6216

Acne

217

1408

1.55

8.53

2.2

1.9

174.47

198.28

pmol/l

1.85

209

1354

Other symptoms and signs involving cognitive functions and awareness

622

4283

1.29

8.50

2.0

1.9

195.69

199.25

pmol/l

0.29

583

4045

COPD/asthma/ILD related infections

1560

6621

1.18

8.50

2.0

1.8

193.20

198.91

pmol/l

1.15

1488

6307

COPD/asthma related infections

1560

6621

1.18

8.50

2.0

1.8

193.20

198.91

pmol/l

1.15

1488

6307

Other and unspecified mood [affective] disorders

138

807

1.74

8.47

2.1

1.9

178.19

202.42

pmol/l

1.73

129

778

Acute appendicitis, no complications

1068

8786

1.21

8.44

2.0

1.9

201.64

202.80

pmol/l

0.15

1011

8404

Non-allergic asthma (mode)

246

1636

1.50

8.37

2.2

1.8

193.81

196.66

pmol/l

0.17

235

1551

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1146

8695

1.21

8.34

2.1

1.9

198.33

200.93

pmol/l

0.32

1091

8329

Ischaemic Stroke, excluding all haemorrhages

464

4529

0.75

8.33

1.9

198.06

201.47

pmol/l

0.34

423

4260

Non-allergic asthma (mode), excluding more controls

246

1638

1.50

8.33

2.2

1.8

193.81

196.61

pmol/l

0.17

235

1555

Spermatocele

182

1154

1.61

8.23

2.0

1.8

215.54

208.95

pmol/l

0.42

173

1082

Chronic lower respiratory diseases

2120

9730

1.15

8.11

2.1

1.9

195.20

201.31

pmol/l

1.88

2011

9287

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1701

0.54

8.10

1.8

1.9

196.77

200.49

pmol/l

0.12

1604

Triptan medication for migraine, single purchase ok

1295

7381

1.19

8.10

2.1

1.9

188.61

203.92

pmol/l

6.03

1254

7080

Migraine, single triptan purchase ok & required. ICD-code if available is included

1295

7381

1.19

8.10

2.1

1.9

188.61

203.92

pmol/l

6.03

1254

7080

Oral corticosteroids

1819

9209

1.16

8.05

2.0

1.9

196.59

200.30

pmol/l

0.78

1726

8786

Seborrhoeic dermatitis

193

1245

1.57

8.05

2.1

1.9

192.36

209.55

pmol/l

1.59

187

1172

Disorders of vestibular function (Vertigo)

502

3725

1.32

8.05

2.0

1.9

189.32

196.84

pmol/l

1.05

471

3517

Presbyopia

144

865

1.69

8.04

2.0

217.18

203.88

pmol/l

0.91

135

824

Other disorders of ear

1457

8003

1.18

8.01

2.0

1.9

195.82

201.96

pmol/l

1.54

1392

7617

Poisoning by drugs, medicaments and biological substances

450

3390

1.34

7.97

2.2

1.9

178.28

201.07

pmol/l

2.72

423

3256

Other follicular disorders

155

952

1.66

7.96

2.1

1.9

175.08

208.26

pmol/l

3.55

149

900

Constipation

1276

7274

1.19

7.95

2.1

1.9

190.59

198.27

pmol/l

1.70

1189

6912

Other viral diseases, not elsewhere classified, including avohilmo

474

3574

1.33

7.94

2.0

1.9

198.00

198.69

pmol/l

0.04

459

3426

Other symptoms and signs involving the urinary system

183

1171

1.59

7.90

2.0

1.9

188.34

208.37

pmol/l

1.65

175

1104

Benign paroxysmal vertigo

284

1985

1.44

7.87

2.0

1.9

191.94

198.29

pmol/l

0.57

269

1855

Obsessive-compulsive disorder

136

809

1.71

7.87

2.3

1.7

185.23

199.20

pmol/l

0.68

131

780

Injury of muscle and tendon at hip and thigh level

210

1390

1.53

7.82

2.2

1.9

212.05

208.57

pmol/l

0.17

198

1317

COPD related to multimorbidity

276

3308

0.70

7.77

2.1

1.8

182.38

197.07

pmol/l

1.59

245

3081

Retinal breaks without detachment

222

1486

1.51

7.75

2.0

1.9

203.22

200.05

pmol/l

0.18

212

1408

Functional dyspepsia

316

2262

1.41

7.68

1.8

1.9

202.30

197.43

pmol/l

0.29

297

2140

Thyroiditis, ILD-related definition

114

649

1.77

7.65

2.3

1.8

175.83

185.96

pmol/l

0.43

109

607

Undetermined asthma

168

1059

1.60

7.64

2.2

1.8

188.38

195.69

pmol/l

0.45

157

1006

Dementia

184

1924

0.65

7.55

1.8

182.55

192.47

pmol/l

0.82

161

1775

Presence of other devices

235

1573

1.48

7.51

1.7

1.8

181.22

194.42

pmol/l

1.47

215

1448

Any dementia, excluding more controls

122

1403

0.59

7.47

1.6

1.8

167.79

193.73

pmol/l

2.97

110

1298

Mixed and other personality disorders

177

1145

1.57

7.37

2.5

1.9

183.11

210.16

pmol/l

2.75

166

1093

All pneumoniae

1764

9957

1.15

7.34

2.0

1.9

195.59

202.15

pmol/l

1.61

1670

9518

Heart failure and coronary heart disease

344

3272

0.73

7.33

1.9

186.17

204.41

pmol/l

2.11

323

3061

Ptosis of eyelid

126

748

1.70

7.33

1.9

202.48

196.64

pmol/l

0.23

115

706

Disorders of muscles

169

1081

1.58

7.32

2.2

1.8

203.56

209.06

pmol/l

0.26

162

1036

Anaemias

379

1788

1.37

7.31

2.3

1.6

192.70

209.99

pmol/l

2.20

368

1744

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

571

4496

1.28

7.29

1.9

203.75

202.63

pmol/l

0.09

548

4334

Undetermined asthma, excluding more controls

168

1072

1.58

7.28

2.2

1.8

188.38

195.21

pmol/l

0.41

157

1016

Endometriosis

165

2.22

7.27

1.3

16.56

21.61

pmol/l

1.23

148

357

2361

1.37

7.26

1.9

1.8

187.06

192.88

pmol/l

0.58

328

2180

Trigger finger

177

1147

1.56

7.21

2.1

1.8

186.55

202.43

pmol/l

1.41

161

1096

Disorders of parathyroid gland

141

857

1.63

7.10

2.0

1.6

184.58

201.12

pmol/l

1.29

134

806

Other diseases of lip and oral mucosa

568

4481

1.27

7.10

2.1

1.9

197.13

197.21

pmol/l

0.01

533

4270

Open wound of wrist and hand

1051

8541

1.20

7.09

1.9

201.20

206.03

pmol/l

0.91

1000

8186

Pollen allergy

315

2256

1.39

7.09

2.3

1.9

202.78

198.04

pmol/l

0.31

306

2161

Keratitis

613

4886

1.26

7.06

2.1

1.9

198.83

204.96

pmol/l

0.84

592

4664

Other benign neoplasms of skin

423

3213

1.32

7.06

2.0

1.9

195.61

195.72

pmol/l

0.01

392

3028

Superficial injury of lower leg

378

2827

1.35

7.05

1.9

195.34

198.80

pmol/l

0.26

355

2710

Heartburn

170

1099

1.56

7.04

2.1

1.9

206.65

202.53

pmol/l

0.21

160

1043

Seminoma of testis, including Hilmo

278

2.29

7.03

2.6

2.0

204.93

244.29

pmol/l

1.67

265

Injuries to the abdomen, lower back, lumbar spine and pelvis

621

4885

1.26

7.02

2.0

1.9

202.09

201.12

pmol/l

0.06

590

4645

Symptoms and signs involving cognition, perception, emotional state and behaviour

1575

9112

1.16

6.94

2.0

1.9

196.26

199.47

pmol/l

0.53

1486

8688

Chronic laryngitis and laryngotracheitis

158

1007

1.58

6.94

1.9

197.84

196.05

pmol/l

0.07

148

955

Acne vulgaris

176

1151

1.55

6.92

2.3

1.9

182.44

202.47

pmol/l

1.20

169

1107

Sulfonylureas

189

2231

0.67

6.88

2.1

1.8

173.68

202.21

pmol/l

3.81

167

2069

Fever of other and unknown origin

892

6412

1.21

6.81

2.2

1.8

190.27

202.60

pmol/l

2.83

849

6121

Other diseases of anus and rectum

373

2790

1.34

6.77

1.9

1.8

193.90

200.25

pmol/l

0.63

351

2631

Degenerative diseases of the nervous system

128

1484

0.62

6.76

1.6

1.9

175.70

191.39

pmol/l

1.14

114

1367

Non-invasive ventilation

391

2548

1.33

6.72

2.0

1.7

198.66

214.91

pmol/l

2.05

376

2465

Recurrent aphthous stomatitis , including avohilmo

187

1248

1.51

6.69

2.0

1.9

198.80

198.34

pmol/l

0.02

179

1174

Other inflammation of eyelid

173

1136

1.54

6.68

1.8

1.9

212.31

199.81

pmol/l

0.67

165

1077

Heart failure, not strict

841

6813

0.83

6.66

2.0

1.9

179.53

205.34

pmol/l

10.36

790

6480

Pneumonias (Asthma/COPD co-morbidities)

1744

9962

1.15

6.66

2.0

1.9

195.40

202.28

pmol/l

1.72

1649

9523

Poisoning by medicine

396

3012

1.33

6.65

2.2

1.9

179.23

200.48

pmol/l

2.07

373

2890

Other specified and unspecified personality disorders

176

1165

1.53

6.63

2.1

2.0

188.22

206.89

pmol/l

0.78

166

1105

Injury, poisoning and certain other consequences of external causes

795

3252

1.23

6.63

2.0

1.8

201.53

195.92

pmol/l

0.61

752

3107

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

221

1540

1.47

6.55

2.4

2.0

199.00

219.50

pmol/l

1.35

206

1487

Menorrhagia

129

2.29

6.53

1.4

1.3

15.10

21.23

pmol/l

1.46

115

Dementia, including avohilmo

217

2127

0.69

6.53

1.8

184.22

193.12

pmol/l

0.75

190

1957

Seminoma of testis

240

2.34

6.52

2.5

2.0

202.63

250.12

pmol/l

1.94

230

Asthma, hospital admissions , main diagnosis only

1280

9572

1.17

6.46

2.1

1.9

197.74

199.66

pmol/l

0.27

1220

9111

Dyspnoea

1350

8398

1.16

6.44

2.2

1.9

188.22

198.70

pmol/l

3.38

1264

7997

Chromosomal abnormalities, not elsewhere classified

229

2.25

6.44

2.9

2.0

191.66

220.55

pmol/l

1.04

217

Other disorders of bone

335

2500

1.35

6.43

2.1

1.9

195.04

202.87

pmol/l

0.78

323

2382

Hard cardiovascular diseases

1429

7299

1.16

6.40

2.1

1.9

203.01

208.20

pmol/l

1.08

1364

6966

Radiculopathy

178

1188

1.51

6.37

2.0

1.8

198.54

203.48

pmol/l

0.22

169

1129

Other symptoms and signs involving the circulatory and respiratory systems

106

627

1.71

6.34

2.1

1.8

209.43

209.55

pmol/l

0.00

100

597

Complications of procedures, not elsewhere classified

1234

8534

1.17

6.31

2.0

1.9

192.28

199.18

pmol/l

1.34

1166

8120

Urolithiasis

534

4255

1.26

6.24

1.9

189.56

202.79

pmol/l

3.05

501

4019

Disorders of tooth development and eruption

280

1655

1.39

6.20

1.9

202.40

212.97

pmol/l

1.04

270

1608

Other sexually transmitted chlamydial diseases, including avohilmo

226

1594

1.44

6.18

2.0

1.9

214.43

196.31

pmol/l

1.23

218

1539

Nontoxic multinodular goitre

518

1.76

6.17

1.9

1.7

166.11

186.28

pmol/l

1.03

481

Urticaria and erythema

448

3496

1.29

6.17

2.1

1.9

185.51

191.01

pmol/l

0.49

415

3339

Other disorders of the musculoskeletal system and connective tissue

202

1394

1.46

6.16

2.1

1.9

217.63

204.00

pmol/l

0.64

194

1319

Macular pucker

152

989

1.55

6.15

1.9

1.8

206.19

192.13

pmol/l

0.55

144

913

Calculus of kidney and ureter

500

3962

1.27

6.14

1.9

190.15

203.41

pmol/l

2.90

468

3744

Benign neoplasm of other and ill-defined parts of digestive system

185

1257

1.48

6.09

1.9

192.63

197.60

pmol/l

0.19

169

1180

Asthma-related pneumonia

447

3484

1.28

6.06

2.0

1.8

191.47

200.92

pmol/l

1.00

420

3298

Hyperaldosteronism

209

2.25

6.05

2.7

1.6

186.02

214.55

pmol/l

1.24

193

Lesion of ulnar nerve

258

1870

1.40

6.02

2.2

1.9

199.27

205.33

pmol/l

0.51

246

1784

Erectile dysfunction

149

976

1.55

5.96

1.9

231.75

201.66

pmol/l

1.96

139

915

Asthma-related pneumonia or sepsis

447

3492

1.28

5.95

2.0

1.8

191.47

200.93

pmol/l

1.00

420

3305

Asthma, hospital admissions 3, pneumonia

447

3492

1.28

5.95

2.0

1.8

191.47

200.93

pmol/l

1.00

420

3305

Myocardial infarction

542

4709

0.80

5.94

1.9

195.37

206.19

pmol/l

2.03

516

4457

Mycoses

404

3131

1.30

5.93

2.0

1.9

192.97

199.15

pmol/l

0.57

386

2963

Hydrocele

252

1830

1.39

5.85

1.9

1.8

214.11

208.16

pmol/l

0.48

242

1726

Acute nasopharyngitis (common cold)

391

3011

1.31

5.85

2.0

1.9

206.98

213.74

pmol/l

0.88

382

2905

Oedema, not elsewhere classified

392

2960

1.30

5.81

2.0

1.8

180.37

197.92

pmol/l

2.60

363

2795

Erosion of teeth , including avohilmo

460

3637

1.27

5.79

2.1

1.9

193.35

198.93

pmol/l

0.50

441

3486

Benign lipomatous neoplasm

400

3107

1.30

5.78

2.1

1.9

198.69

201.98

pmol/l

0.28

374

2942

Abrasion of teeth

433

3397

1.28

5.76

2.0

1.9

198.04

196.51

pmol/l

0.10

407

3223

Viral infections characterized by skin and mucous membrane lesions

708

5859

1.21

5.76

2.1

1.9

201.64

200.95

pmol/l

0.06

679

5603

Abnormal weight loss

119

745

1.62

5.74

2.5

1.9

203.56

199.79

pmol/l

0.15

112

699

Hypothyroidism, strict autoimmune

859

4725

1.20

5.73

2.0

1.7

173.86

190.41

pmol/l

3.90

805

4464

Tonsillectomy and adenotomy

1082

6446

1.17

5.72

1.9

198.96

201.48

pmol/l

0.31

1037

6210

Gout

425

2857

1.28

5.65

2.0

1.8

189.43

204.49

pmol/l

2.29

388

2705

Ganglion

248

1803

1.38

5.64

2.1

1.8

192.64

194.51

pmol/l

0.10

236

1726

Coxarthrosis

691

3669

1.22

5.63

2.0

1.8

195.30

203.75

pmol/l

1.34

640

3487

Viral and other specified intestinal infections, including avohilmo

562

4387

1.24

5.62

2.0

1.9

195.87

204.41

pmol/l

0.99

535

4227

Non-ischemic cardiomyopathy

227

2489

0.72

5.61

1.9

174.57

204.19

pmol/l

5.07

211

2328

Malignant neoplasm of prostate

444

3316

0.79

5.55

1.8

1.9

187.70

202.54

pmol/l

1.91

411

3131

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

417

3232

1.28

5.55

2.0

1.7

167.44

197.18

pmol/l

4.96

393

3119

Early lumbar disc prolapse operation

282

2107

1.36

5.54

2.2

2.0

198.13

208.33

pmol/l

0.68

271

2024

Congenital malformations, deformations and chromosomal abnormalities

1020

8287

1.17

5.54

2.1

1.9

200.98

201.04

pmol/l

0.00

975

7939

Other problems related to primary support group, including family circumstances

145

931

1.53

5.53

1.9

1.8

179.79

188.58

pmol/l

0.38

140

880

Disorders of conjunctiva

1304

8802

1.15

5.50

2.0

1.9

197.72

200.20

pmol/l

0.37

1246

8409

Lichen ruber planus, wide definition including periferal and oral lichen planus

246

1795

1.38

5.49

1.8

1.9

193.08

203.32

pmol/l

0.94

234

1695

Benign neoplasm: Transverse colon

147

978

1.52

5.46

2.1

1.9

185.62

202.66

pmol/l

0.92

138

920

Myocardial infarction, strict

511

4479

0.80

5.45

1.8

1.9

195.23

206.06

pmol/l

2.05

487

4233

Chronic apical periodontitis

1868

9320

1.13

5.43

2.0

1.9

194.48

201.49

pmol/l

2.02

1749

8928

Diseases of inner ear

631

4968

1.22

5.42

2.0

1.9

191.58

198.74

pmol/l

1.16

594

4698

Benign neoplasm: Colon, unspecified

309

2340

1.33

5.42

1.8

1.9

184.19

198.98

pmol/l

2.20

276

2197

Hypothyroidism, drug reimbursement

173

823

1.48

5.36

1.9

1.6

186.73

207.52

pmol/l

1.87

161

798

Diplopia

175

1210

1.46

5.35

2.2

1.8

195.25

205.13

pmol/l

0.66

166

1138

Striking against or struck by other objects

776

6526

1.20

5.34

2.0

1.9

207.81

208.86

pmol/l

0.10

741

6272

Implicit viral Sepsis

283

2122

1.34

5.33

2.1

1.9

189.84

203.03

pmol/l

1.25

269

1999

Weight loss

124

799

1.57

5.32

2.4

1.9

199.44

200.67

pmol/l

0.05

117

750

Other diseases of oesophagus

133

871

1.54

5.32

2.0

1.9

206.47

207.35

pmol/l

0.04

127

825

Transient global amnesia

521

1.71

5.30

2.0

1.9

197.02

206.22

pmol/l

0.38

485

Early onset COPD

215

2954

0.72

5.27

2.2

1.9

193.64

203.15

pmol/l

0.58

201

2791

Diseases of pulp and periapical tissues and dental caries

991

4334

1.18

5.26

2.0

1.9

202.18

204.85

pmol/l

0.27

922

4187

Retinal detachments and breaks

444

3538

1.26

5.25

1.9

204.12

199.73

pmol/l

0.44

418

3325

Conjunctivitis (acute, non atopic)

419

3303

1.27

5.23

2.0

1.9

199.32

196.67

pmol/l

0.19

399

3157

Viral Sepsis

283

2128

1.34

5.23

2.1

1.9

189.84

203.12

pmol/l

1.26

269

2004

Persons encountering health services in circumstances related to reproduction

1310

7681

1.15

5.23

2.0

212.59

210.26

pmol/l

0.36

1264

7400

Other arrhythmias

978

6258

1.17

5.18

2.1

1.9

198.24

200.93

pmol/l

0.37

933

5973

Sequelae of injuries of upper limb

196

1396

1.42

5.17

2.1

2.0

205.53

213.16

pmol/l

0.31

187

1325

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

142

2086

0.67

5.16

1.9

186.61

206.08

pmol/l

1.82

135

1975

Diseases of pulp and periapical tissues, including avohilmo

1687

7739

1.13

5.13

2.0

1.9

189.85

202.76

pmol/l

4.59

1573

7435

Solid cancers

1091

7381

0.86

5.12

1.9

203.62

203.10

pmol/l

0.05

1039

7056

Visual field defects

107

673

1.61

5.12

2.4

1.9

181.29

204.70

pmol/l

1.32

101

633

Alcohol withdrawal state with delirium

1286

0.59

5.11

1.7

2.0

190.14

211.36

pmol/l

1.48

1223

Chronic gastritis

243

1791

1.36

5.11

2.3

1.8

192.19

197.98

pmol/l

0.42

222

1664

Assault

374

2940

1.29

5.10

2.0

209.43

213.91

pmol/l

0.30

352

2828

Overexertion and strenuous or repetitive movements

202

1451

1.41

5.08

2.2

2.0

211.72

209.63

pmol/l

0.07

196

1380

Noninfective enteritis and colitis

750

6318

1.19

5.05

1.9

203.82

203.50

pmol/l

0.03

718

6038

Flat foot [pes planus] (acquired)

551

1.66

5.05

1.9

1.8

169.16

200.10

pmol/l

2.03

526

Polyarthrosis

136

812

1.51

5.02

2.1

1.7

199.50

197.13

pmol/l

0.08

127

765

Alcoholic liver disease

100

1567

0.63

5.02

1.8

1.9

185.71

207.30

pmol/l

1.48

1483

Other viral hepatitis

173

1216

1.45

5.00

2.5

2.0

184.36

217.01

pmol/l

3.35

165

1167

Hyperparathyroidism

118

754

1.55

4.98

1.9

1.6

189.63

201.80

pmol/l

0.74

113

708

Other viral hepatitis, including avohilmo

181

1285

1.44

4.95

2.5

2.0

186.56

215.54

pmol/l

2.89

172

1235

Sensorineural hearing loss

1026

5898

1.16

4.95

1.9

194.46

201.15

pmol/l

1.48

969

5576

Later onset COPD

108

1342

0.64

4.94

1.9

1.7

180.25

188.09

pmol/l

0.35

1216

Acute bronchitis

579

4686

1.22

4.93

1.9

191.47

201.02

pmol/l

1.50

550

4461

Primary adrenocortical insufficiency

2.80

4.93

2.9

2.0

169.71

228.44

pmol/l

1.31

Other general symptoms and signs

379

1.80

4.93

2.1

1.8

193.90

204.32

pmol/l

0.32

357

Torsion of testis

532

1.71

4.92

1.9

210.36

228.65

pmol/l

1.32

506

Panniculitis affecting regions of neck and back

276

1.95

4.91

2.5

1.7

195.23

209.19

pmol/l

0.47

265

Fall on same level involving ice and snow

839

7156

1.18

4.91

2.0

1.9

195.17

201.12

pmol/l

1.00

789

6829

Appendectomy

1076

8902

1.15

4.90

2.0

1.9

199.59

201.65

pmol/l

0.28

1022

8520

Disorders of continuity of bone

149

1019

1.48

4.88

2.1

1.9

184.99

206.33

pmol/l

1.75

142

961

Inguinal hernia

1421

8347

1.14

4.87

1.9

215.68

210.41

pmol/l

1.25

1365

7971

Acute pharyngitis

342

2645

1.29

4.86

2.0

1.9

196.81

199.44

pmol/l

0.18

332

2544

Other bursopathies

174

1226

1.43

4.85

2.1

1.8

190.23

206.98

pmol/l

1.97

163

1173

Dizziness and giddiness

983

6593

1.16

4.84

2.0

1.9

195.96

195.52

pmol/l

0.04

925

6255

Brachial plexus disorders

126

836

1.52

4.79

2.5

1.9

184.60

201.74

pmol/l

1.08

119

790

Superficial injury of abdomen, lower back and pelvis

253

1900

1.34

4.79

1.8

1.9

202.46

203.85

pmol/l

0.05

244

1805

Viral hepatitis

182

1301

1.42

4.79

2.5

2.0

181.90

215.65

pmol/l

3.79

174

1248

Status post-ami

211

2177

0.73

4.78

1.8

185.31

202.07

pmol/l

1.87

203

2022

Vasomotor rhinitis (mode)

569

1.64

4.75

2.1

1.8

206.49

201.67

pmol/l

0.17

540

Other diseases of liver

280

2136

1.32

4.75

2.1

1.9

188.19

208.55

pmol/l

2.81

267

2029

Olecranon bursitis

139

946

1.49

4.75

2.1

1.9

195.20

214.62

pmol/l

1.92

132

911

Other disorders of eye and adnexa

174

1232

1.42

4.72

1.8

1.9

195.22

197.86

pmol/l

0.12

165

1163

Procreative management

700

4858

1.19

4.72

2.0

204.65

211.58

pmol/l

0.90

681

4682

Calcific tendinitis of shoulder

403

1.76

4.72

2.0

1.9

187.26

209.59

pmol/l

0.87

391

Lichen planus, including avohilmo

208

1518

1.38

4.72

1.7

1.9

190.81

203.39

pmol/l

1.18

197

1437

Chronic viral hepatitis

157

1098

1.46

4.72

2.5

2.0

181.67

218.86

pmol/l

3.75

150

1055

Otitis externa

335

2620

1.29

4.70

2.1

1.9

183.21

201.02

pmol/l

2.59

312

2485

Enlarged lymph nodes

236

1760

1.35

4.68

1.9

1.8

192.04

204.39

pmol/l

1.09

223

1669

Viral hepatitis, including avohilmo

190

1375

1.40

4.66

2.5

2.0

184.08

215.13

pmol/l

3.45

181

1320

Acute laryngitis and tracheitis

247

1830

1.34

4.63

1.9

1.8

197.27

211.13

pmol/l

1.21

236

1765

Fracture at wrist and hand level

754

6401

1.18

4.62

2.0

1.9

212.96

209.54

pmol/l

0.33

718

6164

Disorders of eyelid, lacrimal system and orbit

1181

7584

1.14

4.62

2.0

1.9

201.48

194.42

pmol/l

1.24

1101

7205

Gestational diabetes (for exclusion)

138

638

1.49

4.60

1.3

16.36

18.92

pmol/l

1.58

127

586

Sequelae of external causes of morbidity and mortality

331

2592

1.28

4.60

2.3

1.9

189.97

201.28

pmol/l

1.22

315

2442

193

1399

1.39

4.59

2.0

1.9

178.26

197.94

pmol/l

1.63

181

1334

Other predominantly sexually transmitted diseases, not elsewhere classified

252

1905

1.33

4.57

2.0

1.9

194.17

193.73

pmol/l

0.02

234

1832

Dental caries, including avohilmo

1107

4935

1.15

4.54

2.0

1.9

203.66

204.32

pmol/l

0.06

1032

4760

Spondylopathies (FG)

241

1815

1.34

4.51

2.0

1.9

205.35

208.71

pmol/l

0.21

232

1743

Atrial fibrillation and flutter

643

3477

1.20

4.49

2.0

1.9

208.76

219.00

pmol/l

1.73

614

3361

Benign neoplasm: Caecum

117

776

1.52

4.48

2.1

1.9

188.01

200.35

pmol/l

0.73

107

721

Malignant neoplasm

1154

7690

0.88

4.47

1.9

203.68

203.69

pmol/l

0.00

1099

7355

Trochanteric bursitis

515

1.64

4.47

2.0

1.8

162.05

188.83

pmol/l

1.37

494

Conductive and sensorineural hearing loss

1105

6414

1.15

4.45

1.9

195.91

201.20

pmol/l

1.09

1049

6075

Malignant neoplasm

1157

7705

0.88

4.44

1.9

203.93

203.69

pmol/l

0.03

1101

7370

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

113

746

1.53

4.43

1.9

163.25

198.76

pmol/l

3.55

105

700

Other diseases of blood and blood-forming organs, wide

283

2184

1.30

4.42

2.3

1.9

196.75

203.77

pmol/l

0.50

269

2064

Dental caries

442

3391

1.24

4.42

2.1

1.9

189.06

211.11

pmol/l

4.28

413

3276

Other hammer toe(s) (acquired)

102

596

1.56

4.41

2.1

1.7

189.20

200.66

pmol/l

0.55

569

Adverse effects, not elsewhere classified

236

1777

1.34

4.40

1.9

175.69

192.17

pmol/l

1.39

219

1681

Childhood asthma (age<16)

278

1668

1.31

4.39

1.8

1.7

198.15

201.44

pmol/l

0.18

270

1624

Childhood asthma (age<16), excluding more controls

278

1668

1.31

4.38

1.8

1.7

198.15

200.96

pmol/l

0.15

270

1624

Other/unspecified synovitis and tenosynovitis

145

1009

1.45

4.37

1.9

1.8

188.77

204.59

pmol/l

0.95

139

966

Ethmoidectomy

223

1670

1.35

4.37

2.1

1.9

203.79

205.53

pmol/l

0.08

213

1588

Mental disorders, not otherwise specified

137

945

1.47

4.36

2.0

1.9

178.33

206.48

pmol/l

2.12

129

898

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

292

2273

1.30

4.32

2.0

1.9

175.71

204.19

pmol/l

3.12

275

2176

Additional codes for the location of defect, injury or illness

546

1.62

4.29

1.6

2.0

189.12

206.56

pmol/l

0.68

521

Malignant neoplasm of prostate, including Hilmo

479

3431

0.82

4.27

1.8

1.9

189.82

203.07

pmol/l

1.76

446

3244

Otalgia

554

1.60

4.25

2.2

1.9

174.29

194.81

pmol/l

0.96

522

Lactose intolerance

248

1.93

4.25

1.7

1.8

195.00

209.33

pmol/l

0.35

239

Nontoxic goitre/thyroid nodule

144

1005

1.44

4.24

1.9

160.87

183.22

pmol/l

1.73

134

933

Unspecific neurodegenerative disorder

171

1615

0.72

4.21

1.8

183.01

189.44

pmol/l

0.48

149

1472

Cutaneous abscess, furuncle and carbuncle

492

4072

1.22

4.21

2.1

1.9

188.10

206.83

pmol/l

2.96

470

3896

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

151

1069

1.43

4.20

2.4

1.9

212.70

208.44

pmol/l

0.19

142

1026

Other viral diseases

524

4347

1.21

4.19

2.1

1.9

204.17

201.27

pmol/l

0.25

504

4175

Other spirochaetal diseases

433

3537

1.23

4.19

1.9

204.47

199.37

pmol/l

0.50

407

3352

Autoimmune diseases related-to ILD

1382

10297

1.12

4.18

2.0

1.9

197.18

201.01

pmol/l

0.72

1321

9816

Sequelae of injuries of lower limb

171

1239

1.40

4.16

2.1

2.0

210.16

208.79

pmol/l

0.06

161

1176

Open wound of lower leg

239

1821

1.32

4.15

1.8

2.0

199.26

206.99

pmol/l

0.43

234

1730

Nonalcoholic fatty liver disease

179

1308

1.38

4.14

2.0

186.92

213.21

pmol/l

2.71

167

1245

Urticaria

355

2841

1.25

4.14

2.1

1.9

185.00

190.98

pmol/l

0.46

330

2713

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1662

9964

1.11

4.14

2.0

1.9

195.37

202.39

pmol/l

1.68

1570

9523

Care involving use of rehabilitation procedures

992

7810

1.15

4.12

2.1

1.9

187.38

202.95

pmol/l

5.08

929

7441

Other spirochaetal diseases, including avohilmo

439

3598

1.23

4.12

1.9

205.14

199.72

pmol/l

0.54

413

3409

Lyme disease, including avohilmo

428

3501

1.23

4.10

1.9

204.48

199.38

pmol/l

0.50

402

3318

Lyme disease

428

3501

1.23

4.10

1.9

204.48

199.38

pmol/l

0.50

402

3318

Injuries to the thorax

808

6985

1.16

4.07

2.0

1.9

197.40

205.16

pmol/l

1.32

757

6654

Cellulitis

395

3211

1.24

4.05

2.2

1.9

192.16

208.07

pmol/l

1.85

378

3067

Caries of dentine, including avohilmo

1194

5388

1.14

4.04

2.0

1.9

200.86

204.57

pmol/l

0.47

1111

5193

Myocardial infarction, unclassifiable

113

1477

0.68

4.04

1.8

1.9

176.43

196.10

pmol/l

1.64

100

1360

Adenocarcinoma and ductal carcinoma of pancreas

248

0.28

4.01

1.4

2.0

204.29

200.75

pmol/l

—

232

Benign thyroid growths and nodules

171

1154

1.38

3.99

2.0

1.8

164.46

185.85

pmol/l

1.94

157

1079

Superficial injury of thorax

255

1973

1.30

3.98

2.0

192.84

208.76

pmol/l

1.71

240

1878

Inflammatory diseases of female pelvic organs

152

734

1.42

3.98

1.2

1.3

16.68

18.91

pmol/l

0.92

139

675

Peripheral arterial reconstruction

1321

0.65

3.97

1.9

172.70

197.15

pmol/l

1.36

1219

Acute alcohol intoxication, ICD10

307

3850

0.79

3.97

1.9

2.0

195.31

207.56

pmol/l

1.38

283

3690

Other neurological diseases

945

6406

1.15

3.95

2.0

1.9

191.98

198.84

pmol/l

1.37

901

6050

Glaucoma, exfoliation

356

1.72

3.95

1.9

1.8

191.39

200.95

pmol/l

0.26

334

Diabetic nephropathy, excluding more controls

141

1606

0.71

3.94

1.8

2.0

182.23

176.83

pmol/l

0.27

134

1507

FESS (DNB20)

213

1612

1.33

3.93

2.1

2.0

203.75

204.37

pmol/l

0.03

204

1531

Other specified/unspecified arthritis

330

2639

1.26

3.91

1.9

1.8

190.52

198.04

pmol/l

0.78

310

2525

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

681

5762

1.17

3.89

2.0

1.9

198.83

201.41

pmol/l

0.25

650

5535

Alzheimer disease

998

0.66

3.89

1.7

1.8

169.78

186.69

pmol/l

1.24

902

Disorders of puberty

126

2.28

3.89

2.0

1.5

120.61

222.59

pmol/l

4.18

119

In situ neoplasms

274

2143

1.28

3.88

1.7

1.8

177.91

173.13

pmol/l

0.23

249

1989

Provisional assignment of new diseases of uncertain etiology

740

6330

1.16

3.86

1.8

1.9

187.31

195.74

pmol/l

1.37

699

6013

Motorcycle rider injured in other and unspecified transport accidents

179

1329

1.37

3.86

1.9

2.0

212.66

216.82

pmol/l

0.20

169

1269

Impacted cerumen

134

943

1.43

3.85

2.1

1.9

194.10

205.59

pmol/l

0.72

126

889

Zoster [herpes zoster], including avohilmo

570

4648

1.19

3.84

2.0

1.9

192.06

196.16

pmol/l

0.41

545

4388

Codes for special purposes

740

6334

1.16

3.83

1.8

1.9

187.31

195.73

pmol/l

1.36

699

6017

Spirochaetal infections, other/unspecified, including avohilmo

428

3529

1.22

3.82

1.9

204.48

199.29

pmol/l

0.51

402

3346

Other sexually transmitted chlamydial diseases

146

1048

1.41

3.82

2.0

214.83

202.16

pmol/l

0.53

139

1004

Need for other prophylactic measures

103

692

1.51

3.82

1.9

215.07

217.78

pmol/l

0.10

659

Mental and behavioural disorders due to use of other stimulants, including caffeine

101

680

1.53

3.81

2.5

2.0

193.49

224.72

pmol/l

1.01

653

Injury of muscle and tendon at lower leg level

320

2565

1.26

3.80

1.9

2.0

214.23

210.43

pmol/l

0.26

308

2453

Acute suppurative otitis media

531

4168

1.19

3.76

1.8

1.9

204.02

202.39

pmol/l

0.11

509

4011

Schizophrenia or delusion

452

5421

0.83

3.76

1.9

2.0

182.57

211.02

pmol/l

5.28

422

5224

Dermatitis and eczema

1864

10041

1.10

3.75

2.0

1.9

197.85

201.27

pmol/l

0.67

1782

9564

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

189

1416

1.35

3.74

2.1

1.9

197.92

204.28

pmol/l

0.37

180

1345

Nontraumatic intracranial haemmorrhage

118

1683

0.70

3.74

1.9

207.11

201.94

pmol/l

0.10

109

1571

Unspecified/other endometriosis

2.40

3.70

1.1

1.3

13.89

23.33

pmol/l

1.59

Postprocedural musculoskeletal disorders, not elsewhere classified

511

1.58

3.70

2.0

1.9

210.79

203.25

pmol/l

0.23

480

Other keratitis

192

1445

1.34

3.70

2.1

2.0

198.76

205.21

pmol/l

0.37

184

1375

Nonsuppurative otitis media, including avohilmo

508

3687

1.20

3.69

2.0

1.8

199.64

195.66

pmol/l

0.31

481

3531

Schizophrenia, schizotypal and delusional disorders

453

5420

0.83

3.68

1.9

2.0

182.44

211.04

pmol/l

5.35

423

5222

Other local infections of skin and subcutaneous tissue

163

1199

1.37

3.66

2.2

1.9

180.63

209.13

pmol/l

3.27

158

1138

Acute alcohol intoxication

372

4528

0.82

3.64

1.9

191.89

207.21

pmol/l

2.30

340

4331

Other gastritis (incl. Duodenitis)

270

2131

1.27

3.62

2.1

1.9

189.49

203.52

pmol/l

1.78

258

2003

Suppurative and unspecified otitis media

676

5157

1.17

3.62

1.8

1.9

201.34

200.71

pmol/l

0.05

645

4957

Dialysis, with operation codes

128

1782

0.71

3.58

1.6

2.0

191.04

211.90

pmol/l

1.59

120

1688

Localized swelling, mass and lump of skin and subcutaneous tissue

410

3391

1.21

3.57

2.0

1.9

196.53

198.01

pmol/l

0.10

387

3212

Cholecystectomy

724

5321

1.16

3.57

1.9

182.51

191.64

pmol/l

1.51

678

5017

Other disorders of veins

395

3203

1.22

3.54

2.1

1.9

185.29

195.92

pmol/l

1.48

375

3017

Convergence insufficiency and excess

2.42

3.53

2.2

1.8

171.14

206.53

pmol/l

0.67

Primary amenorrhea

6.29

3.52

1.1

12.75

21.62

pmol/l

—

Unspecified haematuria

636

4446

1.17

3.52

1.9

186.29

202.32

pmol/l

3.78

589

4186

Assault by bodily force

211

1627

1.31

3.51

2.1

2.0

211.50

214.99

pmol/l

0.14

202

1569

Other and unspecified local infections of skin and subcutaneous tissue

153

1123

1.38

3.50

2.2

1.9

177.87

209.99

pmol/l

3.84

148

1067

Diabetes mellitus in pregnancy

123

544

1.44

3.49

1.3

17.96

18.48

pmol/l

0.12

114

497

Injury of eye and orbit

332

2701

1.24

3.48

1.9

208.90

210.10

pmol/l

0.08

313

2601

Any event in cancer register

1245

8094

0.90

3.46

1.9

200.28

198.86

pmol/l

0.17

1181

7736

Abnormal results of function studies

137

990

1.40

3.45

2.0

1.9

177.94

204.04

pmol/l

1.93

123

939

COPD (mode)

263

2581

0.79

3.45

2.1

1.8

190.74

201.42

pmol/l

0.80

232

2438

Other disorders of bladder

168

1254

1.35

3.45

2.5

1.9

197.69

202.75

pmol/l

0.26

152

1176

Myocardial infarction, with ST-elevation

138

1887

0.73

3.44

1.8

1.9

197.32

201.32

pmol/l

0.21

125

1755

Missing teeth due to accident, extraction or parodontitis

825

6460

1.14

3.44

1.9

186.89

201.29

pmol/l

2.84

766

6126

Car occupant injured in other and unspecified transport accidents

306

2469

1.25

3.43

2.2

1.9

196.64

201.14

pmol/l

0.23

290

2363

Other and unspecified effects of external causes

411

3417

1.21

3.42

2.1

1.9

198.52

197.71

pmol/l

0.04

388

3263

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

866

6629

1.14

3.41

2.0

1.9

187.22

200.31

pmol/l

3.80

801

6288

Caries of dentine

394

3146

1.21

3.41

2.2

1.9

187.43

212.55

pmol/l

4.84

367

3044

Lactose intolerance, other/unspecified

224

1.86

3.40

1.7

1.8

196.46

213.63

pmol/l

0.38

215

Peripheral artery operations in Hilmo

1178

0.66

3.40

2.0

1.9

179.25

203.24

pmol/l

1.23

1098

Superficial injury of wrist and hand

346

2833

1.23

3.38

2.0

1.9

200.94

199.79

pmol/l

0.07

328

2725

Other specified disorders of external ear

446

1.60

3.36

2.0

1.9

204.48

208.91

pmol/l

0.11

422

Personal history of certain other diseases

141

2.10

3.35

1.9

1.7

179.17

196.21

pmol/l

0.33

129

Cardiodefibrillation

479

4036

1.19

3.33

2.0

1.9

198.73

201.72

pmol/l

0.30

443

3786

Other skin changes

208

1607

1.30

3.33

1.8

1.9

185.04

197.44

pmol/l

0.96

191

1502

Stomatitis and related lesions

270

2156

1.26

3.32

2.0

1.9

198.02

201.36

pmol/l

0.18

255

2052

Complications of internal orthopaedic prosthetic devices, implants and grafts

208

1608

1.30

3.31

2.4

1.8

189.02

200.48

pmol/l

0.96

195

1503

Disorders of mineral metabolism

114

804

1.43

3.31

2.3

1.8

210.53

209.86

pmol/l

0.02

100

770

Pruritus

638

1.48

3.31

2.0

1.9

179.39

186.75

pmol/l

0.26

595

Coronary artery bypass grafting

226

2134

0.78

3.30

1.7

1.8

194.77

201.69

pmol/l

0.34

204

1979

Malignant neoplasm of stomach

425

0.44

3.29

1.6

1.9

204.42

203.30

pmol/l

0.01

400

Fibroblastic disorders

264

2105

1.26

3.29

1.9

1.8

207.28

199.87

pmol/l

0.44

243

1993

Other systemic involvement of connective tissue (FG)

180

1340

1.32

3.28

2.1

1.7

191.19

183.63

pmol/l

0.32

171

1259

Dermatophytosis

219

1710

1.29

3.27

1.9

189.78

208.54

pmol/l

2.14

210

1615

Candidiasis

147

1084

1.36

3.26

2.1

1.9

193.77

193.74

pmol/l

0.00

139

1019

Excessive earwax

931

7483

1.13

3.26

2.0

1.9

198.95

201.87

pmol/l

0.39

886

7101

Peritonsillar abscess

368

3045

1.22

3.26

1.9

201.60

201.50

pmol/l

0.01

355

2930

Mental and behavioural disorders due to psychoactive substance use

1228

10141

1.11

3.25

2.1

1.9

196.77

206.38

pmol/l

2.10

1134

9717

Examination and encounter for administrative purposes

123

883

1.41

3.25

1.9

1.8

208.90

203.80

pmol/l

0.16

115

842

Disorders of puberty, all

164

2.00

3.24

2.3

1.7

128.19

204.15

pmol/l

3.11

154

Other and unspecified drugs and medicaments

102

708

1.45

3.23

2.0

163.29

201.73

pmol/l

3.70

670

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1481

9079

1.10

3.23

2.0

1.9

194.89

202.09

pmol/l

1.59

1390

8677

Certain disorders involving the immune mechanism

281

2265

1.25

3.21

2.1

1.9

200.19

207.59

pmol/l

0.61

262

2156

Thyrotoxicosis, other and/or unspecified

158

1181

1.34

3.21

1.9

1.8

188.19

192.74

pmol/l

0.20

139

1114

Fracture of rib(s), sternum and thoracic spine

502

4279

1.18

3.19

2.0

1.9

196.02

205.03

pmol/l

1.07

467

4074

Other arthritis (FG)

394

3287

1.20

3.19

1.9

1.8

190.04

199.03

pmol/l

1.11

370

3140

Primary coxarthrosis, bilateral

265

2123

1.25

3.17

2.1

1.9

199.11

198.47

pmol/l

0.03

246

1996

Carbimazole or st.post thyroidectomy, condition for graves disease

167

1263

1.33

3.14

1.7

1.9

175.84

188.83

pmol/l

0.83

152

1191

Spondyloarthritis

276

2228

1.25

3.12

2.0

1.9

203.86

206.54

pmol/l

0.18

267

2123

Solid cancers, including Hilmo

1194

7710

0.90

3.09

1.9

205.48

203.29

pmol/l

0.29

1139

7377

Asthma (diagnoses ohter than nonallergic)

1289

9426

1.11

3.08

2.1

1.9

190.80

198.72

pmol/l

2.02

1222

8967

117

782

1.40

3.07

1.8

184.18

182.94

pmol/l

0.05

105

716

Recurrent dislocation and subluxation of joint

132

970

1.38

3.06

2.5

1.9

219.01

209.24

pmol/l

0.49

125

931

Misadventures to patients during surgical and medical care

156

1175

1.34

3.04

2.2

1.9

200.49

201.35

pmol/l

0.03

147

1109

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

110

544

1.42

3.02

2.1

1.7

188.64

221.46

pmol/l

3.35

101

515

Melanocytic naevi of trunk

168

1282

1.32

3.01

1.7

1.9

201.73

201.53

pmol/l

0.01

158

1212

Ankylosing spondylitis

157

1188

1.33

3.01

1.9

210.85

210.95

pmol/l

0.00

150

1137

Fracture of skull and facial bones

450

3825

1.18

3.01

1.9

211.42

211.37

pmol/l

0.00

431

3675

Inguinal or femoral hernia, bilateral

202

1584

1.29

2.98

1.8

1.9

218.91

205.67

pmol/l

0.76

190

1487

Nail disorders

137

1018

1.36

2.97

2.0

189.36

212.67

pmol/l

1.80

130

973

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

301

2437

1.22

2.95

2.0

1.9

176.67

173.76

pmol/l

0.13

287

2312

Covid-19 confirmed case

464

3951

1.18

2.95

1.9

189.43

196.39

pmol/l

0.69

434

3738

Coxarthrosis, primary, with hip surgery

452

3562

1.18

2.94

2.0

1.9

195.64

197.76

pmol/l

0.18

421

3334

Major coronary heart disease event excluding revascularizations

731

5473

0.88

2.93

1.9

195.68

207.30

pmol/l

2.84

696

5188

Other disorders of nervous system

657

1.45

2.93

1.9

2.0

189.53

206.43

pmol/l

0.97

616

Alzheimer disease, including avohilmo

125

1175

0.73

2.92

1.7

1.8

172.30

187.31

pmol/l

1.32

108

1069

Pleural effusion

1305

0.70

2.92

2.2

1.9

203.08

197.93

pmol/l

0.17

1218

Inguinal hernia, bilateral

201

1580

1.28

2.92

1.8

1.9

219.15

205.69

pmol/l

0.77

189

1484

Thyrotoxicosis

183

1418

1.29

2.91

2.0

1.9

188.34

188.46

pmol/l

0.00

163

1335

Nephropathy related operations

127

1705

0.74

2.90

1.7

2.0

194.44

210.58

pmol/l

1.05

119

1611

Other specified/unspecified inflammatory spondylopathies

454

1.54

2.90

2.0

1.8

204.96

208.25

pmol/l

0.10

433

Autoimmune diseases excluding thyroid diseases

1825

9110

1.09

2.88

1.9

199.53

202.79

pmol/l

0.69

1737

8695

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1547

8398

1.09

2.88

2.0

1.9

182.70

211.43

pmol/l

22.03

1448

8057

Heterophoria

684

1.43

2.87

1.8

1.9

179.10

190.94

pmol/l

0.41

645

Other viral diseases, not elsewhere classified

289

2361

1.23

2.86

2.0

1.9

204.17

201.89

pmol/l

0.13

278

2251

Thoracic aortic aneurysm

258

2092

1.24

2.86

1.9

203.24

206.56

pmol/l

0.22

245

1965

Bacterial infection, other or unspecified

571

5535

0.87

2.84

2.0

1.9

187.32

203.53

pmol/l

2.82

524

5238

Dilated cardiomyopathy

113

1539

0.73

2.84

1.6

1.9

219.23

207.88

pmol/l

0.43

107

1451

Early syphilis, including avohilmo

286

1.71

2.84

1.9

2.0

230.15

220.59

pmol/l

0.25

273

Insulin, combination of fast acting with intermediate-acting or long-acting

846

8583

0.89

2.79

1.9

182.93

205.77

pmol/l

9.31

783

8188

Benign neoplasm of mouth and pharynx

137

1028

1.34

2.79

1.9

191.07

203.03

pmol/l

0.71

129

972

Rosacea

120

882

1.37

2.78

2.0

1.9

189.86

194.14

pmol/l

0.16

115

827

Type 1 diabetes, strict (exclude DM2)

131

1732

0.75

2.78

1.7

2.0

215.94

219.53

pmol/l

0.14

124

1667

Cramp and spasm

516

1.49

2.78

2.5

2.0

213.75

204.60

pmol/l

0.15

488

Haemorrhagic disorder due to circulating anticoagulants

0.00

2.77

0.0

1.7

—

212.77

—

Abnormalities of gait and mobility

127

943

1.36

2.77

1.8

1.9

186.42

197.63

pmol/l

0.62

119

886

Other disorders of binocular movement

181

1.85

2.77

1.8

177.88

197.99

pmol/l

0.50

169

Gout, FINNGEN

425

3598

1.18

2.76

2.0

1.9

189.43

201.84

pmol/l

1.70

388

3385

Benign neoplasm: Adrenal gland

640

1.43

2.75

1.9

182.84

201.40

pmol/l

1.15

602

Residual foreign body in soft tissue

100

717

1.41

2.74

2.0

1.9

203.66

212.77

pmol/l

0.24

689

Colorectal cancer

176

2154

0.78

2.73

1.6

1.9

198.24

200.13

pmol/l

0.09

168

2023

Habitual aborter

5.03

2.73

1.1

1.4

13.29

21.14

pmol/l

—

Ocular pain

691

1.41

2.73

2.0

1.9

196.04

198.58

pmol/l

0.08

646

Chronic periodontitis, including avohilmo

1620

9507

1.09

2.73

2.0

1.9

190.81

204.94

pmol/l

6.88

1513

9096

Cardiac murmurs and other cardiac sounds

658

1.42

2.72

1.9

1.7

201.77

196.63

pmol/l

0.09

627

Other disorders of skin and subcutaneous tissue

899

6796

1.12

2.71

2.0

1.9

187.90

197.82

pmol/l

1.76

850

6427

Cardiomyopathy (excluding other)

129

1709

0.75

2.71

1.7

1.9

216.95

209.00

pmol/l

0.31

122

1606

Pneumonia, organism unspecified

1496

9412

1.09

2.70

2.0

1.9

196.75

203.28

pmol/l

1.37

1409

8999

Malignant neoplasm, wide definition

1248

7968

0.91

2.69

1.9

205.47

203.77

pmol/l

0.22

1195

7626

Mild mental retardation

321

0.43

2.68

3.1

1.9

146.50

218.07

pmol/l

2.31

303

Sequelae of cerebrovascular disease

293

3019

0.83

2.68

1.9

189.27

198.97

pmol/l

1.30

272

2828

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

255

2081

1.23

2.66

1.9

192.61

204.66

pmol/l

1.23

239

1969

Sequelae of injuries of head

114

841

1.37

2.66

1.9

2.0

205.07

214.58

pmol/l

0.41

107

803

Convalescence

359

1.57

2.65

2.0

1.9

180.84

200.12

pmol/l

0.70

339

Other acute lower respiratory infections

845

7202

1.12

2.65

2.0

1.9

196.04

203.04

pmol/l

1.22

804

6885

Primary open-angle glaucoma

232

1802

1.24

2.64

1.9

1.8

194.90

196.77

pmol/l

0.10

213

1677

Deep bite

150

1008

1.31

2.63

1.9

1.8

199.09

194.80

pmol/l

0.17

141

963

Other bacterial intestinal infections, including avohilmo

284

2346

1.22

2.63

2.1

1.9

195.52

202.69

pmol/l

0.59

271

2228

Fracture of femur

155

1801

0.77

2.61

1.8

189.92

202.20

pmol/l

0.80

146

1678

Intracerebral haemorrhage

923

0.67

2.60

2.1

1.9

181.32

204.31

pmol/l

0.95

866

Diseases of arteries, arterioles and capillaries

754

6204

0.89

2.60

1.9

194.01

202.36

pmol/l

1.55

707

5863

Atopic dermatitis, strict definition with reimbursement

435

3588

1.17

2.58

2.0

1.8

201.25

192.49

pmol/l

0.70

412

3429

Unknown and unspecified causes of morbidity

607

1.43

2.57

2.5

1.9

181.28

205.28

pmol/l

1.55

575

Pediculosis, acariasis and other infestations, including avohilmo

294

2445

1.21

2.57

2.0

1.9

198.94

199.97

pmol/l

0.06

284

2336

Hypothyroidism, strict autoimmune, 3 medication purchases required

852

5122

1.12

2.56

1.9

1.8

172.86

185.90

pmol/l

2.60

799

4844

Type 1 diabetes, definitions combined

134

1742

0.76

2.55

1.7

2.0

216.64

220.11

pmol/l

0.14

127

1677

Other diseases of pleura

417

4219

0.86

2.54

2.1

1.9

193.32

199.96

pmol/l

0.70

387

3955

Malignant neoplasm, including Hilmo

1250

7959

0.91

2.53

1.9

205.37

203.77

pmol/l

0.21

1197

7616

Herpesviral [herpes simplex] infections

131

993

1.33

2.52

2.2

1.9

200.70

198.60

pmol/l

0.08

126

933

Budesonide

204

1637

1.25

2.52

1.9

202.54

204.17

pmol/l

0.07

196

1549

Sequelae with surgical and medical care as external cause

229

1861

1.24

2.51

2.4

1.9

188.91

202.09

pmol/l

1.15

217

1748

Polyarthropathies

1008

5855

1.11

2.49

1.9

1.8

194.33

201.01

pmol/l

1.23

932

5620

Noninfectious colitis NAS

174

1372

1.28

2.49

1.9

2.0

202.05

206.15

pmol/l

0.22

165

1296

Early syphilis

266

1.68

2.49

1.8

2.0

237.16

222.14

pmol/l

0.42

254

Abnormal spermatozoa

235

1921

1.23

2.49

2.5

1.8

211.18

201.13

pmol/l

0.83

225

1792

Special screening examination for neoplasms

637

1.41

2.48

1.7

1.8

187.98

204.12

pmol/l

0.94

612

Other diseases of urinary system

1222

7499

0.91

2.46

1.9

181.73

195.25

pmol/l

4.33

1148

7115

Benign neoplasm: Skin of eyelid, including canthus

133

1014

1.32

2.46

2.0

1.9

202.25

200.05

pmol/l

0.09

122

961

Malignant neoplasm of breast, ER-positive, including Hilmo

143

0.36

2.45

1.1

1.4

31.14

16.09

pmol/l

—

126

Inflammatory bowel disease

544

4772

1.14

2.45

2.0

1.9

202.75

206.10

pmol/l

0.32

524

4567

Complications of surgical and medical care, not elsewhere classified

1508

9277

1.09

2.44

2.0

1.9

191.68

200.05

pmol/l

2.19

1424

8837

Otitis externa, unspecified

158

1235

1.29

2.44

2.3

1.9

179.25

205.22

pmol/l

2.83

148

1168

Other systemic involvement of connective tissue

187

1490

1.26

2.44

2.1

1.8

192.25

185.71

pmol/l

0.28

177

1398

Fall on and from ladder

147

1141

1.30

2.44

2.1

1.9

203.03

210.36

pmol/l

0.36

134

1081

Other congenital malformations, including avohilmo

155

1210

1.29

2.41

1.9

173.77

198.37

pmol/l

2.18

148

1147

Bacterial pneumoniae

454

4589

0.87

2.41

1.9

182.70

203.57

pmol/l

4.04

432

4357

Syncope and collapse

604

4450

1.14

2.40

2.0

1.8

190.94

200.23

pmol/l

1.30

559

4220

Substance abuse

1188

10110

1.09

2.39

2.1

1.9

196.82

206.69

pmol/l

2.11

1095

9690

Emotional disorders starting during childhood or adolecense, excluding more controls

381

1.51

2.37

2.2

1.5

140.56

187.22

pmol/l

1.73

366

Open wound of forearm

175

1392

1.27

2.37

2.0

192.62

209.62

pmol/l

0.95

165

1326

Coxarthrosis, primary

641

4717

1.13

2.37

2.0

1.9

194.15

198.02

pmol/l

0.45

593

4432

Other peripheral vertigo

592

1.41

2.36

1.9

2.0

194.20

195.04

pmol/l

0.03

556

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

377

1.52

2.36

1.2

1.3

16.82

18.63

pmol/l

0.54

349

COPD-related respiratory insufficiency

974

0.69

2.36

2.0

1.9

179.39

199.99

pmol/l

0.82

913

Cardiomyopathies, Primary/intrinsic

124

1616

0.76

2.36

1.6

1.9

217.67

208.23

pmol/l

0.37

117

1520

Periodontitis

1613

9520

1.08

2.35

2.0

1.9

190.85

204.98

pmol/l

6.84

1508

9109

Prepatellar bursitis

100

739

1.37

2.35

2.3

1.9

205.11

216.02

pmol/l

0.43

713

N06DA Anticholinesterases

128

1287

0.77

2.35

1.8

181.97

190.43

pmol/l

0.56

113

1170

Use of anticholinesterases

128

1287

0.77

2.35

1.8

181.97

190.43

pmol/l

0.56

113

1170

Diabetic nephropathy

141

1783

0.78

2.34

1.8

2.0

182.23

175.98

pmol/l

0.33

134

1661

Insulin medication

846

7766

0.90

2.33

1.9

182.93

211.34

pmol/l

13.80

783

7446

Suggestive for eosinophilic asthma

130

998

1.31

2.33

2.1

1.9

197.48

207.51

pmol/l

0.67

124

945

Colorectal adenocarcinoma

148

1860

0.78

2.33

1.6

1.9

199.36

199.21

pmol/l

0.01

142

1748

Other noninfective gastroenteritis and colitis

292

2449

1.20

2.33

1.9

202.71

200.60

pmol/l

0.13

276

2328

Carcinoma in situ of skin

486

1.45

2.31

1.7

1.8

234.69

195.78

pmol/l

0.98

450

Malignant neoplasm of breast, HER-positive

143

0.36

2.31

1.1

1.4

31.14

16.09

pmol/l

—

126

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

219

1790

1.23

2.30

1.9

191.22

204.38

pmol/l

1.24

206

1697

Papulosquamous disorders

539

4747

1.14

2.30

1.9

188.31

203.04

pmol/l

2.98

506

4528

Persons encountering health services for specific procedures, not carried out

150

1177

1.28

2.29

1.9

198.65

208.61

pmol/l

0.38

141

1119

Scabies, including avohilmo

253

2103

1.21

2.27

2.0

1.9

198.69

200.96

pmol/l

0.14

244

2003

Early onset COPD, excluding more controls

215

2614

0.82

2.26

2.2

1.8

193.64

203.83

pmol/l

0.64

201

2486

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

147

1145

1.28

2.25

2.1

1.9

193.08

199.24

pmol/l

0.22

134

1093

Melanocytic naevi, other sites/unspecified

108

812

1.34

2.25

2.0

186.51

201.62

pmol/l

0.92

103

763

Neuromuscular dysfunction of bladder

117

890

1.32

2.25

1.9

212.39

205.96

pmol/l

0.26

111

840

Primary gonarthrosis, bilateral

512

3761

1.14

2.25

2.2

1.8

192.03

197.22

pmol/l

0.62

477

3530

Foreign body in respiratory tract

432

1.47

2.24

2.1

1.9

175.80

204.49

pmol/l

0.87

414

Normotensive glaucoma

342

1.53

2.24

1.8

198.45

197.13

pmol/l

0.03

320

Bacterial Sepsis

512

4806

0.88

2.23

2.0

1.9

182.04

203.13

pmol/l

4.73

475

4536

Ulcerative colitis

415

3601

1.16

2.23

1.9

203.75

206.11

pmol/l

0.19

404

3449

Urinary track infection

140

538

1.30

2.23

1.3

17.83

18.58

pmol/l

0.21

132

488

Thyroiditis

351

1.52

2.22

2.3

1.9

155.30

186.62

pmol/l

1.21

329

Respiratory insufficiency

553

0.61

2.22

2.6

1.8

175.32

199.01

pmol/l

0.60

515

Colorectal cancer, including Hilmo

207

2353

0.82

2.21

1.7

1.8

196.24

199.98

pmol/l

0.23

197

2210

Corneal ulcer

301

2550

1.19

2.20

2.1

1.9

198.47

206.76

pmol/l

0.84

294

2438

Acute and transient psychotic disorders

136

1732

0.78

2.19

2.0

172.41

213.69

pmol/l

4.50

127

1656

Bacterial infection, other or unspecified, including avohilmo

663

6064

0.89

2.18

2.0

1.9

187.76

203.47

pmol/l

3.21

613

5744

Bacterial, viral and other infectious agents, including avohilmo

201

1644

1.23

2.17

2.0

206.19

211.14

pmol/l

0.31

195

1579

Other/unspecified seropositive rheumatoid arthritis

126

1621

0.78

2.17

2.0

1.9

201.20

198.28

pmol/l

0.14

116

1526

Seropositive rheumatoid arthritis, wide

129

1654

0.78

2.16

2.0

1.9

200.08

198.64

pmol/l

0.06

119

1556

Bacterial pneumonia, not elsewhere classified

417

4203

0.87

2.16

1.9

182.08

202.59

pmol/l

3.54

396

3984

Galactorrhea

4.33

2.16

1.2

1.1

22.17

19.21

pmol/l

—

Primary open-angle glaucoma, strict

185

1493

1.24

2.15

1.9

1.8

189.67

195.21

pmol/l

0.31

170

1389

Psoriatic arthropathies

142

1116

1.28

2.15

1.9

1.8

200.02

208.02

pmol/l

0.37

131

1068

Asthma, unspecified (mode), excluding more controls

731

4698

1.12

2.15

2.1

1.8

185.53

199.70

pmol/l

3.14

689

4505

Phlebitis and thrombophlebitis (not including DVT)

265

2224

1.20

2.15

2.0

1.9

191.45

203.42

pmol/l

1.11

256

2094

Sarcoidosis

186

1509

1.24

2.15

2.2

2.0

202.37

208.48

pmol/l

0.34

174

1432

Other otitis externa (chronic)

622

1.38

2.13

2.1

1.9

197.65

201.22

pmol/l

0.12

590

L02BB Anti-androgens

824

0.69

2.13

1.7

1.8

115.20

197.02

pmol/l

5.29

758

Nonsuppurative otitis media

367

2745

1.16

2.12

2.0

1.8

202.27

197.32

pmol/l

0.31

348

2621

Autoimmune diseases excluding thyroid diseases, strict definition

1738

8816

1.07

2.11

1.9

1.8

200.09

203.33

pmol/l

0.67

1654

8426

Chondropathies

231

1921

1.21

2.09

2.1

2.0

200.46

204.30

pmol/l

0.25

223

1827

Erectile dysfunction, exclusion

0.00

2.09

0.0

1.8

—

232.86

—

Cyst of kidney

624

1.37

2.09

1.9

205.23

203.35

pmol/l

0.04

588

Special screening examination for other diseases and disorders

151

1199

1.26

2.09

2.1

1.8

199.15

199.20

pmol/l

0.00

145

1141

Other diseases of intestine

193

1577

1.23

2.08

2.0

1.8

201.61

202.54

pmol/l

0.04

173

1488

Renal failure

487

4699

0.88

2.08

2.0

1.9

184.07

202.36

pmol/l

4.02

454

4421

Other complications of surgical and medical care, not elsewhere classified

104

788

1.33

2.07

1.9

189.83

196.79

pmol/l

0.24

740

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

126

1608

0.78

2.05

2.0

1.9

201.20

198.55

pmol/l

0.12

116

1513

Other superficial mycoses, including avohilmo

183

1491

1.24

2.05

2.0

199.67

207.21

pmol/l

0.37

175

1418

Injury of muscle and tendon at forearm level

304

1.55

2.03

2.3

2.0

225.65

216.51

pmol/l

0.11

293

All chronic kidney diseases

618

5495

0.89

2.02

1.9

185.35

202.40

pmol/l

3.86

576

5205

Other congenital malformations

101

765

1.33

2.02

2.0

1.9

185.36

198.57

pmol/l

0.59

725

Ulcerative proctitis

750

1.33

2.01

1.9

205.88

207.08

pmol/l

0.03

708

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1287

9354

0.93

2.00

2.1

1.9

192.08

199.86

pmol/l

1.88

1216

8911

Small cell lung cancer

148

0.33

2.00

2.0

1.8

183.80

209.28

pmol/l

—

139

Small cell lung cancer, including Hilmo

148

0.33

2.00

2.0

1.8

183.80

209.28

pmol/l

—

139

Event of undetermined intent

129

1014

1.28

2.00

2.2

2.0

204.22

212.11

pmol/l

0.21

123

967

Delivery

409

0.68

2.00

1.4

1.2

15.77

21.08

pmol/l

2.95

373

Asthma, unspecified (mode)

736

4796

1.11

1.99

2.1

1.8

184.99

199.44

pmol/l

3.26

694

4596

Other specified/unspecified spondylopathies

126

1.84

1.99

2.0

1.7

206.52

211.03

pmol/l

0.05

118

Gout, unspecified

295

2520

1.18

1.99

2.0

1.9

185.10

202.93

pmol/l

2.54

268

2366

Persons encountering health services for specific procedures and health care

1771

9781

1.07

1.98

2.0

1.9

191.50

202.16

pmol/l

4.06

1673

9338

Other bacterial diseases, including avohilmo

1654

9643

1.07

1.97

2.1

1.9

190.76

204.92

pmol/l

5.68

1567

9216

Coxarthrosis [arthrosis of hip](FG)

704

4366

1.11

1.97

2.0

1.9

194.72

202.85

pmol/l

1.30

653

4138

Central nervous system disorder causing precocious puberty

3.92

1.96

3.2

1.1

93.00

191.19

pmol/l

—

Inflammatory diseases of the central nervous system

123

963

1.29

1.96

1.8

1.9

182.50

210.67

pmol/l

2.06

117

915

Glucosamine medication

304

2073

1.17

1.96

2.1

1.8

196.78

194.14

pmol/l

0.20

281

1921

Other maternal disorders predominantly related to pregnancy

127

618

1.29

1.95

1.4

1.3

18.36

18.48

pmol/l

0.02

119

562

Benign neoplasm: Stomach

572

1.37

1.94

1.8

1.9

197.57

193.35

pmol/l

0.07

536

Other and unspecified urticaria

211

1754

1.21

1.93

2.1

1.9

182.36

195.39

pmol/l

0.99

194

1661

Endometriosis of rectovaginal septum and vagina

2.73

1.93

1.3

26.78

14.65

pmol/l

—

Bacterial, viral and other infectious agents

190

1568

1.22

1.93

2.0

206.04

212.32

pmol/l

0.40

184

1508

Conotruncal defects

156

0.38

1.92

1.8

143.50

234.09

pmol/l

—

150

Polypectomy (DHB20)

122

958

1.29

1.92

1.9

196.51

208.20

pmol/l

0.74

116

910

Separation of retinal layers (serosa)

670

1.35

1.92

1.9

2.0

215.10

211.45

pmol/l

0.13

640

Injuries to unspecified part of trunk, limb or body region

137

1090

1.26

1.91

1.9

191.09

206.59

pmol/l

0.84

128

1030

5-aminosalicylic acid

372

3246

1.15

1.91

1.9

212.68

206.25

pmol/l

0.55

359

3106

Congenital malformations of genital organs

444

1.42

1.91

2.4

1.8

166.40

170.30

pmol/l

0.09

418

Malignant neoplasm of oral cavity

369

0.56

1.90

1.5

1.9

207.05

208.19

pmol/l

0.03

346

Atopic dermatitis, strict definition

399

3419

1.14

1.89

1.9

1.8

199.85

189.49

pmol/l

0.82

379

3273

malignant neoplasm of male genital organs

548

3692

0.89

1.89

1.9

191.35

206.45

pmol/l

2.47

514

3494

Type 1 diabetes, strict definition

118

1491

0.78

1.89

1.6

2.0

218.11

221.29

pmol/l

0.11

111

1440

Atrial fibrillation and flutter with reimbursement

442

2450

1.14

1.89

1.9

1.8

196.82

216.86

pmol/l

4.62

421

2357

Fall on and from stairs and steps

329

2847

1.16

1.88

2.0

1.9

187.12

200.12

pmol/l

1.61

306

2709

Gonarthrosis, primary, with knee surgery

572

3983

1.12

1.88

2.1

1.8

191.10

197.06

pmol/l

0.79

529

3733

Small cell lung cancer, helper endpoint

143

0.35

1.87

2.0

1.8

183.80

210.50

pmol/l

—

131

Systemic connective tissue disorders

257

2182

1.18

1.86

2.0

1.8

190.08

189.19

pmol/l

0.04

242

2035

Mental and behavioural disorders due to cannabinoids

745

1.33

1.86

2.4

2.0

171.41

228.54

pmol/l

7.53

719

Superficial injury of shoulder and upper arm

177

1455

1.22

1.85

2.3

1.9

206.73

206.59

pmol/l

0.01

165

1376

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

101

778

1.31

1.84

1.9

186.75

203.72

pmol/l

0.37

738

Asthma mixed form (mode)

367

1.45

1.84

1.9

1.7

199.81

196.06

pmol/l

0.11

344

Acute posthaemorrhagic anaemia

200

0.45

1.84

2.2

2.0

174.22

200.37

pmol/l

—

189

Other diseases of stomach and duodenum

485

1.39

1.83

1.9

180.59

204.14

pmol/l

1.34

462

Speech therapy

189

2272

0.83

1.81

1.8

1.9

191.35

201.03

pmol/l

0.73

172

2147

Faecal incontinence

262

1.53

1.81

2.3

1.9

198.26

190.68

pmol/l

0.19

243

Disorders in reading

216

1.60

1.80

2.2

2.0

209.41

227.86

pmol/l

0.26

208

Asthma mixed form (mode), excluding more controls

369

1.45

1.80

1.9

1.8

199.81

196.61

pmol/l

0.09

347

Diabetes, insulin treatment (Kela reimbursement)

1621

9037

1.07

1.80

2.0

1.9

181.91

208.96

pmol/l

20.80

1516

8665

Arthropod-borne viral fevers and viral haemorrhagic fevers

154

1254

1.24

1.79

1.9

2.0

197.16

206.74

pmol/l

0.66

146

1192

Varicella [chickenpox]

124

988

1.27

1.79

2.0

213.62

209.61

pmol/l

0.16

119

944

Superficial injury of ankle and foot

198

1653

1.20

1.78

1.8

1.9

182.42

202.24

pmol/l

1.32

191

1574

Other specified and unspecified retinal disorders

280

1.52

1.78

1.8

2.0

213.93

211.30

pmol/l

0.06

265

Alzheimer’s disease, strict definition

765

0.74

1.78

1.7

1.8

176.69

187.52

pmol/l

0.56

690

Alcohol dependence

455

5108

0.89

1.77

2.0

1.9

194.04

209.23

pmol/l

2.50

411

4891

Other bursitis of elbow

110

1.87

1.77

1.6

1.7

191.30

226.63

pmol/l

0.87

104

Other CVD

174

1434

1.22

1.77

1.9

179.97

197.84

pmol/l

1.78

160

1331

Scissor bite

222

1.58

1.76

2.1

1.8

198.60

186.99

pmol/l

0.27

213

Problems related to lifestyle

201

1684

1.20

1.75

2.0

1.9

189.33

208.49

pmol/l

1.15

184

1613

D07AA Corticosteroids, weak (group I)

191

1589

1.21

1.75

1.9

185.03

196.99

pmol/l

0.84

174

1514

Gout, idiopatic and unspecified

361

3166

1.14

1.75

2.0

1.9

190.40

202.75

pmol/l

1.51

328

2972

Impacted maxillary molar

645

1.33

1.74

1.6

1.8

163.46

181.26

pmol/l

0.59

615

Paroxysmal tachycardia

314

2263

1.16

1.72

2.3

1.8

203.06

209.31

pmol/l

0.57

293

2174

Lichen planus

116

918

1.27

1.72

1.7

1.9

182.28

204.28

pmol/l

1.75

109

866

Presence of cardiac and vascular implants and grafts

493

4051

0.89

1.72

1.8

1.9

191.32

203.42

pmol/l

1.73

470

3796

Endometriosis of intestine

3.86

1.71

1.2

18.20

17.71

pmol/l

—

Fracture of lower leg, including ankle

810

7291

1.09

1.71

1.9

190.69

205.66

pmol/l

4.00

762

6981

Diabetic retinopathy

341

2419

0.87

1.70

2.1

2.0

181.97

173.41

pmol/l

0.78

315

2258

Septicaemia

433

4435

0.89

1.69

2.1

1.9

173.19

202.66

pmol/l

8.01

407

4182

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

684

1.31

1.68

1.7

1.9

186.08

191.73

pmol/l

0.26

625

Collapsed vertebra, not elsewhere classified

2.62

1.67

1.1

2.0

127.75

215.77

pmol/l

—

Disorders of psychological development

215

1687

1.19

1.67

2.1

1.8

179.03

216.77

pmol/l

4.06

206

1620

Malignant neoplasm of rectosigmoid junction

145

0.41

1.66

4.0

2.0

182.67

210.93

pmol/l

—

136

Transient ischemic attack

561

4028

1.11

1.66

1.9

193.06

199.75

pmol/l

0.93

534

3779

Immunodeficiencies

393

1.41

1.65

2.1

2.0

187.75

210.70

pmol/l

0.89

372

Varicella [chickenpox], including avohilmo

130

1051

1.25

1.65

1.9

2.0

210.46

207.45

pmol/l

0.12

125

1005

Bacterial pneumonia (organism specified)

484

4882

0.90

1.64

1.9

184.57

202.01

pmol/l

3.04

462

4625

Benign neoplasm: Skin of ear and external auricular canal

261

1.51

1.64

2.2

1.9

182.18

205.68

pmol/l

0.77

246

All dysplastic lesions of the cervix uteri, vagina or vulva

558

1.33

1.63

1.2

1.3

17.91

17.82

pmol/l

0.02

511

Suicide or other Intentional self-harm

394

3495

1.13

1.62

2.1

1.9

176.30

202.92

pmol/l

4.03

371

3355

Diseases of the digestive system

559

5016

1.11

1.62

1.8

1.9

200.32

198.39

pmol/l

0.16

521

4737

Disorders of adrenal gland, other and/or unspecified

2.56

1.61

3.0

1.5

182.38

206.11

pmol/l

—

Failure and rejection of transplanted organs and tissues

191

1.61

1.6

2.0

199.37

224.17

pmol/l

0.81

179

Benign neoplasm: Lip

167

1.64

1.60

2.3

1.9

203.37

220.94

pmol/l

0.40

158

Necrosis of pulp, including avohilmo

1011

9277

1.08

1.60

2.0

1.9

193.51

203.16

pmol/l

2.23

963

8879

Vestibular neuronitis

103

813

1.27

1.59

2.3

1.9

209.94

203.09

pmol/l

0.33

765

Evidence of alcohol involvement determined by blood alcohol level

234

0.50

1.59

2.3

1.9

155.08

222.56

pmol/l

1.58

223

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

141

0.41

1.59

1.5

2.0

207.83

232.69

pmol/l

—

132

Glaucoma suspect

314

2746

1.15

1.59

1.9

185.35

198.76

pmol/l

1.84

291

2581

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

417

3718

1.12

1.58

2.0

1.9

167.44

192.03

pmol/l

3.60

393

3564

Carcinoma in situ of skin of other and unspecified parts of face

329

1.43

1.58

1.9

1.7

221.10

194.71

pmol/l

0.32

307

Contact with machinery

262

2270

1.16

1.58

2.0

197.54

212.42

pmol/l

2.02

248

2167

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

694

3993

1.10

1.57

2.0

1.8

192.01

208.97

pmol/l

4.22

668

3850

Effects of foreign body entering through natural orifice

518

4682

1.11

1.56

2.0

1.9

204.24

210.13

pmol/l

0.71

488

4483

Other hearing loss

237

1971

1.17

1.55

2.0

1.8

192.07

199.60

pmol/l

0.60

227

1838

Type 1 diabetes, strict definition, subgroup 1

115

1418

0.80

1.54

1.6

2.0

217.73

222.08

pmol/l

0.15

108

1369

All dysplastic lesions of the cervix uteri

535

1.33

1.53

1.3

18.26

17.77

pmol/l

0.11

488

Injury of unspecified body region

738

1.28

1.53

1.8

2.0

192.94

203.73

pmol/l

0.35

703

Other strabismus

274

2375

1.15

1.52

1.8

1.9

187.29

198.26

pmol/l

0.93

258

2266

Non-small cell lung cancer, adenocarcinoma

395

0.63

1.52

1.6

1.9

177.96

197.80

pmol/l

0.72

369

Valvular heart disease excluding rheumatic fever

544

4284

0.90

1.52

2.0

1.9

188.85

205.50

pmol/l

4.25

513

4069

Focal epilepsy

214

2496

0.85

1.51

2.0

1.9

193.82

205.27

pmol/l

0.88

197

2371

Cardiomyopathy

191

2247

0.85

1.51

1.8

1.9

223.75

206.52

pmol/l

1.06

182

2127

Delirium, not induced by alcohol and other psychoactive substances

1006

0.77

1.51

2.0

1.9

161.90

206.67

pmol/l

4.11

948

Abnormal findings on diagnostic imaging of lung

554

4762

1.10

1.50

1.9

189.30

200.67

pmol/l

2.33

509

4484

Disorders of gallbladder, biliary tract and pancreas

1232

8179

0.94

1.50

1.9

185.11

199.64

pmol/l

5.53

1162

7769

Vascular dementia (multiple infarctions)

0.00

1.50

0.0

1.8

—

210.25

—

Acute lymphadenitis

688

1.29

1.50

2.0

1.9

198.81

212.94

pmol/l

0.74

655

Amblyopia ex anopsia

342

1.41

1.49

1.9

205.17

197.06

pmol/l

0.17

327

Hypertensive heart and/or renal disease

241

2037

0.86

1.49

1.8

183.20

210.43

pmol/l

3.14

225

1926

Strabismus

327

2877

1.14

1.49

1.8

1.9

186.81

198.48

pmol/l

1.21

308

2743

Amputation of foot

255

0.54

1.49

2.7

1.9

181.43

214.32

pmol/l

0.65

239

Degeneration of macula and posterior pole

384

2635

1.13

1.48

2.0

1.8

197.74

194.22

pmol/l

0.22

355

2442

Malignant neoplasm of head and neck, including Hilmo

1093

0.78

1.47

1.9

206.72

205.66

pmol/l

0.04

1033

Emotional disorders and disorders of social functioning with onset specific to childhood

469

1.34

1.47

2.1

1.7

143.53

185.63

pmol/l

1.69

446

Other disorders of conjunctiva

139

1146

1.22

1.47

2.0

1.9

198.27

203.85

pmol/l

0.30

132

1081

Psoriasis vulgaris

291

2552

1.15

1.47

1.9

186.16

207.19

pmol/l

3.48

275

2428

Other disorders of cornea

122

994

1.23

1.46

1.9

201.38

211.39

pmol/l

0.62

117

941

Aortic aneurysm

331

2872

1.13

1.45

1.9

199.98

201.55

pmol/l

0.11

316

2672

Nausea and vomiting

259

2198

1.15

1.44

1.8

182.60

195.00

pmol/l

0.68

241

2084

Viral haemorrhagic fevers, not elsewhere classified/unspecified

124

1015

1.23

1.44

1.8

2.0

197.20

207.60

pmol/l

0.64

119

963

Non-small cell lung cancer, adenocarcinoma, helper endpoint

389

0.64

1.44

1.6

1.8

177.96

202.02

pmol/l

0.90

359

Type of accident

438

3943

1.11

1.43

1.9

204.23

202.56

pmol/l

0.11

421

3764

Psoriatic and enteropathic arthropathies

167

1406

1.19

1.43

1.9

201.68

209.37

pmol/l

0.41

156

1347

Non-rheumatic valve diseases

541

4243

0.91

1.43

2.0

1.9

188.96

205.54

pmol/l

4.21

511

4030

Benign lipomatous neoplasm of other sites/unspecified

657

1.29

1.43

2.1

1.9

183.87

202.22

pmol/l

1.10

624

Maternal care related to the fetus and amniotic cavity and possible delivery problems

570

0.77

1.42

1.3

14.67

19.33

pmol/l

3.56

523

Atopic conjunctivitis

397

1.37

1.41

2.0

1.9

192.69

208.35

pmol/l

0.45

377

Iridocyclitis

297

2616

1.14

1.41

2.1

1.9

198.53

203.15

pmol/l

0.34

286

2488

Retinal detachment with retinal break

164

1381

1.19

1.41

1.8

1.9

212.66

201.31

pmol/l

0.83

155

1306

Intracranial injury

900

7797

1.08

1.41

2.0

1.9

200.93

201.24

pmol/l

0.02

852

7432

Seropositive rheumatoid arthritis

129

1553

0.82

1.40

2.0

1.8

200.08

196.62

pmol/l

0.17

119

1459

ILD medications: azathioprine

223

1927

1.16

1.40

2.0

1.9

194.74

205.89

pmol/l

0.98

211

1830

Other maltreatment syndromes

644

1.29

1.40

1.8

2.0

198.73

222.31

pmol/l

1.18

619

Diabetic retinopathy, excluding more controls

292

1858

0.88

1.39

2.2

2.0

186.41

174.13

pmol/l

1.13

270

1744

Rheumatoid arthritis, including avohilmo

245

2810

0.87

1.39

1.8

1.9

196.39

194.40

pmol/l

0.11

229

2641

Later onset COPD, excluding more controls

103

973

0.80

1.39

1.9

1.7

182.49

190.46

pmol/l

0.34

889

Osteonecrosis due to drugs

122

0.40

1.38

1.8

2.0

164.20

228.67

pmol/l

—

111

Diabetic retinopathy, strict definition

176

1835

0.85

1.38

2.1

2.0

183.71

171.13

pmol/l

0.86

165

1718

Contact with sharp glass

662

1.28

1.38

2.0

1.9

203.91

214.69

pmol/l

0.40

631

Medical abortion

622

0.79

1.38

1.4

1.3

14.39

19.47

pmol/l

3.78

574

Intestinal malabsorption

503

1.32

1.38

1.8

1.9

232.00

207.40

pmol/l

0.65

481

Gout, strict definition

257

2248

1.15

1.37

2.0

1.9

185.98

201.61

pmol/l

1.61

230

2107

All influenza

419

3776

1.11

1.36

2.0

1.9

201.69

206.29

pmol/l

0.39

395

3595

Acquired clawhand, clubhand, clawfoot and clubfoot

2.18

1.36

3.1

2.0

199.80

235.62

pmol/l

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

222

0.54

1.36

2.9

1.9

200.17

202.07

pmol/l

0.02

207

Mental and behavioural disorders due to alcohol, excluding acute intoxication

838

8924

0.93

1.36

2.0

1.9

200.06

207.71

pmol/l

1.13

769

8544

Explicit Sepsis

440

4430

0.90

1.35

2.1

1.8

172.79

198.98

pmol/l

6.24

414

4174

Aplastic and other anaemias

379

3864

0.90

1.35

1.9

174.78

197.50

pmol/l

5.03

355

3605

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

2.15

1.33

1.3

17.11

15.51

pmol/l

—

Herpesviral keratitis and keratoconjunctivitis

376

1.37

1.33

2.5

1.8

186.45

209.24

pmol/l

0.90

355

Type 2 diabetes, wide definition

1188

7036

1.07

1.33

2.1

1.9

175.49

212.09

pmol/l

33.90

1105

6735

Benign neoplasm: Skin, unspecified

325

1.40

1.33

1.6

2.0

205.80

206.75

pmol/l

0.01

308

Lipomatosis, not elsewhere classified

2.58

1.32

1.0

2.5

154.67

228.92

pmol/l

—

Scleritis and episcleritis

551

1.30

1.31

1.9

192.30

206.68

pmol/l

0.60

518

Pilonidal cyst

222

1933

1.16

1.31

2.2

2.0

191.83

216.75

pmol/l

3.26

212

1857

Acute tubulo-interstitial nephritis

607

4703

1.09

1.30

1.9

1.8

173.74

184.50

pmol/l

1.57

563

4416

Maternal care for cervical incompetence

2.10

1.30

1.6

1.2

17.44

15.97

pmol/l

—

AV-block

184

1345

1.17

1.29

1.9

1.8

184.06

203.05

pmol/l

2.36

173

1256

Abscess of anal and rectal regions

172

1469

1.18

1.29

2.0

1.9

195.67

212.59

pmol/l

1.79

167

1406

Diabetic neuropathy

146

1223

1.19

1.29

1.8

2.0

167.15

184.16

pmol/l

1.41

137

1142

Other disorders of Eustachian tube

243

1.45

1.29

3.0

1.8

181.74

205.98

pmol/l

0.84

229

Presbycusis

441

1.32

1.28

1.8

1.7

182.74

191.60

pmol/l

0.30

393

Episcleritis

474

1.32

1.28

2.0

1.9

187.24

205.49

pmol/l

0.77

446

Alcohol abuse, main dg

249

2829

0.88

1.28

2.0

1.9

192.63

207.03

pmol/l

1.51

225

2704

Adenocarcinoma and papillary adenocarcinoma of stomach

230

0.56

1.28

1.5

2.0

235.23

209.33

pmol/l

0.25

217

Other septicaemia

372

3893

0.90

1.26

2.1

1.9

172.54

202.61

pmol/l

7.26

352

3661

Ischaemic heart disease, wide definition

1169

6769

1.06

1.26

2.0

1.9

200.12

206.94

pmol/l

1.40

1108

6450

Superficial injury of head

322

2872

1.12

1.26

2.0

1.9

194.93

203.53

pmol/l

0.90

305

2747

Other disorders of urethra and urinary system

530

4028

0.91

1.26

1.9

1.8

174.07

180.49

pmol/l

0.62

488

3771

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

139

1648

0.84

1.25

1.7

1.9

189.07

202.08

pmol/l

0.82

134

1552

Sub-endpoint used in defining T1D endpoints

404

4388

0.90

1.25

1.9

2.0

195.52

207.95

pmol/l

1.77

379

4201

Fracture of lumbar spine and pelvis

211

1829

1.15

1.25

1.9

189.24

202.07

pmol/l

0.98

196

1717

Other septicaemia, including avohilmo

386

4010

0.90

1.25

2.1

1.9

172.36

202.61

pmol/l

7.64

365

3775

Ankylosing spondylitis, ICD10

153

1299

1.19

1.25

1.9

211.77

214.16

pmol/l

0.11

146

1234

Pedal cyclist injured in transport accident

366

3296

1.11

1.24

2.0

1.9

207.16

205.71

pmol/l

0.10

349

3159

Other bursitis of knee

188

1.51

1.23

1.8

192.68

212.08

pmol/l

0.49

182

Injury of nerves at lower leg level

116

1.67

1.23

1.8

2.1

203.95

222.34

pmol/l

0.35

109

Viral warts

134

1126

1.20

1.22

2.2

1.9

215.60

203.04

pmol/l

0.44

128

1064

Other abnormal auditory perceptions

1.82

1.22

1.9

182.36

221.77

pmol/l

0.77

Infection of intervertebral disc (pyogenic)

132

1.62

1.22

2.2

1.7

167.14

222.49

pmol/l

1.78

124

Traumatic subdural haemorrhage

127

992

1.20

1.22

1.6

1.7

207.58

211.57

pmol/l

0.11

120

934

Focal brain injury

728

1.24

1.20

1.9

1.7

226.64

225.23

pmol/l

0.03

696

Acute and subacute iridocyclitis

254

2245

1.14

1.20

2.1

1.9

197.29

206.59

pmol/l

0.76

244

2132

Superficial injury of forearm

141

1193

1.19

1.20

2.1

2.0

192.09

202.40

pmol/l

0.53

132

1140

Disorders of optic nerve and visual pathways

801

1.23

1.19

2.1

1.9

182.47

202.68

pmol/l

1.10

753

Azathioprine

223

1956

1.14

1.19

2.0

1.9

194.74

207.13

pmol/l

1.15

211

1858

Alzheimer’s disease (Late onset)

619

0.77

1.19

1.6

1.7

177.69

184.56

pmol/l

0.27

554

Oxycodone

434

3375

1.10

1.18

2.2

1.8

187.26

203.31

pmol/l

1.74

412

3207

Psoriasis

414

3765

1.10

1.17

2.0

1.9

192.21

203.98

pmol/l

1.61

390

3587

162

1191

1.17

1.16

1.9

1.8

181.13

187.82

pmol/l

0.45

146

1096

Squamous cell neoplasms and carcinomas of the skin

516

1.28

1.16

1.6

1.9

171.58

192.38

pmol/l

1.51

472

Congenital malformations of the urinary system, including avohilmo

643

1.25

1.15

1.6

1.9

193.45

206.64

pmol/l

0.51

607

malignant neoplasm of male genital organs, including Hilmo

591

3840

0.92

1.15

1.9

192.70

206.46

pmol/l

2.32

557

3640

Dependence on enabling machines and devices, not elsewhere classified

111

0.44

1.14

1.0

1.8

218.60

234.76

pmol/l

—

104

Explicit Sepsis, including avohilmo

460

4549

0.91

1.13

2.1

1.8

173.35

199.18

pmol/l

6.40

433

4290

Implicit bacterial Sepsis

439

4115

0.91

1.13

1.9

179.80

203.00

pmol/l

4.91

404

3874

Focal epilepsy, strict definition

201

2292

0.87

1.12

2.0

1.9

194.84

206.37

pmol/l

0.83

185

2178

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

106

880

1.21

1.12

2.1

1.9

187.38

199.27

pmol/l

0.28

827

Spirochaetal infections, other/unspecified

762

1.23

1.12

2.1

1.9

204.71

203.71

pmol/l

0.03

713

Acidosis

220

0.58

1.12

2.3

1.8

210.08

215.67

pmol/l

0.05

213

Other bacterial intestinal infections

190

1656

1.15

1.12

2.0

1.9

189.65

205.30

pmol/l

1.32

180

1565

Ankyloglossia

151

1.54

1.11

1.7

1.8

236.74

208.14

pmol/l

0.38

146

Rheumatic valve diseases

137

0.51

1.10

1.0

2.1

216.43

225.06

pmol/l

—

130

Cholecystitis

132

1120

1.18

1.10

2.1

1.9

195.20

198.67

pmol/l

0.15

124

1045

Oesophagitis

549

1.26

1.09

1.8

1.9

201.00

208.92

pmol/l

0.29

521

Other congenital malformations of the digestive system, including avohilmo

439

1.30

1.09

2.0

1.9

213.23

203.26

pmol/l

0.25

416

Rheumatoid arthritis

209

2102

0.88

1.09

1.8

193.97

193.89

pmol/l

0.00

197

1989

Abnormal blood-pressure reading, without diagnosis

364

1.33

1.08

2.3

1.7

236.30

215.08

pmol/l

0.45

348

Bronchitis, not specified as acute or chronic

133

1132

1.18

1.08

1.9

214.25

212.55

pmol/l

0.07

127

1072

Anterior Iridocyclitis

263

2348

1.12

1.08

2.1

2.0

196.26

206.27

pmol/l

0.88

253

2230

Abnormal findings in secretions and smears from cervix uteri vagina vulva

108

661

1.20

1.07

1.2

1.3

16.85

18.26

pmol/l

0.50

611

Fracture of foot, except ankle

371

3376

1.10

1.07

1.8

1.9

190.05

203.48

pmol/l

1.71

353

3233

Other encephalitis

279

1.37

1.07

1.7

1.9

173.12

216.14

pmol/l

1.54

265

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

500

0.74

1.06

2.8

1.9

212.28

208.39

pmol/l

0.09

477

Other disorders of breast

153

1.51

1.06

1.1

1.3

14.83

17.85

pmol/l

0.57

136

Hypertensive Heart Disease

217

1861

0.88

1.05

1.7

1.8

176.57

209.17

pmol/l

5.53

203

1758

Encephalitis

297

1.36

1.05

1.7

1.9

174.26

216.75

pmol/l

1.60

281

Insulin, intermediate and long-acting

803

8244

0.94

1.05

1.9

184.17

206.63

pmol/l

8.84

746

7860

Injury of nerves at shoulder and upper arm level

130

1.56

1.04

1.6

2.0

221.05

220.50

pmol/l

0.01

121

Burns and corrosions confined to eye and internal organs

447

1.29

1.04

1.7

2.0

190.96

213.09

pmol/l

0.93

428

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

311

2811

1.11

1.04

1.9

210.78

207.03

pmol/l

0.24

301

2687

Malignant neoplasm of penis, including Hilmo

106

0.46

1.04

1.8

2.0

219.20

221.71

pmol/l

—

Vitreous haemorrhage

125

1063

1.18

1.04

1.9

198.72

208.34

pmol/l

0.58

118

1005

Tuberculosis, wide

429

0.72

1.04

1.5

1.8

190.77

205.60

pmol/l

0.48

405

Accidental poisoning by and exposure to alcohol

263

0.64

1.03

2.1

1.8

199.12

208.10

pmol/l

0.14

251

Rash and other nonspecific skin eruption

679

1.23

1.03

2.4

1.9

181.59

196.02

pmol/l

0.71

639

Congenital malformations and deformations of the musculoskeletal system

107

893

1.20

1.03

2.3

1.9

198.03

200.30

pmol/l

0.06

850

Focal epilepsy, mode (most common among epilepsy diagnosis)

191

2169

0.88

1.03

2.1

1.9

195.39

206.40

pmol/l

0.75

177

2057

Bullous keratopathy

1.94

1.03

1.4

1.7

193.00

246.26

pmol/l

—

Infliximab

369

1.32

1.02

2.0

215.60

225.64

pmol/l

0.33

355

Acute myeloid leukaemia, including Hilmo

107

0.46

1.02

2.8

2.1

186.20

231.35

pmol/l

—

100

Acute myeloid leukaemia

107

0.46

1.02

2.8

2.1

186.20

231.35

pmol/l

—

100

Acute myeloid leukaemia, helper endpoint

107

0.46

1.02

2.8

2.1

186.20

231.35

pmol/l

—

100

Tuberculosis, wide, including avohilmo

439

0.73

1.02

1.5

1.8

189.72

205.13

pmol/l

0.53

415

Other obstetric conditions, not elsewhere classified

117

621

1.19

1.02

1.4

1.2

16.74

18.94

pmol/l

1.05

106

573

Other disorders of fluid, electrolyte and acid-base balance

262

2749

0.90

1.01

2.2

1.8

180.98

204.16

pmol/l

2.83

234

2596

Alcohol use disorder, ICD-based

781

8306

0.94

1.01

2.0

1.9

197.71

208.24

pmol/l

1.75

718

7947

Schizoid personality disorder

285

0.66

1.01

2.0

1.9

217.21

225.80

pmol/l

0.10

271

Hypothyroidism due to medicaments and other exogenous substances

1.79

1.01

1.7

1.8

187.67

211.27

pmol/l

0.41

Other and unspecified mononeuropathies, also in other diseases

239

1.39

1.01

1.9

1.8

208.07

216.73

pmol/l

0.17

226

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

284

2560

1.11

1.01

1.9

2.0

207.18

206.60

pmol/l

0.03

276

2447

Calcific aortic valvular stenosis, including rheumatic fever

203

2206

0.88

1.01

1.8

175.54

198.44

pmol/l

3.21

186

2045

Pedestrian injured in other and unspecified transport accidents

115

1.59

1.01

2.4

1.9

205.28

239.11

pmol/l

0.55

107

Biological medication for rheuma

286

2579

1.11

1.01

1.8

2.0

199.55

207.62

pmol/l

0.71

275

2471

Ulcerative colitis (strict definition, require KELA)

291

2627

1.11

1.01

1.9

208.25

206.21

pmol/l

0.13

282

2511

Vitamin deficiency

369

1.31

1.00

2.3

1.9

174.81

212.24

pmol/l

1.71

352

Vitamin deficiency, wide

369

1.31

1.00

2.3

1.9

174.81

212.24

pmol/l

1.71

352

Atopic dermatitis

905

6795

1.06

1.00

1.9

198.67

200.13

pmol/l

0.13

873

6504

Glomerular disorders in diseases classified elsewhere

131

1524

0.86

1.00

1.8

2.0

190.68

209.51

pmol/l

1.45

124

1441

Other infective otitis externa

574

1.24

1.00

2.0

1.9

181.14

206.06

pmol/l

1.05

548

Malignant neoplasm of eye and adnexa, including Hilmo

131

0.53

1.00

1.0

2.0

205.14

225.46

pmol/l

—

123

Other and unspecified disorders of white blood cells

335

1.32

0.99

2.2

1.9

180.38

204.77

pmol/l

1.13

318

Implicit bacterial Sepsis, including avohilmo

508

4559

0.92

0.99

2.0

1.9

180.91

202.63

pmol/l

5.04

469

4297

Peripheral retinal degeneration

232

1.39

0.98

2.0

1.8

178.41

198.39

pmol/l

0.48

220

Benign neoplasm: Skin of other and unspecified parts of face

711

1.21

0.98

1.9

195.11

199.73

pmol/l

0.15

674

Tuberculosis, IBD comorbidity

424

0.73

0.98

1.5

1.8

190.77

205.66

pmol/l

0.49

400

Hypotension

141

1217

1.16

0.98

1.9

181.85

197.77

pmol/l

1.19

128

1129

Gastrojejunal ulcer

100

1.62

0.98

1.8

230.75

213.63

pmol/l

0.31

Congenital malformations of anterior segment of eye

1.82

0.97

1.7

1.8

174.44

205.27

pmol/l

—

Bacterial intestinal infections, IBD co-morbidities

189

1667

1.14

0.97

2.0

1.9

192.68

204.08

pmol/l

0.84

179

1570

Malignant neoplasm of brain, including Hilmo

570

0.77

0.97

1.9

196.53

214.90

pmol/l

0.63

543

Burn and corrosion of ankle and foot

198

0.60

0.97

1.8

1.9

179.08

220.31

pmol/l

0.73

185

Contact with other sharp object(s)

135

1165

1.17

0.96

1.7

2.0

180.57

210.88

pmol/l

2.31

129

1111

Maternal care for other known or suspected fetal problems

493

0.80

0.96

1.3

1.2

18.54

19.22

pmol/l

0.15

454

Other and unspecified injuries of head

786

1.20

0.96

2.0

179.74

204.76

pmol/l

1.47

749

Emotional disorders starting during childhood or adolescence

465

1.26

0.96

2.2

1.8

140.56

189.32

pmol/l

1.87

447

Operations 2 for CAVS

203

2199

0.89

0.96

1.8

175.54

198.41

pmol/l

3.20

186

2039

Calcific aortic valvular stenosis, diagnosis (helper)

203

2199

0.89

0.96

1.8

175.54

198.41

pmol/l

3.20

186

2039

Injury of other and unspecified intrathoracic organs

922

0.82

0.95

2.2

2.0

203.55

214.07

pmol/l

0.41

880

Covid-19 suspected case

279

2521

1.11

0.95

1.7

1.9

182.72

194.82

pmol/l

1.26

266

2405

Presence of other functional implants

629

4019

1.07

0.95

2.0

1.9

190.62

199.89

pmol/l

1.31

595

3762

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

116

619

1.18

0.95

1.4

1.2

16.59

18.95

pmol/l

1.16

105

571

Other disorders of optic [2nd] nerve and visual pathways

551

1.24

0.95

2.3

1.9

187.13

204.50

pmol/l

0.67

524

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

678

1.21

0.94

1.9

2.0

203.41

204.58

pmol/l

0.04

644

Aneurysms, operations, SAH

121

1409

0.86

0.94

2.2

1.9

210.20

201.56

pmol/l

0.19

115

1332

Insulin, fast-acting (human)

206

2311

0.89

0.94

1.9

2.0

201.19

212.90

pmol/l

0.89

194

2215

Renal agenesis and other reduction defects of kidney

1.77

0.94

2.1

2.3

178.56

221.93

pmol/l

—

Disorders of calcium metabolism

498

1.25

0.93

2.2

1.8

203.60

209.66

pmol/l

0.15

475

Pyogenic arthritis

716

1.21

0.93

2.5

1.7

199.26

209.49

pmol/l

0.30

685

Palmar fascial fibromatosis [Dupuytren]

165

1449

1.14

0.92

1.9

1.8

219.22

202.33

pmol/l

0.82

147

1377

Other disorders of kidney and ureter

149

1300

1.15

0.92

1.8

1.9

192.66

205.47

pmol/l

0.57

141

1225

Calcific aortic valvular stenosis, operated

204

2202

0.89

0.92

1.8

174.82

198.39

pmol/l

3.36

187

2042

Calcific aortic valvular stenosis

204

2202

0.89

0.92

1.8

174.82

198.39

pmol/l

3.36

187

2042

Traction detachment of retina

102

0.48

0.91

1.8

2.1

216.20

219.18

pmol/l

—

1199

9948

1.05

0.90

2.0

1.9

198.17

206.69

pmol/l

1.90

1116

9518

Intentional self-harm by hanging, strangulation and suffocation

129

0.53

0.90

3.1

1.8

148.43

237.87

pmol/l

—

121

Tuberculosis of other organs, strict, including avohilmo

101

0.49

0.89

1.8

197.60

225.57

pmol/l

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

661

1.19

0.89

1.2

1.3

17.45

18.12

pmol/l

0.23

605

Angina pectoris

763

4767

1.06

0.89

2.0

1.9

192.78

206.23

pmol/l

3.21

722

4513

Tumor necrosis factor alpha inhibitors

250

2257

1.11

0.89

1.8

2.0

199.31

207.75

pmol/l

0.68

241

2157

Viral conjunctivitis, including avohilmo

350

1.29

0.89

2.1

1.9

206.02

199.61

pmol/l

0.15

330

Secondary hypertension

116

981

1.17

0.89

2.0

1.8

190.45

217.61

pmol/l

2.40

111

935

Chronic periodontitis, complicated

740

7642

0.94

0.89

1.9

189.59

204.27

pmol/l

4.40

677

7282

Benign neoplasm: Conjunctiva

254

1.35

0.89

2.0

1.9

196.71

205.31

pmol/l

0.19

238

Oesophageal varices

483

0.76

0.88

2.1

1.9

187.41

213.79

pmol/l

1.30

454

Hyperlipidaemia, other/unspecified

483

4033

1.08

0.88

2.1

1.9

184.12

206.29

pmol/l

7.54

452

3820

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1323

8735

0.96

0.88

2.0

1.9

195.91

201.98

pmol/l

1.46

1264

8298

Unspecified fall

699

6458

1.06

0.88

1.9

201.91

201.65

pmol/l

0.02

655

6158

Viral infections of central nervous system, not elsewhere classified/unspecified

136

1.49

0.88

1.7

2.0

226.00

228.25

pmol/l

0.02

127

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

760

0.81

0.88

1.9

2.0

202.71

211.20

pmol/l

0.29

720

Other fall from one level to another

364

3348

1.09

0.87

1.9

201.61

201.97

pmol/l

0.02

335

3198

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

103

879

1.18

0.86

2.0

191.71

204.02

pmol/l

0.48

832

Arthropathic psoriasis

154

1355

1.14

0.86

1.9

200.07

209.46

pmol/l

0.47

143

1283

Glaucoma secondary to other eye disorders

333

0.72

0.86

1.8

1.9

189.42

210.67

pmol/l

0.73

313

Tuberculosis

344

0.72

0.85

1.5

1.8

186.24

207.24

pmol/l

0.67

323

Maternal care for known or suspected fetal abnormality and damage

398

0.76

0.84

1.3

1.2

20.97

19.12

pmol/l

0.14

363

Ulcerative colitis (strict definition, all Crohn cases excluded)

247

2239

1.11

0.84

1.9

2.0

201.66

208.23

pmol/l

0.48

240

2138

Fitting and adjustment of other devices

337

2725

1.09

0.83

1.8

196.34

197.49

pmol/l

0.08

312

2533

Polyarteritis nodosa and related conditions

114

0.52

0.83

3.3

1.9

210.50

236.09

pmol/l

—

104

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

140

0.57

0.83

1.8

1.9

206.88

207.86

pmol/l

—

131

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

163

1.43

0.83

1.9

2.0

235.74

234.39

pmol/l

0.01

154

Emphysema

656

0.80

0.83

1.6

1.8

207.21

207.40

pmol/l

0.00

615

Disorders of porphyrin and bilirubin metabolism

138

1.47

0.83

1.6

1.9

225.95

220.54

pmol/l

0.07

133

Burn and corrosion confined to eye and adnexa

391

1.27

0.82

1.8

2.0

187.93

214.64

pmol/l

1.03

374

Other disorders of white blood cells

471

1.24

0.82

2.3

1.9

183.55

206.90

pmol/l

1.10

447

Neovascular glaucoma

330

0.72

0.82

1.8

1.9

189.42

211.09

pmol/l

0.76

311

Left bundle-branch block

571

1.21

0.82

1.8

1.9

181.69

206.49

pmol/l

1.53

535

Other and unspecified injuries of lower leg

810

1.18

0.82

1.9

180.59

207.02

pmol/l

1.76

764

Other and specified injuries of hip and thigh

189

1.39

0.81

2.5

1.9

212.00

214.70

pmol/l

0.04

178

Cystitis

745

4686

0.94

0.81

1.8

160.46

184.14

pmol/l

7.17

701

4399

Bell's palsy

136

1192

1.14

0.81

1.8

1.9

199.06

204.76

pmol/l

0.30

126

1131

Use of memantine

826

0.85

0.81

1.5

1.8

172.70

185.39

pmol/l

0.83

749

Use of other anti-dementia drugs

826

0.85

0.81

1.5

1.8

172.70

185.39

pmol/l

0.83

749

Infectious mononucleosis

144

1269

1.14

0.80

2.1

1.9

211.30

198.30

pmol/l

0.69

138

1217

Infectious mononucleosis, including avohilmo

144

1269

1.14

0.80

2.1

1.9

211.30

198.30

pmol/l

0.69

138

1217

Malignant neoplasm of base of tongue

0.50

0.80

1.2

2.0

173.80

214.41

pmol/l

—

Contact with hot air and gases

0.51

0.80

7.2

1.7

212.40

225.75

pmol/l

—

Atrophic disorders of skin

775

1.18

0.79

1.5

1.9

172.12

197.17

pmol/l

1.28

728

Dipeptidyl peptidase 4 (DPP-4) inhibitors

629

5230

0.94

0.79

2.0

1.8

171.12

207.88

pmol/l

20.02

575

4968

Toxic effects of substances chiefly nonmedicinal as to source

185

1658

1.12

0.79

2.0

196.07

208.25

pmol/l

1.00

180

1580

IBD patients in KELA-register

400

3716

1.08

0.79

1.9

208.90

207.39

pmol/l

0.10

385

3563

Other epidermal thickening

375

1.26

0.79

1.6

1.9

186.19

207.47

pmol/l

0.78

358

Rheumatic fever incl heart disease

199

0.65

0.78

1.8

2.1

241.00

217.33

pmol/l

0.31

186

Tuberculosis of other organs

0.51

0.78

1.8

197.60

228.58

pmol/l

—

Varicose veins

437

3541

0.93

0.78

1.8

1.9

190.52

194.57

pmol/l

0.34

414

3311

Congenital malformations of the circulatory system

210

1841

1.11

0.78

2.2

2.0

200.76

205.10

pmol/l

0.25

200

1751

Alzheimer disease, excluding more controls

557

0.83

0.78

1.7

1.6

172.76

200.91

pmol/l

2.16

518

Benign neoplasm of breast

0.51

0.77

1.2

1.3

12.00

15.01

pmol/l

—

Leisure time condition

235

2135

1.10

0.77

2.0

1.9

191.70

204.86

pmol/l

1.13

224

2032

Other abnormal products of conception

507

1.18

0.77

1.3

15.04

18.96

pmol/l

2.31

467

Tuberculosis of other organs, strict

100

0.50

0.77

1.8

197.60

227.32

pmol/l

—

Viral and other specified intestinal infections

376

3403

1.08

0.77

2.1

1.9

204.65

205.47

pmol/l

0.05

356

3284

Childhood allergy (age < 16)

216

1610

1.11

0.77

1.8

1.7

202.43

190.33

pmol/l

0.78

210

1540

Otitis media, unspecified

139

1129

1.14

0.76

2.0

1.8

195.96

193.40

pmol/l

0.08

134

1077

Liquid cancers, including Hilmo

365

3468

0.93

0.76

1.9

191.28

203.15

pmol/l

1.42

351

3271

Diagnoses used for exclusion with ILD

304

2798

1.09

0.76

2.3

1.9

199.48

203.79

pmol/l

0.31

282

2641

Cytomegalovirus infection, IBD co-morbidity

262

1.31

0.75

1.5

1.9

189.56

214.16

pmol/l

1.01

248

Sequelae of other and unspecified infectious and parasitic diseases

799

1.17

0.75

2.3

2.0

212.42

212.19

pmol/l

0.01

760

Amiodarone users

1037

0.86

0.75

1.6

1.9

194.26

204.33

pmol/l

0.41

975

Hereditary ataxia

135

0.59

0.74

1.1

2.0

190.75

220.90

pmol/l

—

127

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

801

1.17

0.74

2.3

2.0

212.42

212.28

pmol/l

0.00

762

Injury of blood vessels at neck level

1.64

0.74

1.3

1.9

155.33

206.00

pmol/l

—

Coronary atherosclerosis

950

5717

1.05

0.73

2.0

1.9

200.87

208.05

pmol/l

1.26

898

5437

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

109

0.54

0.73

2.0

1.9

232.00

208.72

pmol/l

—

101

Other condition

216

1963

1.10

0.73

1.9

2.0

214.31

206.82

pmol/l

0.41

210

1864

Acute pancreatitis

283

2604

1.09

0.72

1.9

195.47

206.05

pmol/l

1.05

268

2468

Foreign body on external eye

383

3571

1.08

0.72

1.9

2.0

208.07

211.80

pmol/l

0.37

363

3439

All kidney diseases

1446

9328

1.04

0.72

1.9

186.09

198.84

pmol/l

4.71

1355

8908

Other/unspecified cytomegaloviral diseases

229

1.32

0.72

1.5

1.9

196.77

217.69

pmol/l

0.80

216

Viral pneumonia

179

1612

1.11

0.72

1.9

193.22

208.92

pmol/l

1.32

172

1533

Hallux valgus (acquired)

183

1176

1.11

0.72

1.9

1.7

182.40

189.48

pmol/l

0.38

172

1110

Acute nephritic syndrome

252

0.71

1.6

1.9

205.56

213.10

pmol/l

0.10

239

Venous thromboembolism

587

5338

1.06

0.71

2.1

1.9

193.19

199.56

pmol/l

0.72

557

5031

Malignant neoplasm of colon, including Hilmo

137

1535

0.89

0.71

1.7

1.9

197.12

200.53

pmol/l

0.17

130

1441

Contact with blunt object, undetermined intent

1.54

0.71

2.4

1.9

183.43

234.55

pmol/l

1.36

Malignant neoplasm of skin

498

3585

0.94

0.71

1.8

1.9

205.81

200.34

pmol/l

0.61

455

3381

Other anaemias

357

3589

0.93

0.70

1.9

174.97

197.01

pmol/l

4.45

333

3343

Intentional self-harm by unspecified means

178

1.36

0.70

1.8

1.9

132.50

218.19

pmol/l

2.92

171

Other diseases of pancreas

861

1.15

0.69

2.1

1.9

189.26

208.34

pmol/l

1.01

810

Foreign body or object entering through skin

118

1040

1.14

0.69

1.9

2.0

219.61

213.08

pmol/l

0.25

110

995

Leiomyoma of uterus

329

1.19

0.69

1.4

17.90

15.93

pmol/l

0.31

297

Acute appendicitis, with complications

266

2448

1.09

0.69

2.0

205.30

204.99

pmol/l

0.02

256

2329

Diabetic maculopathy

140

1481

0.89

0.69

1.9

2.0

191.48

170.09

pmol/l

1.90

130

1393

Other and unspecified anaemias

354

3568

0.93

0.69

1.9

175.22

197.17

pmol/l

4.37

330

3325

Abnormality of white blood cells, not elsewhere classified

1.61

0.69

1.5

1.7

170.36

219.30

pmol/l

0.97

L02BX Other hormone antagonists and related agents

596

0.82

0.69

2.0

1.8

130.71

200.54

pmol/l

3.31

550

Other congenital malformations of upper alimentary tract

1.54

0.69

2.8

1.7

189.00

223.26

pmol/l

—

Postdysenteric arthropathy

117

0.59

0.69

1.1

1.9

274.71

231.89

pmol/l

—

109

Implicit Sepsis, including avohilmo

1236

8489

1.04

0.69

2.0

1.9

189.73

202.62

pmol/l

3.95

1151

8096

Alcoholic cardiomyopathy

0.53

0.68

3.2

1.8

198.60

213.84

pmol/l

—

Acute renal failure

225

2460

0.91

0.68

2.0

1.9

181.05

204.19

pmol/l

2.96

213

2307

Erysipelas

840

7577

0.95

0.68

2.0

1.9

184.05

208.11

pmol/l

8.23

794

7220

Malignant neoplasm of floor of mouth, including Hilmo

0.53

0.68

2.0

231.40

218.99

pmol/l

—

Seronegative rheumatoid arthritis

695

1.17

0.68

1.6

1.8

181.67

199.56

pmol/l

0.98

660

Retention of urine

432

3273

1.07

0.68

2.0

1.9

186.35

200.06

pmol/l

2.00

397

3057

Pregnancy hypertension

645

1.16

0.67

1.2

1.3

17.18

18.26

pmol/l

0.40

591

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

402

1.23

0.67

1.8

2.0

183.39

201.72

pmol/l

0.74

382

Benign neoplasm: Peripheral nerves and autonomic nervous system

162

1.37

0.67

2.9

1.9

197.91

222.18

pmol/l

0.57

153

Other secondary gonarthrosis

466

1.21

0.67

2.1

1.9

198.49

203.94

pmol/l

0.15

447

Valvular operations

162

1796

0.90

0.67

1.9

196.24

209.75

pmol/l

1.24

154

1690

Hypertrophy of tongue papillae

111

1.45

0.66

2.8

2.0

185.50

221.04

pmol/l

0.69

104

Benign neoplasm: Choroid

448

1.21

0.66

2.1

1.8

201.39

203.54

pmol/l

0.05

423

Other abnormal findings of blood chemistry

430

1.21

0.66

1.9

1.8

207.10

201.80

pmol/l

0.14

409

Acute myeloid leukaemia and myelodysplastic syndromes

155

0.64

0.66

2.0

163.20

217.69

pmol/l

—

147

Conduction disorders

332

2472

1.08

0.66

2.0

1.8

187.49

203.57

pmol/l

2.74

312

2321

Other and unspecified nonorganic psychotic disorders

319

3429

0.93

0.66

2.0

177.89

213.40

pmol/l

5.23

298

3297

Asymptomatic human immunodeficiency virus [HIV] infection status

155

1.39

0.66

2.6

1.9

230.95

225.56

pmol/l

0.12

149

Malignant neoplasm of tongue

236

0.71

0.65

1.6

1.9

208.82

213.51

pmol/l

0.12

224

Ventral hernia

241

2215

1.09

0.65

2.2

1.8

189.81

199.49

pmol/l

0.79

227

2081

Respiratory tuberculosis, not confirmed, including avohilmo

225

0.71

0.65

1.6

1.8

184.25

211.51

pmol/l

0.78

208

Inflammatory bowel disease, strict (require KELA)

400

3750

1.07

0.65

1.9

208.90

206.96

pmol/l

0.14

385

3593

Other bacterial diseases

1404

9620

0.96

0.65

2.0

1.9

186.81

206.77

pmol/l

9.49

1322

9192

Invasive ventilation

797

0.85

0.65

2.2

2.0

192.88

206.97

pmol/l

0.49

755

Pedal cyclist injured in noncollision transport accidents

184

1672

1.10

0.65

2.1

2.0

204.41

209.59

pmol/l

0.33

176

1592

Use of disulfiram, acamprosate or naltrexone

208

1903

1.10

0.65

2.2

2.0

190.91

215.00

pmol/l

3.49

200

1820

Short stature starting before birth

1.75

0.64

1.8

1.4

186.00

279.69

pmol/l

—

Respiratory tuberculosis, not confirmed

224

0.71

0.64

1.6

1.8

184.25

211.86

pmol/l

0.80

207

Supplementary factors related to causes of morbidity and mortality classified elsewhere

465

4384

1.06

0.64

1.9

203.69

202.47

pmol/l

0.08

446

4189

Injury of blood vessels at wrist and hand level

102

0.58

0.63

2.8

1.9

170.67

234.57

pmol/l

—

Ulcerative colitis, NAS

210

1923

1.10

0.63

1.9

2.0

206.11

206.89

pmol/l

0.04

203

1830

Malignant neoplasm of pyriform sinus

0.00

0.63

0.0

1.6

—

261.20

—

Systemic sclerosis (FG)

1.50

0.63

2.5

1.8

184.54

202.67

pmol/l

0.31

Other lesions of median nerve

155

1.36

0.63

2.1

1.8

159.57

207.02

pmol/l

1.54

147

Campylobacter enteritis

324

1.24

0.63

2.3

1.9

209.82

211.53

pmol/l

0.03

308

Diseases of liver

483

4562

1.06

0.63

2.0

1.9

191.51

204.42

pmol/l

2.09

459

4341

All influenza (not pneumonia)

263

2433

1.08

0.63

2.0

1.9

214.16

209.91

pmol/l

0.25

251

2326

Polycythaemia vera

270

1.27

0.62

2.1

1.9

178.79

208.81

pmol/l

1.07

256

Speech disturbances, not elsewhere classified

729

1.16

0.62

1.9

2.0

212.05

205.00

pmol/l

0.11

686

Legal intervention

0.00

0.62

0.0

2.4

—

266.95

—

Glomerular diseases

213

2320

0.92

0.62

1.8

2.0

187.71

207.85

pmol/l

2.46

204

2200

Other renal tubulo-interstitial diseases

130

1.39

0.61

1.4

2.0

139.67

202.93

pmol/l

1.88

121

Other psoriatic arthropathies

138

1240

1.12

0.61

1.9

199.62

210.44

pmol/l

0.54

127

1173

Psoriatic arthropathies, ICD10

140

1259

1.12

0.61

1.9

200.95

209.77

pmol/l

0.42

129

1191

Sequelae of infectious and parasitic diseases, including avohilmo

100

881

1.14

0.61

2.3

2.0

208.94

210.66

pmol/l

0.05

100

839

Collagenous colitis

684

1.16

0.61

2.0

1.9

192.19

202.66

pmol/l

0.35

645

Fracture of spine, level unspecified

0.00

0.61

0.0

1.7

—

222.00

—

Other acantholytic disorders

0.00

0.61

0.0

1.8

—

212.62

—

Myocardial infarction, without ST-elevation

401

3845

0.94

0.60

1.8

1.9

194.30

197.92

pmol/l

0.33

377

3591

Cytomegaloviral disease, including avohilmo

290

1.25

0.60

1.6

1.9

193.86

217.61

pmol/l

0.89

275

Sequelae of infectious and parasitic diseases

873

1.14

0.60

2.3

2.0

209.13

210.83

pmol/l

0.05

831

Hypokalaemia

940

0.87

0.60

2.0

1.8

177.81

207.86

pmol/l

2.19

890

Spasmodic torticollis

183

1.32

0.60

1.7

192.63

200.22

pmol/l

0.15

171

Epilepsy

355

3317

1.07

0.59

2.0

1.8

184.72

209.41

pmol/l

4.55

330

3159

Exposure to other and unspecified inanimate mechanical forces

132

1186

1.12

0.59

2.0

216.80

213.74

pmol/l

0.12

122

1128

Duodenal ulcer

971

0.87

0.59

2.0

1.9

188.11

204.54

pmol/l

0.94

908

Other diseases of the digestive system

367

3446

1.07

0.59

1.9

193.01

201.45

pmol/l

0.88

342

3248

Type 1 diabetes

402

4258

0.94

0.58

2.0

1.9

196.23

214.63

pmol/l

3.35

376

4097

Injuries to the hip and thigh

601

5129

1.05

0.58

2.1

1.9

203.62

201.96

pmol/l

0.12

575

4857

Rubella [German measles], including avohilmo

109

973

1.13

0.58

1.9

2.0

221.67

205.89

pmol/l

0.95

102

934

Viral agents as the cause of diseases classified to other chapters

211

1.29

0.57

1.8

1.9

197.52

212.90

pmol/l

0.32

200

Malignant neoplasm of skin, including Hilmo

554

3902

0.95

0.57

1.8

1.9

206.80

201.28

pmol/l

0.67

511

3685

Respiratory tuberculosis

320

0.78

0.57

1.5

1.8

186.24

210.41

pmol/l

0.80

301

Respiratory tuberculosis, confirmed and not-confirmed

320

0.78

0.57

1.5

1.8

186.24

210.41

pmol/l

0.80

301

Hydronephrosis

1010

0.88

0.57

2.0

1.9

176.46

201.74

pmol/l

1.34

945

Folate deficiency anaemia

0.56

2.4

1.7

265.60

211.29

pmol/l

—

Non-Hodgkin lymphoma, all, including Hilmo

140

1266

1.11

0.56

2.0

1.9

197.50

203.89

pmol/l

0.27

135

1187

Cholelithiasis, broad definition with cholecystitis

890

6158

0.96

0.56

1.9

180.24

194.31

pmol/l

3.65

833

5808

Cerebrovascular diseases (FINNGEN)

436

3231

0.94

0.56

2.1

1.8

205.92

214.90

pmol/l

0.74

411

3114

Heart failure and antihypertensive medication

299

2078

0.93

0.56

2.1

1.8

196.00

219.74

pmol/l

2.60

284

2013

Other and unspecified pemphigoid

1.63

0.56

2.3

1.9

221.17

200.53

pmol/l

—

Nummular dermatitis

102

907

1.13

0.56

2.1

1.9

182.21

205.02

pmol/l

1.29

854

Viral agents as the cause of diseases classified to other chapters, including avohilmo

248

1.26

0.55

1.7

1.9

191.90

208.77

pmol/l

0.41

237

Other specified and unspecified disorders of eyelid

133

1.37

0.55

2.7

1.9

230.00

212.55

pmol/l

0.29

124

Malignant neoplasm of tonsil and base of tongue, including Hilmo

339

0.79

0.55

2.0

191.91

211.52

pmol/l

0.54

320

Cytomegaloviral disease

285

1.24

0.54

1.6

1.9

187.74

215.32

pmol/l

1.24

270

Drug-induced osteoporosis

1.43

0.54

1.9

1.8

189.50

223.27

pmol/l

0.72

Disorder of lipoprotein metabolism, unspecified

138

1251

1.11

0.54

1.9

1.8

177.61

207.75

pmol/l

2.54

127

1174

Diseases of the myoneural junction and muscle

141

1280

1.10

0.54

2.0

1.9

212.88

207.36

pmol/l

0.16

131

1218

Shigellosis, including avohilmo

1.45

0.54

1.5

2.1

179.38

234.10

pmol/l

1.46

Tibial collateral bursitis [Pellegrini-Stieda]

1.50

0.54

3.2

1.7

232.27

220.62

pmol/l

0.18

Wet age-related macular degeneration

595

1.15

0.53

1.7

178.41

184.19

pmol/l

0.27

543

Acute pancreatitis (for exclusion)

283

2647

1.07

0.53

1.9

195.47

206.50

pmol/l

1.12

268

2516

Macular cyst

178

1.30

0.53

1.6

1.9

182.83

214.98

pmol/l

0.89

164

Renal agenesis and other reduction defects of kidney, including avohilmo

1.45

0.53

2.1

2.2

178.56

225.77

pmol/l

—

Pediculosis and phthiriasis, including avohilmo

100

1.42

0.53

1.6

2.0

206.21

236.14

pmol/l

0.53

Hypothermia

226

0.75

0.53

1.4

1.9

209.12

221.23

pmol/l

0.17

212

Dissection of cerebral arteries, nonruptured

0.60

0.53

2.0

289.17

218.96

pmol/l

—

Meningococcal infection

0.60

0.53

1.0

2.1

225.50

239.29

pmol/l

—

Purpura and other haemorrhagic conditions

147

1339

1.10

0.52

1.8

1.9

185.03

203.82

pmol/l

1.29

137

1263

Meningococcal infection, including avohilmo

100

0.59

0.52

1.0

2.1

225.50

239.79

pmol/l

—

Gastrointestinal stromal tumor and sarcoma

0.61

0.52

1.8

2.0

198.67

212.92

pmol/l

—

Other and unspecified aplastic anaemias

0.60

0.52

1.3

1.8

128.00

203.08

pmol/l

—

Mental and behavioural disorders due to hallucinogens

118

1.39

0.52

1.8

2.3

198.75

237.29

pmol/l

0.98

112

Follicular cysts of skin and subcutaneous tissue

257

2401

1.07

0.51

1.9

195.19

208.02

pmol/l

1.26

242

2286

Rubella [German measles]

108

973

1.12

0.51

1.9

2.0

220.26

205.89

pmol/l

0.84

101

934

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

249

2256

1.07

0.51

1.9

2.0

194.15

204.84

pmol/l

0.95

236

2151

Ulcer of lower limb, not elsewhere classified

129

1420

0.91

0.51

1.9

176.74

203.25

pmol/l

1.98

120

1338

Familial erythrocytosis

1.52

0.51

1.7

1.8

167.30

243.40

pmol/l

—

Cholelithiasis

828

5865

0.96

0.50

1.9

178.09

193.12

pmol/l

3.92

776

5529

Malignant neoplasm of liver and intrahepatic bile ducts

280

0.78

0.50

1.8

2.0

208.73

208.56

pmol/l

0.00

263

Other and unspecified spinal muscular atrophies

1.51

0.50

1.9

1.8

147.20

220.80

pmol/l

—

Unspecified urinary incontinence

288

1.22

0.50

1.5

1.8

150.60

198.97

pmol/l

1.50

272

Unspecified privation

134

1220

1.10

0.50

1.7

2.0

199.93

205.64

pmol/l

0.26

123

1154

Other bullous disorders

216

1.26

0.49

1.8

201.93

208.57

pmol/l

0.15

205

Pneumocystosis, including avohilmo

167

0.71

0.49

2.1

1.9

178.75

223.59

pmol/l

0.73

157

Pneumocystosis

167

0.71

0.49

2.1

1.9

178.75

223.59

pmol/l

0.73

157

Arteriovenous malformation of cerebral vessels

107

0.65

0.49

2.1

1.9

187.57

229.08

pmol/l

—

100

Scleritis

110

1.37

0.49

1.3

1.8

227.27

223.13

pmol/l

0.06

103

Malignant neoplasm of renal pelvis, including Hilmo

109

0.64

0.49

1.7

2.0

180.29

215.03

pmol/l

—

102

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

784

1.13

0.49

2.0

1.9

212.53

208.63

pmol/l

0.18

741

Malignant neoplasm of colon

109

1207

0.90

0.49

1.6

1.9

192.27

200.14

pmol/l

0.43

104

1129

Use of galantamine

234

0.77

0.48

1.9

1.8

156.50

201.81

pmol/l

2.09

216

Lung diseases due to external agents

115

1268

0.91

0.48

2.3

1.9

194.24

205.91

pmol/l

0.65

107

1186

Infections of genitourinary tract in pregnancy

172

1.28

0.48

1.1

1.2

17.91

18.31

pmol/l

0.05

157

Other infestations, including avohilmo

177

0.73

0.48

2.6

1.9

201.31

224.36

pmol/l

0.24

167

Erysipelas, including avohilmo

1202

8643

1.03

0.47

2.0

1.9

188.31

208.97

pmol/l

8.74

1139

8252

Malignant neoplasm of hypopharynx, including Hilmo

0.60

0.46

1.2

1.9

202.20

227.74

pmol/l

—

Pleural plaque without asbestos

191

1.26

0.46

1.6

1.8

182.33

204.05

pmol/l

0.51

175

Enterocolitis due to Clostridium difficile

771

0.88

0.46

1.5

1.9

168.34

202.63

pmol/l

2.42

726

Chalazion

134

1226

1.10

0.46

2.0

1.9

189.64

201.88

pmol/l

0.74

120

1161

Osteomalacia

1.44

0.46

2.0

1.6

216.45

236.28

pmol/l

0.18

Supervision of high-risk pregnancy

285

1.16

0.45

1.3

15.46

21.88

pmol/l

2.92

259

Paralytic ileus and intestinal obstruction

246

2307

1.07

0.44

2.3

1.8

195.85

203.74

pmol/l

0.68

237

2179

Other orthopaedic follow-up care

587

0.87

0.44

1.6

2.0

180.00

213.83

pmol/l

1.49

559

malignant neoplasm of female genital organs, including Hilmo

1.39

0.44

1.7

1.3

12.42

14.68

pmol/l

0.38

Alcohol induced polyneuropathy

130

0.68

0.44

1.1

1.8

209.00

214.41

pmol/l

—

121

Retinal vascular disorders

781

1.12

0.44

1.7

1.9

196.80

195.67

pmol/l

0.04

730

Malnutrition

140

0.71

0.43

1.9

2.0

234.20

221.10

pmol/l

—

131

Dyslexia and other symbolic dysfunctions, not elsewhere classified

1.63

0.43

1.4

1.8

149.40

239.08

pmol/l

—

Infective dermatitis

132

1212

1.09

0.43

1.9

206.93

203.91

pmol/l

0.14

123

1140

Chronic pancreatitis

198

1849

1.07

0.43

1.8

2.0

210.44

209.89

pmol/l

0.03

187

1756

Contusion of ankle

518

1.14

0.43

1.8

1.9

191.46

211.89

pmol/l

0.46

494

Injury of muscle and tendon at wrist and hand level

252

2375

1.06

0.42

2.1

2.0

208.01

208.07

pmol/l

0.00

236

2285

Salpingitis and oophoritis

122

1.31

0.42

1.2

1.3

15.62

14.74

pmol/l

0.14

108

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

453

3195

0.96

0.42

1.8

1.9

205.12

199.44

pmol/l

0.59

414

3007

Sulfasalazine

348

3309

1.05

0.42

1.9

201.66

199.27

pmol/l

0.18

332

3152

Retinal vascular occlusion

774

1.11

0.42

1.7

1.9

195.95

195.98

pmol/l

0.00

724

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

139

0.72

0.42

1.8

196.80

211.12

pmol/l

—

128

Moyamoya

0.00

0.42

0.0

1.5

—

216.88

—

Narcolepsy and cataplexy

1.39

0.42

2.1

1.9

253.88

233.53

pmol/l

—

Underdevelopment of the second kidney

0.00

0.42

0.0

1.9

—

182.00

—

Disorders of glossopharyngeal nerve

0.00

0.42

0.0

1.9

—

223.33

—

Unspecified severe protein-energy malnutrition

0.00

0.41

0.0

2.2

—

213.88

—

Disorders of lens

901

5413

1.03

0.41

1.9

197.96

201.94

pmol/l

0.54

847

5138

Other cataract

484

3446

1.04

0.41

1.9

199.19

201.42

pmol/l

0.16

454

3252

L04AC Interleukin inhibitors

107

977

1.10

0.41

1.9

2.0

205.35

215.02

pmol/l

0.50

101

933

Other specified congenital malformation syndromes affecting multiple systems

186

1.24

0.40

2.0

1.8

194.43

228.17

pmol/l

0.63

179

Osteochondrodysplasia with defects of growth of tubular bones and spine

0.00

0.40

0.0

1.4

—

213.61

—

Transient acantholytic dermatosis [Grover]

0.00

0.40

0.0

1.8

—

218.44

—

Anaemia in chronic diseases classified elsewhere

227

0.79

0.40

1.9

184.67

218.92

pmol/l

0.85

212

Postzoster neuralgia

1.37

0.40

2.9

1.8

157.67

224.83

pmol/l

2.37

Use of levodopa decarboxylase inhibitor

101

920

1.10

0.40

1.6

1.9

193.07

197.41

pmol/l

0.16

851

Pediculosis and phthiriasis

1.41

0.40

1.8

2.0

219.82

249.62

pmol/l

0.49

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

103

0.67

0.40

1.7

2.2

237.14

212.74

pmol/l

—

Benign neoplasm: Oesophagus

102

0.68

0.40

2.6

1.8

148.00

222.84

pmol/l

—

Enteropathic arthropathies

223

1.22

0.40

1.7

1.8

208.93

202.69

pmol/l

0.13

214

Hypo-osmolality and hyponatraemia

132

1418

0.92

0.40

2.3

1.8

174.68

205.65

pmol/l

2.19

114

1339

Other CVD (FINNGEN)

124

869

1.09

0.40

2.0

1.7

189.26

210.45

pmol/l

1.74

114

827

Contracture of joint

105

0.66

0.39

2.0

1.7

166.86

235.00

pmol/l

—

Systemic sclerosis

1.34

0.39

2.5

1.9

184.54

206.32

pmol/l

0.39

Maternal care for known or suspected disproportion

1.31

0.39

2.0

1.3

9.75

16.33

pmol/l

—

Other blood glucose lowering drugs, excl. Insulins

148

1373

1.08

0.39

2.0

1.9

174.02

205.73

pmol/l

3.92

138

1300

Benign neoplasm: Epididymis

1.37

0.39

1.1

2.2

211.89

225.47

pmol/l

—

Melanoma in situ of trunk

133

1.29

0.39

1.9

2.0

215.24

221.01

pmol/l

0.14

124

Coagulation defects, purpura and other haemorrhagic conditions

203

1906

1.07

0.39

2.0

1.9

189.18

200.79

pmol/l

0.76

192

1803

Family history of other conditions

142

1.28

0.39

1.8

1.9

157.28

217.08

pmol/l

1.75

136

GI-bleeding

365

3484

1.05

0.39

1.9

192.39

202.01

pmol/l

1.05

339

3282

Malignant melanoma, including Hilmo

165

1539

1.07

0.38

1.7

1.9

204.69

200.85

pmol/l

0.22

153

1450

Impacted teeth

322

2630

1.05

0.38

1.7

1.8

178.18

195.37

pmol/l

1.73

308

2522

Use of donepezil

714

0.89

0.38

1.9

1.8

189.59

190.29

pmol/l

0.03

648

Hepatocellular carcinoma

214

0.79

0.38

1.9

201.00

213.29

pmol/l

0.25

202

malignant neoplasm of female genital organs

1.35

0.38

1.8

1.3

13.67

15.97

pmol/l

—

Superficial injury of ankle and foot, unspecified

1.32

0.37

1.7

2.0

200.00

235.48

pmol/l

—

Pyogenic granuloma

179

1.24

0.37

2.0

213.05

221.40

pmol/l

0.08

166

158

0.75

0.37

1.6

1.8

166.25

238.01

pmol/l

1.95

148

Dermatopolymyositis

112

0.71

0.37

2.3

1.9

205.50

220.45

pmol/l

—

106

Primary_lymphoid and hematopoietic malignant neoplasms

249

2357

1.06

0.37

2.0

1.9

197.26

201.42

pmol/l

0.24

240

2209

Achalasia of cardia

143

1.27

0.37

2.5

1.8

197.94

216.76

pmol/l

0.45

134

Loose body in joint

281

1.18

0.37

2.4

1.7

179.00

217.51

pmol/l

1.62

268

Vitamin B12 deficiency anaemia

598

0.88

0.36

2.2

1.8

177.25

196.32

pmol/l

0.86

559

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

0.63

0.36

1.6

1.7

129.60

247.27

pmol/l

—

Other localized connective tissue disorders

1.32

0.35

3.8

2.0

170.38

215.15

pmol/l

0.37

Third [oculomotor] nerve palsy

144

1.26

0.35

1.9

155.67

219.74

pmol/l

1.87

133

Benign neoplasm: Bronchus and lung

124

0.72

0.35

1.9

1.7

241.11

221.64

pmol/l

—

114

Other protozoal intestinal diseases

117

1.29

0.35

2.2

1.8

191.87

231.04

pmol/l

0.56

108

Neuroendocrine tumor and carcinoma of small intestine

125

0.72

0.35

1.7

1.9

152.44

216.73

pmol/l

—

117

Meningitis

565

1.12

0.35

2.0

202.89

206.16

pmol/l

0.08

538

Pyoderma gangrenosum

1.38

0.35

2.7

1.8

184.30

233.16

pmol/l

—

Crohn disease

195

1839

1.06

0.34

2.0

1.9

203.01

206.81

pmol/l

0.22

183

1753

Malignant neoplasm of larynx, including Hilmo

189

0.79

0.34

1.9

223.80

209.25

pmol/l

0.23

178

Pleural plaque

680

1.10

0.34

1.8

184.54

192.91

pmol/l

0.38

617

Other and unspecified injuries of abdomen, lower back and pelvis

163

1.23

0.34

2.8

2.1

223.85

222.55

pmol/l

0.01

152

Other congenital malformations of tongue, mouth and pharynx

126

1.27

0.34

1.3

1.7

243.31

208.88

pmol/l

0.35

121

Personal history of medical treatment

1.35

0.34

2.0

1.8

136.00

202.72

pmol/l

3.03

Mental and behavioural disorders due to alcohol

981

9576

0.97

0.34

2.0

1.9

198.89

207.26

pmol/l

1.51

904

9176

Primary angle-closure glaucoma

218

1.20

0.34

1.5

1.8

175.96

201.36

pmol/l

0.70

203

Xerosis cutis

127

1.27

0.33

1.7

2.0

191.44

212.32

pmol/l

0.42

116

Burns and corrosions

240

2280

1.05

0.33

1.8

2.0

194.48

207.50

pmol/l

1.22

227

2175

Benign neoplasm: Other parts of oropharynx

0.68

0.33

1.8

2.0

119.50

220.96

pmol/l

—

Other degenerative diseases of the nervous system

189

1461

0.94

0.33

1.7

195.96

204.24

pmol/l

0.51

174

1368

Zoster [herpes zoster]

148

1385

1.07

0.33

2.1

1.9

174.71

200.68

pmol/l

2.73

141

1302

Assault by sharp object

407

1.14

0.33

1.9

2.0

215.98

224.29

pmol/l

0.11

387

Benign neoplasm: Brain, unspecified

1.31

0.33

3.7

1.7

135.50

216.83

pmol/l

—

Pneumonia due to other infectious organisms, not elsewhere classified

331

1.15

0.33

2.3

1.9

214.13

212.92

pmol/l

0.02

312

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

397

1.14

0.33

1.9

206.69

213.89

pmol/l

0.16

377

Fracture of shoulder and upper arm

440

4233

1.04

0.33

1.9

204.61

207.05

pmol/l

0.22

417

4043

Cyst of Bartholin Gland

1.31

0.33

1.3

1.2

11.67

15.12

pmol/l

—

Overjet

172

1.22

0.33

1.7

1.9

198.71

182.78

pmol/l

0.25

167

Renal tubulo-interstitial diseases

1031

7733

0.98

0.33

1.9

180.28

194.22

pmol/l

4.14

963

7342

DVT of lower extremities and pulmonary embolism

425

4074

1.04

0.33

2.1

1.9

192.81

200.36

pmol/l

0.73

406

3836

Nutritional anaemias

384

3806

0.96

0.32

2.3

1.8

189.65

189.74

pmol/l

0.01

364

3557

Other and unspecified bullous disorders

1.33

0.32

1.4

1.7

181.18

228.66

pmol/l

0.79

Other injuries of lower limb, level unspecified

101

1.30

0.32

2.0

1.7

206.15

224.53

pmol/l

0.44

Complications predominantly related to the puerperium

483

1.12

0.32

1.2

1.3

21.33

18.27

pmol/l

0.35

443

Chronic kidney disease

311

3121

0.96

0.31

1.9

184.33

202.26

pmol/l

2.67

290

2920

Other surgical follow-up care

333

1.14

0.31

1.9

190.89

206.36

pmol/l

0.43

316

!Aliquae complicationes praecoces traumatis

628

1.10

0.31

1.9

2.0

199.16

215.32

pmol/l

0.60

599

Early complications of trauma

628

1.10

0.31

1.9

2.0

199.16

215.32

pmol/l

0.60

599

Malignant melanoma

145

1361

1.07

0.31

1.7

1.9

204.86

201.01

pmol/l

0.19

133

1280

Pregnancy with abortive outcome

115

645

0.93

0.31

1.2

1.3

17.58

19.55

pmol/l

0.79

104

594

Intussusception

0.71

0.31

4.6

1.7

226.71

227.28

pmol/l

—

Toxic effect of other gases, fumes and vapours

102

1.29

0.30

2.1

196.92

236.78

pmol/l

0.76

Pleural plaque with presence of asbestos

533

1.11

0.30

1.8

181.98

195.93

pmol/l

0.66

489

Cholesteatoma of middle ear

438

1.12

0.30

1.5

1.8

191.56

206.62

pmol/l

0.87

416

Glaucoma secondary to eye trauma

1.28

0.30

1.3

1.7

185.86

206.32

pmol/l

—

Other abnormalities of plasma proteins

130

0.77

0.29

1.8

2.0

152.40

220.12

pmol/l

—

120

Respiratory conditions due to other external agents

107

0.75

0.29

2.9

2.0

183.25

216.83

pmol/l

—

Osteitis due to dental implant

1.23

0.29

2.3

1.8

192.00

245.90

pmol/l

—

Type 1 diabetes, wide definition

354

3669

0.96

0.29

1.9

200.40

215.13

pmol/l

2.02

333

3534

Hereditary corneal dystrophies

176

1.20

0.29

1.5

1.9

189.52

211.90

pmol/l

0.43

165

Other injuries of spine and trunk, level unspecified

112

1.26

0.28

2.2

2.1

151.21

235.62

pmol/l

2.66

106

Spontaneous abortion

561

0.92

0.28

1.1

1.3

17.49

19.35

pmol/l

0.50

517

Malignant neoplasm of other and unspecified parts of tongue

151

0.79

0.28

1.8

1.9

223.42

217.64

pmol/l

0.12

144

Myositis

223

1.17

0.28

2.1

1.8

202.27

219.44

pmol/l

0.56

215

Unspecified mental disorder

656

6386

1.03

0.28

2.1

1.9

179.68

207.59

pmol/l

9.24

615

6138

Severe visual impairment, monocular

1.30

0.28

2.6

1.9

160.25

217.47

pmol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

422

2961

0.97

0.28

1.8

1.9

203.60

198.88

pmol/l

0.44

383

2782

Benign neoplasm of middle ear and respiratory system

835

1.08

0.27

2.2

1.9

223.07

205.19

pmol/l

0.85

789

Cellulitis of external ear

117

0.76

0.27

1.7

2.1

208.22

223.17

pmol/l

—

111

Other/unspecified rheumatoid arthritis

606

0.91

0.27

2.1

1.9

194.45

196.92

pmol/l

0.06

564

Pedal cyclist injured in other and unspecified transport accidents

164

1554

1.06

0.27

1.9

2.0

211.17

209.83

pmol/l

0.06

156

1476

Intestinal stricture

288

2997

0.96

0.27

2.2

1.9

203.02

201.91

pmol/l

0.06

272

2818

Poisoning by medicine, drug-induced

161

0.80

0.27

1.5

2.0

129.08

222.41

pmol/l

3.09

152

Cerebral palsy

215

0.83

0.27

1.9

2.0

214.33

225.84

pmol/l

0.15

207

Thiazolidinediones

121

1136

1.07

0.27

2.2

1.9

177.78

205.56

pmol/l

2.16

111

1077

Donors of organs and tissues

204

0.83

0.27

1.8

1.9

170.18

218.61

pmol/l

1.18

197

Kela-code for severe mental illness

575

5910

0.97

0.27

2.1

1.9

178.72

209.53

pmol/l

9.97

537

5686

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

230

2132

1.05

0.27

1.9

2.0

196.55

205.39

pmol/l

0.69

220

2036

Psoriasis (vulgaris), strict definition

567

1.10

0.27

2.0

1.9

185.37

218.13

pmol/l

2.90

542

Schizophrenia or delusion, excluding more controls

452

4602

0.97

0.27

1.9

1.8

182.57

213.86

pmol/l

6.21

422

4457

Crohn disease (strict definition, all UC cases excluded)

663

1.09

0.27

2.1

1.9

197.85

209.83

pmol/l

0.58

628

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

214

0.84

0.26

1.9

1.8

217.22

211.49

pmol/l

0.13

202

Other nutritional anaemias

0.69

0.26

3.4

1.8

204.80

232.52

pmol/l

—

Other and unspecified psoriasis

712

1.08

0.26

1.8

2.0

182.24

209.19

pmol/l

1.76

675

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

0.67

0.26

1.8

2.2

277.40

223.63

pmol/l

—

Occlusion and stenosis of arteries, not leading to stroke

0.70

0.26

1.0

1.6

168.40

232.08

pmol/l

—

Fibrosarcoma, including Hilmo

0.67

0.26

1.6

1.9

217.20

241.12

pmol/l

—

Malignant neoplasm of eye and adnexa

0.66

0.26

1.0

1.9

190.00

233.83

pmol/l

—

Diabetic maculopathy, excluding more controls

148

1562

0.95

0.26

1.9

192.39

217.59

pmol/l

2.64

137

1491

Chronic Coagulation defects

149

0.80

0.26

3.0

1.8

145.92

204.65

pmol/l

0.98

141

Other superficial mycoses

301

1.13

0.25

2.0

1.9

218.32

211.71

pmol/l

0.09

286

Liquid cancers

314

2865

1.04

0.25

2.0

1.9

192.33

202.70

pmol/l

1.00

304

2700

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

368

2763

1.03

0.25

2.1

1.7

156.73

158.36

pmol/l

0.09

343

2571

Combinations of oral blood glucose lowering drugs

412

3996

1.03

0.25

2.0

1.8

175.74

210.11

pmol/l

11.29

374

3799

Unspecified kidney failure

850

0.93

0.25

2.3

1.9

174.04

206.88

pmol/l

1.92

798

Portal vein thrombosis

170

1.18

0.25

2.2

2.0

198.05

213.66

pmol/l

0.32

157

Burn and corrosion, body region unspecified

1.30

0.24

1.9

1.7

160.50

237.71

pmol/l

—

Pedal cyclist injured in collision with pedestrian or animal

0.73

0.24

2.0

1.9

178.00

223.05

pmol/l

—

Malignant neoplasm of nasal cavity and sinuses

0.71

0.24

1.8

2.2

236.83

218.87

pmol/l

—

Myelodysplastic syndrome

0.74

0.24

1.3

2.0

147.00

209.50

pmol/l

—

Respiratory tuberculosis, clinically confirmed

0.71

0.24

1.3

1.7

163.33

231.22

pmol/l

—

Horner syndrome

115

1.22

0.23

2.0

1.8

242.86

232.87

pmol/l

0.10

108

Coarctation of the aorta

136

0.80

0.23

1.6

1.8

174.18

241.04

pmol/l

1.63

129

Diseases of spleen

179

0.83

0.23

2.1

2.0

163.60

217.72

pmol/l

0.95

169

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

190

1.16

0.23

2.3

1.9

195.18

213.15

pmol/l

0.36

179

Toxic effect of corrosive substances

0.75

0.23

2.7

1.9

187.00

228.26

pmol/l

—

Other congenital malformations of intestine

0.76

0.23

1.4

2.1

225.71

228.13

pmol/l

—

Absence of one kidney, including avohilmo

1.26

0.22

1.0

1.9

191.20

219.20

pmol/l

—

Encephalopathy

0.76

0.22

2.0

2.1

163.00

226.57

pmol/l

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

486

1.09

0.22

1.7

1.8

212.00

193.77

pmol/l

0.54

460

Tetraplegia

0.73

0.22

1.7

1.8

153.29

243.85

pmol/l

—

Superficial injuries involving multiple body regions

295

0.88

0.22

1.6

2.0

221.04

213.11

pmol/l

0.06

280

Pulmonary oedema

0.75

0.22

1.1

1.7

236.29

217.30

pmol/l

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

0.74

0.22

2.0

1.8

192.00

210.11

pmol/l

—

Maternal care for known or suspected malpresentation of fetus

412

0.92

0.22

1.3

12.59

18.56

pmol/l

3.90

378

Periapical abscess

732

7472

0.98

0.22

2.0

1.9

195.56

205.85

pmol/l

1.49

688

7149

Asymmetry of jaw

116

1.21

0.22

2.8

2.0

234.43

197.42

pmol/l

1.11

111

Assault by other and unspecified firearm discharge

1.21

0.22

2.4

2.2

218.40

239.62

pmol/l

—

Explicit viral Sepsis

0.00

0.22

0.0

2.6

—

225.70

—

Explicit viral Sepsis, including avohilmo

0.00

0.22

0.0

2.6

—

225.70

—

Injuries to the elbow and forearm

963

8102

1.02

0.22

2.0

1.9

200.78

200.81

pmol/l

0.00

902

7755

Leprosy [Hansen's disease]

0.00

0.22

0.0

2.6

—

247.09

—

Drowning and submersion in swimming-pool or bath

0.00

0.22

0.0

1.9

—

210.67

—

Leprosy [Hansen's disease], including avohilmo

0.00

0.22

0.0

2.6

—

247.09

—

Other eccrine sweat disorders

0.00

0.22

0.0

1.3

—

212.27

—

Blindness (ICD-9)

0.00

0.22

0.0

1.4

—

229.18

—

Other congenital malformations of posterior segment of eye (coloboma)

0.00

0.22

0.0

2.0

—

201.70

—

Disorders of other digestive organs in diseases classified elsewhere

0.00

0.22

0.0

1.3

—

289.50

—

Mucinosis of skin

0.00

0.21

0.0

1.5

—

206.60

—

Pemphigus foliaceus

0.00

0.21

0.0

1.5

—

199.18

—

Disorders of muscle in diseases classified elsewhere

0.00

0.21

0.0

1.1

—

154.80

—

Other Crohn's disease

1008

0.94

0.21

1.9

2.0

214.67

211.18

pmol/l

0.14

958

Acquired coagulation factor deficiency

0.00

0.21

0.0

1.6

—

206.30

—

Disorders of muscle tone of newborn

0.00

0.21

0.0

1.3

—

206.80

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.21

0.0

1.4

—

171.90

—

Severe bullous disorders, KELA reimbursement

0.00

0.21

0.0

1.7

—

154.60

—

Congenital malformations of heart and great arteries

166

1682

0.96

0.21

2.1

1.9

194.64

207.05

pmol/l

0.93

160

1601

Other diseases of the respiratory system

168

1755

0.96

0.21

2.2

1.9

184.47

202.82

pmol/l

1.44

155

1630

Other respiratory disorders and diseases

168

1755

0.96

0.21

2.2

1.9

184.47

202.82

pmol/l

1.44

155

1630

Benign neoplasm: Urethra

0.00

0.21

0.0

1.7

—

287.17

—

Merkel cell carcinoma of skin

0.00

0.21

0.0

2.1

—

216.67

—

Serous carcinoma of ovary, including Hilmo

0.00

0.21

0.0

1.5

—

17.80

—

Microtia (small ears)

0.00

0.21

0.0

1.5

—

283.50

—

Abnormal findings on diagnostic imaging of breast

0.00

0.21

0.0

1.6

—

93.00

—

Disorders of vagus nerve

0.00

0.21

0.0

1.5

—

233.69

—

Follow-up examination after treatment for conditions other than malignant neoplasms

456

3115

0.97

0.21

1.9

1.8

183.77

198.42

pmol/l

2.25

436

2975

Divergent concomitant strabismus

779

1.07

0.21

1.7

1.9

197.84

203.60

pmol/l

0.21

738

Other and unspecified myopathies

925

1.06

0.21

2.1

1.9

212.73

206.32

pmol/l

0.14

871

Biliary cirrhosis, NAS

0.00

0.21

0.0

1.7

—

219.00

—

Senile cataract

730

4347

1.02

0.21

1.8

1.9

196.50

201.22

pmol/l

0.59

679

4111

Smoking dependency

102

1078

0.94

0.20

2.0

1.9

177.96

203.74

pmol/l

1.70

1025

Nocardiosis

0.00

0.20

0.0

1.7

—

281.00

—

Nocardiosis, including avohilmo

0.00

0.20

0.0

1.7

—

281.00

—

Amputation of ankle

0.00

0.20

0.0

1.6

—

207.93

—

Acute necrotizing ulcerative gingivitis, including avohilmo

0.00

0.20

0.0

1.5

—

222.14

—

Basal cell carcinoma, including Hilmo

430

2987

0.97

0.20

1.8

1.9

203.63

198.93

pmol/l

0.43

389

2808

Cleft lip and cleft lip and palate

111

0.80

0.20

1.4

2.0

248.56

232.37

pmol/l

—

106

Lung transplant status

114

0.78

0.20

3.2

2.0

179.11

230.05

pmol/l

—

107

Lung transplantation

114

0.78

0.20

3.2

2.0

179.11

230.05

pmol/l

—

107

Labour and delivery complicated by fetal stress [distress]

481

1.07

0.20

1.3

15.66

18.71

pmol/l

1.58

443

Infection due to other mycobacteria

112

0.80

0.20

1.4

1.9

155.89

217.04

pmol/l

—

104

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

373

1.10

0.20

1.8

2.0

219.22

215.24

pmol/l

0.07

357

Laparoscopic left hemicolectomy

176

0.85

0.20

1.7

1.9

183.33

220.28

pmol/l

1.06

162

L04AA Selective immunosuppressants

255

2635

0.97

0.20

1.8

1.9

205.43

205.02

pmol/l

0.02

244

2512

Graves ophthalmopathy

115

0.78

0.20

1.8

1.9

160.33

205.41

pmol/l

—

109

Disorders of lacrimal system and orbit in diseases classified elsewhere

115

0.78

0.20

1.8

2.0

160.33

199.27

pmol/l

—

109

Carcinoma in situ of rectum

127

1.19

0.20

1.5

1.8

163.60

205.50

pmol/l

1.22

117

Reimbursement for rheumatic diseases

600

5838

1.02

0.19

2.0

1.9

198.79

197.85

pmol/l

0.09

568

5557

Reiter disease

118

1.20

0.19

1.6

1.9

219.21

240.11

pmol/l

0.33

112

Other obstetric trauma

1.21

0.19

1.1

1.2

16.83

18.09

pmol/l

0.16

Mental and behavioural disorders due to tobacco

102

1075

0.95

0.19

2.0

1.9

177.96

205.28

pmol/l

1.86

1023

Car occupant injured in noncollision transport accident

491

1.08

0.19

1.8

2.0

205.64

213.77

pmol/l

0.20

467

Bleeding

1189

8453

0.99

0.19

1.9

199.40

204.81

pmol/l

0.86

1119

8053

Toxic effect of carbon monoxide

222

1.13

0.19

2.9

1.9

217.72

223.10

pmol/l

0.09

209

Other corneal oedema

1.16

0.19

1.5

173.17

238.21

pmol/l

—

Maltreatment syndromes

812

1.06

0.19

1.9

2.0

211.33

211.40

pmol/l

0.00

774

Familial hypercholesterolemia, with ischemic heart disease

736

0.94

0.19

1.8

1.9

184.38

198.83

pmol/l

0.62

681

Typhoid and paratyphoid fevers, including avohilmo

1.14

0.19

1.3

2.2

178.00

251.76

pmol/l

—

Cleft palate

109

1.20

0.19

1.5

1.7

280.62

219.01

pmol/l

1.34

104

Explicit bacterial Sepsis

109

1145

0.95

0.19

2.2

1.9

185.37

207.58

pmol/l

1.40

100

1085

Benign neoplasm: Bones of skull and face

1.13

0.18

1.2

1.7

183.00

212.36

pmol/l

—

Streptococcal septicaemia

940

0.95

0.18

2.2

1.9

174.97

206.81

pmol/l

2.24

894

Isolated proteinuria with specified morphological lesion

128

1.18

0.18

1.6

1.9

158.93

224.15

pmol/l

2.23

119

Gastric ulcer

148

1420

1.04

0.18

1.9

1.8

204.24

200.84

pmol/l

0.14

140

1320

Long labour

458

1.07

0.18

1.4

1.3

17.02

18.63

pmol/l

0.50

421

Complications of cardiac and vascular prosthetic devices, implants and grafts

153

0.85

0.18

1.4

2.0

166.15

210.65

pmol/l

1.27

141

Other or unspecified ileus, impaction or obstruction

176

1695

1.04

0.18

2.4

1.8

197.92

204.10

pmol/l

0.43

171

1589

Idiopathic gout

118

1127

1.05

0.18

2.1

1.9

201.30

205.59

pmol/l

0.15

107

1064

Migraine with aura, drug-induced

1.15

0.17

3.6

1.8

174.57

233.59

pmol/l

—

Hepatocellular carcinoma, including Hilmo

289

0.90

0.17

1.7

1.9

214.04

208.00

pmol/l

0.09

271

Haemorrhage in early pregnancy

452

0.92

0.17

1.3

17.57

17.87

pmol/l

0.06

409

Insulin, fast-acting or short human

550

5604

0.98

0.17

1.9

191.42

206.78

pmol/l

2.97

509

5352

Malignant neoplasm of small intestine

184

0.87

0.17

1.4

2.0

186.44

214.75

pmol/l

0.60

173

Other disorders of glucose regulation and pancreatic internal secretion

978

0.95

0.17

2.3

2.0

193.09

209.41

pmol/l

0.90

922

Abnormal findings on examination of urine, without diagnosis

444

0.92

0.17

2.0

1.9

185.24

213.30

pmol/l

0.88

420

Benign neoplasm: Skin of scalp and neck

205

1.12

0.17

2.2

1.9

162.04

208.18

pmol/l

1.03

193

ILD, hospital admissions 1, main diag only

113

1080

1.05

0.17

2.1

1.9

194.99

201.58

pmol/l

0.32

101

1008

Alzheimer’s disease (Late onset), excluding more controls

356

0.93

0.17

1.6

1.7

179.22

197.57

pmol/l

0.82

328

Osteopathy in diseases classified elsewhere

0.71

0.17

2.0

1.9

202.40

245.00

pmol/l

—

Aphakia

120

0.83

0.17

2.6

1.8

179.70

226.48

pmol/l

—

113

Mental and behavioural disorders due to use of volatile solvents

1.15

0.17

1.5

2.0

165.12

241.51

pmol/l

—

Urticaria due to cold and heat

1.18

0.16

2.0

1.6

189.00

231.00

pmol/l

—

Malignant melanoma of skin, including Hilmo

133

1277

1.04

0.16

1.6

1.9

202.96

199.95

pmol/l

0.14

125

1198

Colitis, primary sclerosing, strict definition

177

1.14

0.16

2.3

1.9

209.05

233.72

pmol/l

0.87

168

Embedded and impacted teeth

431

3422

1.02

0.16

1.7

1.8

182.87

197.26

pmol/l

1.73

410

3288

Congenital malformations of trachea and bronchus

1.15

0.16

3.5

1.7

254.25

216.05

pmol/l

—

Tic and related disorders

162

0.86

0.16

1.6

2.1

220.21

219.90

pmol/l

0.00

156

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

925

0.95

0.16

2.0

201.17

209.80

pmol/l

0.47

880

Isolated proteinuria

329

0.91

0.16

2.1

1.9

200.33

219.17

pmol/l

0.43

310

Vascular syndromes of brain in cerebrovascular disorders

298

0.90

0.16

2.0

1.8

186.63

206.55

pmol/l

0.58

280

Unstable angina pectoris

406

3118

1.02

0.16

1.9

1.8

189.39

201.93

pmol/l

2.06

380

2918

Use of rivastigmine

523

1.07

0.16

1.6

1.7

168.73

192.58

pmol/l

1.09

474

Complications peculiar to reattachment and amputation

1.11

0.16

2.3

2.0

177.00

217.70

pmol/l

—

Parkinson's disease, including avohilmo

118

1131

1.04

0.16

1.7

1.9

187.34

197.58

pmol/l

0.66

113

1050

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

1.11

0.16

3.1

1.9

248.50

216.61

pmol/l

—

Inflammation of lacrimal passages (chronic)

1.11

0.16

2.0

208.25

233.40

pmol/l

—

Type 1 diabetes, wide definition, subgroup 1

348

3557

0.98

0.16

1.9

200.09

215.47

pmol/l

2.12

329

3429

Lymphangioma, anys site

1.10

0.16

2.1

1.8

188.75

232.34

pmol/l

—

Exclusion endpoint for clefts

225

1.11

0.16

2.0

1.8

179.56

225.52

pmol/l

0.99

215

ILD medications: immunosuppressive drugs

959

8563

1.01

0.16

1.9

199.81

202.68

pmol/l

0.41

917

8172

L04AX Other immunosuppressants

717

7053

1.02

0.15

2.0

1.9

198.23

201.12

pmol/l

0.35

683

6737

Alcohol abuse, main dg, excluding more controls

249

2558

0.97

0.15

2.0

1.8

192.63

211.77

pmol/l

2.37

225

2468

Other disorders affecting eyelid function

1.16

0.15

1.4

1.9

145.56

238.07

pmol/l

—

Fracture of forearm

569

5199

0.98

0.15

1.9

205.73

200.25

pmol/l

0.58

534

4971

Respiratory tuberculosis, bacteriologically and histologically confirmed

140

0.85

0.15

1.2

1.9

171.17

224.96

pmol/l

1.08

131

Nonhereditary hypogammaglobulinemia

102

1.18

0.15

1.2

1.8

200.42

227.84

pmol/l

0.42

Left hemicolectomy

161

0.87

0.15

2.0

1.9

206.71

218.50

pmol/l

0.18

150

Maternal care for known or suspected abnormality of pelvic organs

444

0.94

0.15

1.3

16.79

18.77

pmol/l

0.58

408

Malignant neoplasm of urinary organs, including Hilmo

111

1157

0.96

0.15

1.9

197.48

205.32

pmol/l

0.38

103

1082

Crohn's disease of small intestine

908

1.05

0.15

2.0

202.70

207.75

pmol/l

0.20

858

Other and unspecified syphilis, including avohilmo

0.81

0.15

2.0

1.9

195.71

230.24

pmol/l

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1283

8781

1.01

0.15

2.0

1.9

192.68

203.29

pmol/l

2.73

1202

8377

Chronic suppurative otitis media, including avohilmo

779

0.95

0.15

1.7

1.9

201.74

208.16

pmol/l

0.16

739

Alcohol use disorder, Swedish definition

1076

9657

1.01

0.15

2.0

1.9

198.47

207.16

pmol/l

1.79

999

9235

Convulsions, not elsewhere classified

369

3567

1.02

0.15

2.0

1.8

194.69

205.61

pmol/l

0.99

351

3407

Blindness, monocular

1.09

0.14

1.9

1.8

220.67

227.16

pmol/l

—

Family history of other specific disorders

1.09

0.14

2.0

1.6

203.11

225.49

pmol/l

—

Unspecified acute lower respiratory infection

253

2466

1.03

0.14

2.0

204.00

207.74

pmol/l

0.24

243

2353

Dislocation of lens

0.78

0.14

1.9

1.8

206.29

213.01

pmol/l

—

Other respiratory diseases principally affecting the interstitium

140

1450

0.96

0.14

2.0

1.9

193.45

200.36

pmol/l

0.38

127

1347

Heart failure and hypertrophic cardiomyopathy

181

0.88

0.14

1.8

2.0

226.06

213.13

pmol/l

0.23

168

Recurrent and persistent haematuria

0.82

0.14

1.5

1.8

196.38

220.76

pmol/l

—

Adjustment and management of implanted device

153

1481

1.03

0.14

1.7

1.9

191.17

202.46

pmol/l

0.87

145

1381

Chronic myeloproliferative disease

0.81

0.14

1.9

208.63

220.21

pmol/l

—

Graves ophthalmopathy, strict

0.81

0.13

1.8

146.50

209.13

pmol/l

—

Streptococcal septicaemia, including avohilmo

970

0.96

0.13

2.2

1.9

174.46

207.83

pmol/l

2.55

923

Problems related to social environment

199

1.11

0.13

2.8

2.0

153.41

206.74

pmol/l

1.41

189

Basal cell carcinoma

401

2785

0.98

0.13

1.8

1.9

204.79

199.71

pmol/l

0.45

360

2612

Benign neoplasm: Skin of lip

1.17

0.13

2.4

1.7

207.27

236.48

pmol/l

0.61

Glaucoma

498

4158

1.02

0.13

1.8

1.9

191.51

197.69

pmol/l

0.77

463

3890

Complications of other internal prosthetic devices, implants and grafts

242

0.91

0.13

1.9

187.50

198.62

pmol/l

0.22

227

Other conjunctival vascular disorders and cysts

161

1.12

0.13

1.5

2.0

175.39

212.64

pmol/l

0.93

150

Asthma/COPD (KELA code 203)

1440

9706

0.99

0.13

2.0

1.9

196.76

201.28

pmol/l

0.93

1367

9263

Foreign body entering into or through eye or natural orifice

145

1406

1.03

0.12

2.0

218.95

213.12

pmol/l

0.27

137

1342

Burns and corrosions of external body surface, specified by site

168

1728

0.97

0.12

1.9

2.0

195.06

209.18

pmol/l

0.99

161

1643

Injury of muscle and tendon at ankle and foot level

326

1.08

0.12

2.5

2.0

246.03

210.47

pmol/l

1.27

310

Marginal zone B-cell lymphoma, including Hilmo

127

0.86

0.12

1.8

1.9

205.55

222.83

pmol/l

0.24

118

Iliotibial band syndrome

1.18

0.12

4.3

1.6

235.80

206.87

pmol/l

—

Disorders of choroid and retina

1101

7623

1.01

0.12

1.9

199.92

203.26

pmol/l

0.48

1034

7253

Other meningitis

152

1.12

0.12

3.0

2.0

220.18

225.82

pmol/l

0.05

142

Insulin, fast-acting

550

5575

0.99

0.12

1.9

191.42

207.73

pmol/l

3.29

509

5325

Motor- or nonmotor-vehicle accident in traffic area

114

1.15

0.12

2.6

2.0

241.38

221.75

pmol/l

0.24

108

Infection due to other mycobacteria, including avohilmo

116

0.86

0.12

1.4

2.0

161.60

216.77

pmol/l

—

108

Open wound of head

948

8806

1.01

0.11

2.0

1.9

206.88

208.11

pmol/l

0.13

901

8413

Retinoschisis and retinal cysts

168

0.89

0.11

1.6

1.8

182.33

205.64

pmol/l

0.57

157

Hereditary retinal dystrophy

147

0.88

0.11

1.7

2.0

242.15

210.96

pmol/l

1.13

139

DVT of lower extremities

185

1804

1.03

0.11

2.0

1.9

196.28

204.35

pmol/l

0.50

174

1702

Other embolism and thrombosis

113

1168

0.97

0.11

2.2

1.9

187.35

205.98

pmol/l

1.28

107

1100

Other secondary coxarthrosis

271

0.92

0.11

1.9

177.92

211.68

pmol/l

1.41

254

Lack of expected normal physiological development

142

1.11

0.11

1.3

1.6

181.83

199.16

pmol/l

0.18

137

Measles, including avohilmo

188

0.90

0.11

2.9

1.9

190.00

206.99

pmol/l

0.30

178

Certolizumab pegol

153

1.11

0.11

1.2

1.9

180.47

200.73

pmol/l

0.32

143

Alcohol-induced chronic pancreatitis

124

1203

1.03

0.11

1.8

2.0

209.36

212.50

pmol/l

0.14

118

1141

Exposure to other specified electric current

367

1.07

0.11

2.6

1.9

242.38

221.94

pmol/l

0.42

351

Second line medication for Crohn's disease

753

7435

1.01

0.11

2.0

1.9

199.02

201.58

pmol/l

0.30

716

7101

Mixed conductive and sensorineural hearing loss

878

1.04

0.10

2.0

1.8

190.14

203.34

pmol/l

0.70

821

Postpartum care and examination

267

1.06

0.10

1.2

1.3

16.98

21.68

pmol/l

1.55

242

Pulmonary embolism

271

2659

1.02

0.10

2.1

1.9

192.33

200.62

pmol/l

0.55

260

2495

Colectomy operation

157

1531

1.03

0.10

1.7

1.9

202.33

206.62

pmol/l

0.24

152

1441

Measles

187

0.91

0.10

2.9

1.9

190.00

207.90

pmol/l

0.32

177

Benign neoplasm: Retina

1.11

0.10

1.4

2.2

167.60

207.13

pmol/l

—

Methotrexate

101

979

1.03

0.09

2.0

1.8

187.17

198.63

pmol/l

0.57

917

Pulmonary heart disease

271

2662

1.02

0.09

2.1

1.9

192.33

200.41

pmol/l

0.53

260

2497

Other and unspecified epidermal thickening

242

1.08

0.09

1.5

1.9

180.58

211.43

pmol/l

0.83

230

Embedded teeth, including avohilmo

115

1118

1.03

0.09

1.8

1.9

181.61

192.92

pmol/l

0.51

109

1064

Guttate psoriasis

145

1.11

0.09

2.0

1.8

154.38

229.42

pmol/l

2.66

139

Pre-eclampsia or poor fetal growth

612

1.04

0.09

1.2

1.3

16.20

18.10

pmol/l

0.68

562

ILD, hospital admissions 3, with pneumonia sepsis

635

1.04

0.09

2.2

2.0

199.09

202.70

pmol/l

0.10

596

Other abnormal immunological findings in serum

155

0.90

0.09

2.0

163.86

213.56

pmol/l

1.17

147

Crushing injury of ankle and foot

1.09

0.09

1.8

1.9

225.67

225.60

pmol/l

—

Congenital malformations of great arteries

192

0.92

0.08

1.6

1.8

172.94

216.52

pmol/l

0.99

182

Dermatitis herpetiformis

136

1.11

0.08

2.2

1.9

215.67

206.95

pmol/l

0.16

128

STROKE

777

5275

0.99

0.08

2.0

1.9

201.06

208.96

pmol/l

1.09

735

5041

Valgus deformity, not elsewhere classified

1.04

0.08

1.8

1.7

188.33

208.04

pmol/l

—

Other (seronegative) rheumatoid arthritis, wide

122

1190

1.03

0.08

1.8

1.9

184.47

197.56

pmol/l

0.76

114

1120

Other disorders of peripheral nervous system

1.10

0.08

1.3

1.7

260.29

236.88

pmol/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

936

0.97

0.08

2.0

1.9

187.58

204.83

pmol/l

1.12

884

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

166

1.09

0.08

2.1

1.9

164.39

226.36

pmol/l

1.63

160

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

1.03

0.08

1.6

1.7

190.43

224.31

pmol/l

—

Rhinophyma

0.83

0.07

1.0

1.8

216.17

204.94

pmol/l

—

Cervical root disorders

0.84

0.07

3.2

2.1

192.33

217.82

pmol/l

—

Cholesteatoma of external ear

0.83

0.07

1.7

1.9

175.33

233.52

pmol/l

—

Spondylopathies in diseases classified elsewhere

0.80

0.07

3.3

1.8

233.17

199.75

pmol/l

—

137

1.10

0.07

1.7

99.33

169.58

pmol/l

1.52

132

severe traumatic brain injury, does not include concussion

256

2597

0.99

0.07

1.9

201.95

204.86

pmol/l

0.14

241

2446

Meckel's diverticulum

0.86

0.07

1.4

1.9

212.00

246.05

pmol/l

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.86

0.07

2.4

1.9

214.00

235.71

pmol/l

—

Atypical mycobacterium lung infection

0.84

0.07

1.4

1.6

167.57

230.00

pmol/l

—

False labour

517

0.97

0.07

1.4

1.3

18.27

19.41

pmol/l

0.20

476

Secondary thrombocytopenia

122

0.90

0.07

2.5

1.9

170.73

214.78

pmol/l

0.94

114

Other specified/unspecified deforming dorsopathies

122

0.90

0.07

1.7

1.8

175.73

210.70

pmol/l

0.57

115

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

1.04

0.07

2.1

1.9

186.89

212.71

pmol/l

—

Other obstructed labour

1.03

0.07

1.8

1.3

19.22

16.26

pmol/l

—

Kela reimbursement Agammaglobulinemia (D80-84)

0.84

0.06

1.4

1.8

204.25

235.89

pmol/l

—

1116

9902

1.01

0.06

2.0

1.9

198.42

206.85

pmol/l

1.72

1034

9477

Iron deficiency anaemia

334

3312

0.99

0.06

2.3

1.8

190.70

189.42

pmol/l

0.07

317

3095

Exposure to unspecified smoke, fire and flames

142

0.91

0.06

1.3

2.1

191.15

230.43

pmol/l

0.95

133

Discitis, unspecified

138

1.09

0.06

1.9

1.8

218.20

218.35

pmol/l

0.00

129

Chronic hepatitis NAS

1.11

0.06

1.3

1.9

199.45

223.48

pmol/l

0.20

Cerebral palsy and other paralytic syndromes

117

1146

1.02

0.06

1.9

2.0

194.53

208.59

pmol/l

0.60

109

1086

Contraceptive management

740

5207

0.99

0.06

1.9

2.0

202.23

205.28

pmol/l

0.37

710

5012

Tic disorders

152

0.92

0.06

1.6

2.1

220.21

221.49

pmol/l

0.01

147

Crohn disease (strict definition, require KELA)

871

0.98

0.06

2.0

1.9

200.20

209.63

pmol/l

0.51

829

Adalimumab

142

1396

1.02

0.06

1.7

2.0

204.69

210.47

pmol/l

0.25

133

1331

Congenital deformities of hip, including avohilmo

119

1.09

0.05

1.5

1.6

287.46

192.62

pmol/l

1.07

113

Cleft lip, lip and palate or palate

202

0.94

0.05

1.5

2.0

257.95

217.48

pmol/l

1.03

194

Other and unspecified iron deficiency

258

2547

1.01

0.05

2.2

1.8

190.20

188.45

pmol/l

0.08

244

2374

Synovial hypertrophy, not elsewhere classified

110

0.91

0.05

2.5

1.8

173.20

220.55

pmol/l

—

105

Toxic liver disease

140

1.07

0.04

1.6

1.8

177.60

219.02

pmol/l

1.18

131

IBD (strict) with PSC

150

0.93

0.04

2.6

1.8

216.43

231.46

pmol/l

0.29

143

Traumatic amputation of wrist and hand

735

0.98

0.04

1.6

2.0

196.79

213.10

pmol/l

1.10

699

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1401

8815

1.00

0.04

1.9

190.96

198.29

pmol/l

1.79

1338

8391

Idiopathic pulmonary fibrosis

483

0.97

0.04

2.2

1.8

216.60

203.61

pmol/l

0.39

451

Other specified and unspecified strabismus

109

0.92

0.04

2.3

1.9

169.90

229.05

pmol/l

—

103

Somnolence

111

1.08

0.04

1.3

1.8

212.67

219.98

pmol/l

0.08

104

Other interstitial pulmonary diseases

125

1233

1.01

0.04

2.1

1.9

193.58

201.53

pmol/l

0.45

113

1151

Diseases of arteries, arterioles and capillaries (FINNGEN)

384

2665

0.99

0.03

1.9

1.8

199.78

217.49

pmol/l

2.85

364

2569

Eosinophilic disease (BM)

131

1.07

0.03

2.4

1.8

191.93

207.14

pmol/l

0.18

122

Malignant neoplasm of urinary organs

994

0.99

0.03

1.9

2.0

196.99

204.41

pmol/l

0.32

932

Pulmonary heart disease, diseases of pulmonary circulation

284

2858

0.99

0.03

2.1

1.9

189.96

200.21

pmol/l

0.77

271

2681

Interstitial lung disease endpoints

125

1236

1.01

0.03

2.1

1.9

193.58

201.40

pmol/l

0.44

113

1154

Interstitial lung disease

125

1236

1.01

0.03

2.1

1.9

193.58

201.40

pmol/l

0.44

113

1154

Other abnormal findings in urine

108

0.92

0.03

1.6

1.9

139.20

219.91

pmol/l

—

Schizoaffective disorder

104

1027

1.01

0.03

2.0

170.12

212.96

pmol/l

3.24

974

Ulcerative colitis (strict) with PSC

122

1.07

0.02

2.6

1.9

211.62

231.83

pmol/l

0.39

116

Crohn disease (strict definition, require KELA, min 2 HDR)

852

0.99

0.02

1.9

200.80

209.41

pmol/l

0.44

810

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

261

1.04

0.02

2.1

243.48

225.41

pmol/l

0.50

247

Respiratory tuberculosis, confirmed

128

0.94

0.02

1.3

1.9

171.17

221.39

pmol/l

0.99

119

Cardiomyopathy, other and unspecified

882

0.99

0.02

1.8

1.9

230.80

211.95

pmol/l

0.53

837

Burns classified according to extent of body surface involved

138

0.94

0.02

1.5

2.0

203.85

235.27

pmol/l

0.63

128

Eosinophilia

148

0.94

0.02

2.4

2.0

191.93

227.55

pmol/l

0.52

137

Demyelinating diseases of the central nervous system

769

1.01

0.02

1.6

1.9

220.38

201.86

pmol/l

0.72

727

ILD, hospital admissions

124

1228

1.01

0.02

2.1

1.9

193.07

201.72

pmol/l

0.50

112

1146

Golimumab

469

0.98

0.02

1.8

1.9

199.09

216.08

pmol/l

0.59

450

Tooth eruption problems

175

1701

0.99

0.02

1.8

173.46

184.28

pmol/l

0.63

162

1625

Use of teriflunomide

107

0.93

0.02

1.8

2.0

195.00

232.20

pmol/l

—

101

Other retinal disorders

761

5764

1.00

0.02

1.9

196.83

202.50

pmol/l

0.72

714

5448

Gastroduodenal ulcer

236

2340

1.01

0.02

1.9

202.57

200.78

pmol/l

0.09

224

2195

Explicit bacterial Sepsis, including avohilmo

117

1180

0.99

0.02

2.2

1.8

187.07

207.15

pmol/l

1.29

107

1117

Malignant neoplasm of kidney, except renal pelvis

929

0.99

0.01

1.9

2.0

199.35

204.76

pmol/l

0.20

868

Acute epiglottitis

207

0.97

0.01

1.8

1.7

186.00

209.30

pmol/l

0.52

191

Other diseases of peritoneum

213

1.03

0.01

2.0

172.91

195.62

pmol/l

0.72

200

Implicit Sepsis

1070

7865

1.00

0.01

2.0

1.9

187.77

202.97

pmol/l

4.48

998

7485

Volume depletion

758

0.99

0.01

2.1

1.8

177.44

210.96

pmol/l

1.95

720

ILD, hospital admission 2, with pulmonary infections

783

1.01

0.01

2.1

1.9

193.00

204.21

pmol/l

0.48

729

Hepatomegaly and splenomegaly, not elsewhere classified

106

0.94

0.01

3.2

1.8

157.00

223.69

pmol/l

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

102

1027

0.99

0.00

1.9

200.18

205.12

pmol/l

0.20

961

Malignant melanoma of skin

106

1067

0.99

0.00

1.7

1.9

203.43

201.32

pmol/l

0.08

998

Malignant neoplasm of larynx

144

1.04

0.00

1.9

223.80

214.37

pmol/l

0.13

134

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

166

0.96

0.00

1.6

1.9

184.31

207.63

pmol/l

0.37

156

Multiple myeloma

166

0.96

0.00

1.6

1.9

184.31

207.63

pmol/l

0.37

156

Drug-induced cataract

236

0.97

0.00

1.9

188.52

213.96

pmol/l

0.67

223

Malignant neoplasm of small intestine, including Hilmo

244

1.03

0.00

1.5

1.9

192.52

209.89

pmol/l

0.45

229

Injuries involving multiple body regions

456

0.99

0.00

2.0

1.9

221.76

212.38

pmol/l

0.12

432

Complications of labour and delivery

107

596

1.00

0.00

1.3

16.11

19.36

pmol/l

1.98

545

Familial hypercholesterolemia

132

1316

1.00

0.00

2.0

1.8

185.03

204.42

pmol/l

1.61

119

1236

MS-disease / Multiple Sclerosis

645

1.01

0.00

1.7

1.9

215.20

200.29

pmol/l

0.48

605

Fracture of neck

705

1.01

0.00

2.1

1.9

195.54

215.60

pmol/l

0.99

668

Colorectal neuroendocrine tumor and carcinoma

115

0.96

0.00

1.3

2.0

170.82

215.23

pmol/l

1.07

109

Arthropathy in ulcerative colitis

125

0.96

0.00

1.7

2.0

180.25

217.83

pmol/l

0.60

117

Contusion of toe(s) with damage to nail

155

0.97

0.00

2.2

1.8

127.47

225.28

pmol/l

2.07

148

Respiratory tuberculosis, confirmed, including avohilmo

134

0.97

0.00

1.2

1.9

170.08

221.57

pmol/l

1.15

125

Tularaemia

144

0.97

0.00

1.8

1.7

174.57

219.90

pmol/l

1.32

135

Localized skin eruption due to drugs and medicaments

1.03

0.00

1.8

2.0

138.60

227.36

pmol/l

—

Tularaemia, including avohilmo

214

0.98

0.00

2.1

1.9

186.05

215.45

pmol/l

1.01

202

Sixth [abducent] nerve palsy

266

1.02

0.00

2.0

1.9

190.41

210.69

pmol/l

0.65

251

Inflammation of lacrimal passages (acute and unspecified)

108

1.02

0.00

2.6

2.0

213.18

223.84

pmol/l

0.14

Acute otitis externa, noninfective

142

0.99

0.00

1.5

2.0

175.36

214.65

pmol/l

0.91

133

Moderate visual impairment, binocular

148

1.01

0.00

2.3

2.0

174.53

215.06

pmol/l

1.21

139

Perforation of tympanic membrane

974

1.00

0.00

2.1

1.9

196.07

208.19

pmol/l

0.52

921

Unspecified human immunodeficiency virus [HIV] disease

248

1.01

0.00

2.1

247.68

226.28

pmol/l

0.58

236

Congenital deformities of hip

101

0.99

0.00

1.5

293.50

193.94

pmol/l

—

Obstructed labour due to malposition and malpresentation of fetus

431

1.01

0.00

1.5

1.3

15.05

18.71

pmol/l

1.37

394

Arthropathy in Crohn disease

119

1.01

0.00

1.7

1.8

240.58

232.57

pmol/l

0.14

113

Exposure to uncontrolled fire in building or structure

121

0.99

0.00

2.1

1.7

191.58

228.62

pmol/l

0.61

112

Bacterial meningitis

409

1.00

0.00

1.7

2.0

197.61

208.53

pmol/l

0.31

389

Bitten or struck by other mammals

117

1169

1.00

0.00

1.8

1.9

210.36

197.40

pmol/l

0.43

111

1107

Pacemaker

326

3033

1.00

0.00

1.9

185.24

198.07

pmol/l

1.93

304

2823

Congenital malformations of the nervous system

203

0.98

0.00

2.0

170.90

210.61

pmol/l

0.98

193

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

165

1.03

0.00

1.5

1.8

228.24

210.19

pmol/l

0.25

159

Myelodysplastic syndrome, including Hilmo

173

0.98

0.00

1.4

1.8

169.47

204.35

pmol/l

1.37

162

Sequelae of intentional self-harm, assault and events of undetermined intent

107

1.03

0.00

1.7

2.0

214.18

222.30

pmol/l

0.07

102

Caries in Clefts patients

127

1.02

0.00

1.5

1.9

268.62

222.79

pmol/l

0.76

121

Effects of air pressure and water pressure

107

1.03

0.00

2.4

1.9

296.36

234.88

pmol/l

0.57

102

Hodgkin lymphoma, hilmo

345

1.01

0.00

1.8

1.9

207.49

212.91

pmol/l

0.09

327

Exclusion endpoint for supernumerary teeth

145

0.96

0.00

1.6

2.0

274.07

217.71

pmol/l

1.30

139

Nystagmus and other irregular eye movements

136

1.03

0.00

1.9

2.0

171.29

226.59

pmol/l

1.46

128

Pedestrian injured in collision with other nonmotor vehicle

0.00

0.0

1.4

—

156.25

—

Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]

0.00

0.0

1.3

—

206.00

—

Chronic bullous disease of childhood

0.00

0.0

1.7

—

216.50

—

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

0.00

0.0

1.9

—

185.43

—

Perioral dermatitis, drug-induced

0.00

0.0

1.3

—

294.89

—

Flexion deformity

0.00

0.0

1.0

—

181.50

—

Immobility syndrome (paraplegic)

0.00

0.0

1.0

—

144.80

—

Trichomoniasis

0.00

0.0

1.3

—

158.71

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

0.84

0.00

1.4

1.7

186.60

212.50

pmol/l

—

Histoplasmosis, including avohilmo

0.00

0.0

2.0

—

239.20

—

Brucellosis, including avohilmo

0.00

0.0

1.4

—

265.88

—

Brucellosis

0.00

0.0

1.4

—

191.29

—

Traumatic amputation of forearm

0.00

0.0

1.0

—

189.17

—

Other rickettsioses, including avohilmo

0.00

0.0

1.3

—

170.29

—

Agent resistant to multiple antibiotics

0.00

0.0

1.5

—

202.25

—

Bartonellosis

0.00

0.0

1.9

—

174.22

—

Injury of nerves at ankle and foot level

0.94

0.00

2.9

2.0

163.89

231.43

pmol/l

—

Arenaviral haemorrhagic fever, including avohilmo

0.00

0.0

1.6

—

172.00

—

Coccidioidomycosis

0.00

0.0

1.5

—

203.00

—

Other diseases of spinal cord

290

1.00

-0.00

2.8

1.9

203.69

219.27

pmol/l

0.27

273

Histoplasmosis

0.00

-0.00

0.0

2.0

—

239.20

—

Use of benzatropine

0.00

-0.00

0.0

1.4

—

281.60

—

Chronic respiratory disease originating in the perinatal period

0.00

-0.00

0.0

1.1

—

200.71

—

Congenital ovarian cysts

0.95

-0.00

1.0

1.2

18.57

14.50

pmol/l

—

Nephropathy induced by unspecified drug, medicament or biological substance

0.00

-0.00

0.0

1.5

—

178.83

—

Coccidioidomycosis, including avohilmo

0.00

-0.00

0.0

1.6

—

232.78

—

Neurological devices associated with adverse incidents

0.00

-0.00

0.0

1.4

—

209.75

—

Hereditary factor IX deficiency

0.00

-0.00

0.0

1.6

—

197.67

—

Other rickettsioses

0.00

-0.00

0.0

1.4

—

173.60

—

Phlebitis and thrombophlebitis of unspecified site, drug-induced

0.00

-0.00

0.0

2.1

—

227.43

—

Plasmodium vivax malaria, including avohilmo

0.00

-0.00

0.0

1.4

—

230.56

—

Cardiomyopathies, Secondary/extrinsic

0.94

-0.00

2.3

1.8

181.33

216.49

pmol/l

—

Plasmodium vivax malaria

0.00

-0.00

0.0

1.4

—

230.56

—

Cystic fibrosis with pulmonary manifestations

0.00

-0.00

0.0

1.1

—

291.33

—

Congenital lens malformations

0.94

-0.00

1.8

1.6

431.40

227.65

pmol/l

—

Q fever, including avohilmo

0.00

-0.00

0.0

2.8

—

196.67

—

Diphyllobothriasis and sparganosis

0.00

-0.00

0.0

1.6

—

180.14

—

Crushing injury of neck

0.00

-0.00

0.0

1.6

—

188.86

—

Phlebitis and thrombophlebitis of femoral vein, drug-induced

0.00

-0.00

0.0

2.2

—

205.20

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

0.97

-0.00

1.3

1.8

174.33

239.24

pmol/l

—

Yellow fever, including avohilmo

0.00

-0.00

0.0

2.2

—

197.60

—

Nosocomial condition (hospital)

0.98

-0.00

1.8

1.6

210.80

223.09

pmol/l

—

Wrist or foot drop (acquired)

0.00

-0.00

0.0

1.1

—

172.71

—

Ependymoma

0.00

-0.00

0.0

1.1

—

311.11

—

Sequelae of hyperalimentation

0.00

-0.00

0.0

1.9

—

231.33

—

Carcinoma in situ of other/unspecified male genital organs

0.00

-0.00

0.0

1.6

—

260.00

—

Accident to nonpowered aircraft causing injury to occupant

0.00

-0.00

0.0

1.2

—

407.00

—

Obstructive hydrocephalus

130

1.00

-0.00

2.1

1.8

222.00

225.58

pmol/l

0.05

120

Yellow fever

0.00

-0.00

0.0

2.2

—

197.60

—

Crushing injury of shoulder and upper arm

0.00

-0.00

0.0

1.2

—

264.78

—

Disorder of pancreatic internal secretion, other and/or unspecified

0.91

-0.00

3.5

1.9

240.33

217.23

pmol/l

—

Disorders of accommodation

0.00

-0.00

0.0

1.5

—

376.00

—

Alzheimer’s disease (undefined), excluding more controls

0.00

-0.00

0.0

1.2

—

234.56

—

Female pelvic inflammatory disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

24.60

—

Toxic effect of soaps and detergents

0.00

-0.00

0.0

1.7

—

253.14

—

Hereditary factor XI deficiency

0.00

-0.00

0.0

1.8

—

205.60

—

Alcohol abuse counselling and surveillance

320

1.00

-0.00

2.2

2.0

181.63

222.45

pmol/l

2.43

305

Hereditary erythropoietic porphyria

0.00

-0.00

0.0

2.4

—

232.44

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

0.00

-0.00

0.0

1.5

—

13.67

—

Impacted maxillary canine

0.88

-0.00

1.0

1.5

137.20

167.37

pmol/l

—

Palindromic rheumatism

0.91

-0.00

3.2

1.8

161.50

208.17

pmol/l

—

Ascariasis, including avohilmo

0.00

-0.00

0.0

1.2

—

229.80

—

Acrodermatitis chronica atrophicans

0.00

-0.00

0.0

1.9

—

180.00

—

Ischaemic infarction of muscle

0.00

-0.00

0.0

1.0

—

157.88

—

Eosinophilic cellulitis [Wells]

0.00

-0.00

0.0

1.2

—

186.20

—

Need for immunization against combinations of infectious diseases

0.00

-0.00

0.0

2.0

—

148.50

—

Toxic liver disease with cholestasis, drug-induced

0.00

-0.00

0.0

1.7

—

256.00

—

Excessive and redundant skin and subcutaneous tissue

0.00

-0.00

0.0

1.8

—

294.33

—

Delta-beta thalassaemia

0.00

-0.00

0.0

1.4

—

150.60

—

Abscess of spleen

0.00

-0.00

0.0

1.5

—

272.50

—

Secondary lactase deficiency

0.00

-0.00

0.0

1.6

—

206.57

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

0.90

-0.00

2.0

167.29

221.42

pmol/l

—

Echinococcosis

0.00

-0.00

0.0

1.5

—

195.83

—

Echinococcosis, including avohilmo

0.00

-0.00

0.0

1.5

—

195.83

—

Cystic fibrosis, other manifestations/unspecified

0.00

-0.00

0.0

1.0

—

315.71

—

Accessory breast

0.00

-0.00

0.0

1.4

—

23.20

—

Lymphocyte function antigen-1 [LFA-1] defect

0.00

-0.00

0.0

1.8

—

198.13

—

Acné excoriée

0.00

-0.00

0.0

1.0

—

362.80

—

Pseudomembranous colitis, drug-induced

0.00

-0.00

0.0

1.8

—

187.60

—

Conditions involving the integument and temperature regulation of fetus and newborn

0.00

-0.00

0.0

2.0

—

284.67

—

Immunodeficiency with increased immunoglobulin M [IgM]

0.00

-0.00

0.0

2.5

—

298.63

—

Hyperalimentation, other specified

0.00

-0.00

0.0

2.4

—

223.00

—

Iridocyclitis in diseases classified elsewhere

180

1.00

-0.00

1.9

1.8

219.72

220.42

pmol/l

0.02

170

Genetic anomalies of leukocytes

0.00

-0.00

0.0

1.4

—

170.40

—

Benign neoplasm of mesothelial tissue

0.00

-0.00

0.0

1.2

—

132.50

—

0.00

-0.00

0.0

1.1

—

166.56

—

Neonatal aspiration syndromes

0.00

-0.00

0.0

1.1

—

217.11

—

Other conditions originating in the perinatal period

0.00

-0.00

0.0

1.3

—

218.50

—

Kernicterus

0.00

-0.00

0.0

2.0

—

219.83

—

Other conditions of integument specific to fetus and newborn

0.00

-0.00

0.0

2.0

—

276.20

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Testosterone Free [Moles/volume] in Serum or Plasma by calculation

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS